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Membrane fusion is one of the most fundamental processes in living organisms.1 Main 
performances of natural membrane fusion are for example virus-host cell fusion, 
intracellular fusion (e.g. mitochondria fusion) and extracellular membrane fusion (e.g. 
sperm-egg fusion) (Scheme 1).2-4  
 
Scheme 1. Diagrammatic sketch of different kinds of natural membrane fusion. (A) indicates pathogen with host 
cell fusion. (B) indicates mitochondria fusion as an example of intracellular organelles fusion. (C) indicates sperm 
oocytes fusion as an example of extracellular fusion of eukaryotic cells. 
 
In order to achieve fusion, the two opposing membranes are first brought into close 
proximity, following by surface docking, and the formation of a stalk intermediate 
connecting the membranes. Before cargo transfer can occur, the stalk intermediate further 
develops in a hemifusion state, which is followed by a pore formation and expansion. 
(Scheme 2).5, 6 However, all these processes are energy driven. Studies show that 
membrane fusion proteins are in charge of the energy supply in whole process of 
membrane fusion.7  
 
 
Scheme 2. (A) Two opposing membranes in the pre-fusion state. (B) A point-like membrane protrusion minimizes 
the energy of the hydration repulsion between the proximal leaflets of the membranes coming into immediate 
contact. (C) A hemifusion stalk with proximal leaflets fused and distal leaflets fused and distal leaflets unfused. 
(D) Stalk expansion yields the hemifusion diaphragm. (E) A fusion pore forms either in the hemifusion diaphragm 
bilayer or directly from the stalk.5  
 
The SNARE (soluble N-ethyl maleimide sensitive factor attachment protein receptors) 




exocytic membrane fusion.8-10 However, understanding of membrane fusion at the 
molecular level is at a rather primitive stage due to the complexity of native fusogenic 
systems. According to Nobel prize laureate Sűdhof, how SNARE proteins promote fusion 
remains a major question in cell biology.11 Do SNAREs only bring the opposing 
membranes together, or is there another function to promote membrane fusion? 
Therefore, a bottom-up approach is proposed by several groups using synthetic analogues 
inspired by the natural fusion machinery in order to gain insight in coiled coil mediated 
membrane fusion. In this approach the chemical structure and composition of synthetic 
analogues can be systematically varied in order to study the influence of each segment on 
the fusion process. Thus, studying membrane fusion of this biomimetic model system will 
yield valuable information on the mechanism on a molecular level resulting in a better 
general understanding of coiled coil mediated membrane fusion. Inspired by this this 
fascinating process, our group mimicked the intricate natural SNARE proteins mediated 
membrane fusion into a simple coiled coil peptide complex mediated liposome fusion 
model.12  
The beauty of the reduced membrane fusion system is that all the fusion parts are artificial. 
In our model system, the natural membrane bilayer is replaced by a liposomal bilayer, and 
the SNARE protein coiled coil tetramer is replaced by heterodimeric coiled coil. Previous 
work has shown that this model system can achieve a high efficiency in targeted content 
mixing, which is the hallmark of natural fusion.12-19 Thus our model is a highly controllable 
supramolecular membrane fusion system. The study not only simplifies the membrane 
fusion study, but also opens new possibilities for membrane fusion applications, for 
example it may use as a drug delivery system or nanoreactors.  
 
 
Scheme 1. Schematic diagram of peptide coiled coil induced membrane fusion. (A) liposome membrane is drawn 
in close proximity to lipid bilayer by peptide Coil-K (red) and Coil-E (blue) electrostatic attraction. (B) Liposome 
is docking on surface of lipid bilayer by forming of CC-K/E coiled coil. (C) Accomplishment of membrane fusion 
between liposome and lipid bilayer. DOPE=1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; Peg12=12-




The aim of this thesis was to optimize the reduced membrane fusion model system 
resulting in more efficient content mixing in liposomal membrane fusion studies. One of 
the most essential parts to trigger our fusion model is peptide coiled coil complex. 
Therefore, this thesis starts with coiled coil zipping peptides studies, and following by the 
coiled coil mediated membrane fusion studies, in title of ‘zipping into fusion’.  
Chapter 2 investigates the coiled coil peptide quaternary structure by paramagnetic NMR 
spectroscopy. In this chapter, a new approach of investigating coiled coil self-assembly has 
been described. The innovation of the method is based on a combination of site-directed 
spin labeling and fluorescent aromatic amino acid labeling on peptides. Using this 
approach, coiled coil interactions can be studied by paramagnetic 1H-NMR and compared 
with steady state fluorescence measurements.  
Chapter 3 describes the design and characterization of an antiparallel tetrameric coiled coil 
complex. The coiled coil quaternary structure was determined using the approach described 
in Chapter 2 and confirmed with from experimental and theoretical modeling. Finally, the 
fusogenicity of the antiparallel tetrameric coiled coil was studied and compared with the 
original liposome fusion model. 
In Chapter 4, we tried to manipulate membrane fusion rate and efficiency by tuning either 
fusogen or lipid concentration. DLS and optical microscopy revealed that there are two 
fusion regimes – the fusion of thousands of liposomes through multiple fusion rounds into 
giant liposomes up to 10 μm in diameter, and the fusion of two liposomes. This mapping of 
the rate and route of liposome fusion under different conditions gives a detailed 
understanding of the capacity of the reduced SNARE model to fuse liposome membranes. 
This understanding paves the way for future applications of the minimal model such as 
controlled nanoreactor mixing and the directed delivery of drugs to cells. 
Chapter 5 describes attempts to control the rate of coiled coil driven membrane fusion. In 
this chapter, the thermal stability of the coiled coil motif was varied by changing the length 
of the peptides by using either two, three or four heptad repeat units. This study shows that 
the rate of liposome fusion can be manipulated by tuning coiled coil binding energy. 
In Chapter 6 the liposome fusion efficiency was increased by decreasing the tendency of 
the peptides to aggregate in the prefusion state. In this chapter, the charges of the peptides 
was varied by single amino acid mutations at specific positions. The binding energies of 




revealing that amino acid mutations at positions not critical for coiled coil formation can  
influence the tendency to aggregate in the pre-fusion stage. Further, the membrane fusion 
efficiency was investigated.  
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Here a new method to monitor the aggregation process and orientation of coiled coil 
peptide motifs is described. Peptides Coil-K and Coil-E which are designed to form a 
heterodimeric complex were labeled with aromatic FRET pair tryptophan (W) and tyrosine 
(Y) on the C-terminus respectively as a ‘fingerprint’ residue. One of the peptides was also 
labeled with the paramagnetic probe MTSL. Circular dichroism spectroscopy confirmed 
that the introduction of the MTSL label did not change the peptide secondary structure. 
One dimensional (1D)-proton NMR spectroscopy was used to study the peptide quaternary 
structure by monitoring the fluorophore aromatic NMR signal suppression due to 
proximity of the nitroxyl radical MTSL. 1D-NMR confirmed that peptide Coil-K and Coil-
E form a heterodimer coiled coil with a parallel orientation. In addition, fluorescence 
emission quenching of the aromatic residue due to electron exchange with a nitroxyl 
radical confirmed the parallel coiled coil orientation. Thus, paramagnetic nitroxide and 
aromatic fluorophore labeling of peptides yield valuable information on the quaternary 
structure from 1D-NMR and steady-state fluorescence measurements. This convenient 
method is useful not only to investigate coiled coil assembly, but can also be applied to 
other supramolecular assemblies or biomacromolecules with a defined structure.  
 
Introduction 
Coiled coils are a structural motif comprised of two to seven α-helices folding around each 
other in a superhelical fashion and are one of the important subunit motifs found in 
proteins.1-8 In nature, this versatile protein folding motif assembles in a wide range of 
structures with a variety of functions.9 One of the well-known coiled coil motifs are the so-
called SNARE proteins, which is at center of the highly controlled intracellular membrane 
fusion mechanism enabling cell-to-cell communication in the nervous system.10, 11 Recently, 
a model system for in vitro membrane fusion, mimicking the SNARE protein complex has 
been designed.12-15 Here, membrane fusion was achieved by a pair of complementary 
lipidated peptides comprised of the heterodimeric coiled coil pair CC-K/E.16 However, the 
details of the fusion mechanism are still unclear. To obtain a better view on the membrane 
fusion mechanism, the coiled coil peptide CC-K/E quaternary structure has been studied. 
Typically X-ray diffraction, disulfide exchange, electron paramagnetic resonance (EPR), 
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two-dimensional nuclear magnetic resonance (2D-NMR), 3D-NMR and even 4D-NMR 
techniques are employed to study the architecture of coiled coil peptide quaternary 
structures, for example the number of peptides in an assembly, the stoichiometry and their 
relative orientation.17-28 However most of these techniques require expensive and complex 
equipment, which is not always readily available. Therefore, it is valuable to develop 
simple method that only requires standard laboratory equipment.  
Here, a simple and easy method to investigate the coiled coil peptide assembly and 
orientation with a simple one-dimensional proton nuclear magnetic resonance (1H-NMR) 
and steady state fluorescence measurements is reported.  
To demonstrate our approach, the well-known E/K motif developed by Litowsky and 
Hodges was used as a model system. In recent years this coiled coil has been used by 
several groups in the field of supramolecular chemistry, polymers and membrane fusion.29-
35 The coiled coil peptides Coil-K (Ac-(KIAALKE)3-CONH2) and Coil-E (Ac-
(EIAALEK)3-CONH2) were labeled with tryptophan (W) and tyrosine (Y) at the C- 
terminus as a fluorophore FRET (fluorescence resonance energy transfer) pair respectively. 
Furthermore, the aromatic signals in 1D-proton NMR spectra are well-separated from all 
other proton signals. This allows for easy paramagnetic NMR spectroscopy analysis to 
determine the peptide orientation within the coiled coil motif. According to their 
characteristics in 1H-NMR and fluorescence measurements, W and Y are defined as the 
‘fingerprint’ functional group of peptide Coil-K and Coil-E respectively. 
In this study, the paramagnetic nitroxyl radical MTSL (S-(2,2,5,5-tetramethyl-2,5-dihydro-
1H-pyrrol-3-yl)methyl methanesulfonothioate) (see Appendix Part 6 for its chemical 
structure) was introduced at specific positions in the peptide to investigate the coiled coil 
assembly and peptide orientation.36, 37 In 1H-NMR, there are magnetic dipolar interactions 
if the distance between a nucleus and an unpaired electron of a paramagnetic center is 
within 13.0 Å radius, leading to paramagnetic relaxation enhancement (PRE).38-43 This 
increases the relaxation rate of the nuclear magnetization, and results in the suppression of 
the nucleus NMR signal.40, 44 As a result, the neighboring signal will be drastically 
suppressed when it is located within 10.5 Å of the spin label. For example, in a 1D-proton 
NMR experiment, the proton signals of W or Y will be significantly suppressed when they 
are in proximity of the paramagnetic MTSL probe. In addition, the fluorescence will also 
be quenched by the intermolecular electron-exchange interaction between the ground-state 




Y) when the distance is less than 12 Å.45-49 Thus in both NMR and fluorescence 
measurements, the proximity of a MTSL probe leads to signal suppression (See Appendix 
Figure A11 for the summary of the signal response regions from various measurements). 
An equimolar mixture of Coil-K and Coil-E peptide results in the formation of a 
heterodimeric coiled coil motif CC-K/E. Both C-termini will be in close proximity when a 
parallel orientation is adopted; but will be on opposite sides of the coiled coil when an 
antiparallel orientation is adopted (Scheme 1.).  
 
 
Scheme 1. Schematic illustration of designed peptides and coiled coil motifs. Coil-K 
peptides are labeled with a tryptophan(W) residue while Coil-E peptide are decorated with 
a tyrosine(Y) residue. A red helix represents peptide Coil-K, while a blue helix represents 
peptide Coil-E. Purple ball stands for tryptophan (W) labeled while green ball stands for 
tyrosine (Y) labeled. In this paper W and Y are always decorated on the C-terminus of all 
the peptides. A yellow star represents the MTSL- (*) nitroxyl radical spin label, which 
labeled either on C- or on N- terminus for investigating the possibility of CC-K/E parallel 
and antiparallel orientation respectively. Coiled coils formed by equimolar mixing of 
various Coil-K and Coil-E peptides are defined as CC-K/E. (See Table 1. for primary 
sequences of all peptides.) 
 
The paramagnetic 1D-proton NMR and steady state fluorescence study demonstrates that 
the peptide Coil-K and Coil-E are forming a parallel heterodimeric coiled coil CC-K/E in 
neutral PBS buffer (Phosphate Buffer Saline). This is the first time that a paramagnetic 
nitroxide moiety is used to determine unequivocally the orientation and assembly of 
peptide strands in a coiled coil motif. Furthermore the peptide assembly ratio can be 
determined within a hetero-coiled coil complex. This method does not disturb self-
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assembly and can be used to more complicate coiled coil motifs and allows broader 




Fmoc-protected amino acids and Rink Amide resin (0.53 mmol g-1) were purchased from 
NovaBiochem. HCTU (O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,2,2-tetramethyluronium 
hexafluorophosphate), HOBT (1-Hydroxybenzotriazole) and DIPEA (N,N-
Diisopropylethylamine) were from IRIS Biotech GmbH. NMP (N-methyl-2-pyrrolidone) 
and DMF (N,N-dimethylformamide) were from Biosolve. DCM (dichloromethane), TFE 
(2,2,2-Trifluoroethanol), TFE-D3 (2,2,2-Trifluoroethanol-d3), and deuterium oxide were 
obtained from Sigma-Aldrich. Acetic anhydride, piperidine, MeCN (acetonitrile), TFA 
(trifluoroacetic acid), and TIS (triisopropylsilane) were obtained from Fluka Chemie 
GmbH. MTSL ((S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl 
methanesulfonothioate) was obtained from Toronto Research Chemicals Inc. PBS buffer 
contains: 30 mM K2HPO4, 19 mM KH2PO4, 150 mM NaCl, pH=7.4. The pH value was 
adjusted with either 0.1 M HCl or 0.1 M NaOH. Tris buffer contains 1M tris (2-Amino-2-
hydroxymethyl-propane-1,3-diol), pH=7.0.  
 
Peptide Synthesis. 
Solid-phase peptide synthesis. 
Peptides were synthesized on a CEM-Liberty 1 Single Channel Microwave Peptide 
Synthesizer using standard Fmoc chemistry.50 Fmoc-protected Rink amide resin (0.53 
mmol g-1) was used to synthesize the peptides on a 0.25 mmol scale. The resin was swollen 
in DMF for 30 mins before use. Fmoc deprotection was performed using 20% (v/v) 
piperidine in DMF for 3 mins at 50 W with a maximum temperature of 80 ℃. Four 
equivalents of a Fmoc-amino acid, four equivalents of HCTU and five equivalents of 
DIPEA in DMF were used for amino acid coupling for 5 mins at 40 W with a maximum 
temperature of 80 ℃. For each amino acid coupling cycle, a deprotection and coupling 




mins at 0 W followed by 4 mins at 40 W with a maximum temperature of 50 oC was used. 
Two wash steps (1.5 mL DMF) were performed between every amino acid coupling cycle. 
All peptides were acetylated manually at the N-terminus after completion of the synthesis 
using 20% (v/v) acetic anhydride in DMF for 1.5 hour. Peptides without a cysteine residue, 
were cleaved from the resin and side-chain deprotected using a mixture of 
TFA/water/TIS=95:2.5:2.5 (v/v) for 1 hour.51 Peptides with a Trt (trityl-) protected cysteine 
residue were cleaved from the resin with simultaneous side-chain deprotection using 
TFA/thioanisole/ethandithiol/phenol/H2O=8.4:0.7:0.5:0.2:0.2 (v/v) for 3 hours at room 
temperature.52 The resulting solution was added drop-wise into an excess of 50ml cold 
diethyl ether to precipitate the deprotected peptide, followed by centrifugation and the 
liquid supernatant was removed. This procedure was repeated 3 times with the addition of 
fresh cold diethyl ether. All the peptides were dried under vacuum, dissolved in MilliQ 
water and lyophilized yielding a white powder.  
 
MTSL nitroxyl radical label. 
MTSL was conjugated to the peptide via a disulfide bond with the cysteine residue. One 
equivalent peptide (1 mM) was dissolved in 1 M tris buffer (pH=7.0) and five equivalents 
of MTSL in DMF (50 mM) were added slowly under an argon atmosphere and the final 
mixture was stirred for 3 hours at room temperature.53 Next, the samples were lyophilized 
and stored at -20 ℃ before purification. 
 
Peptide Purification. 
The crude peptides were purified by RP-HPLC, using a Shimadzu HPLC system with two 
LC-8A pumps, and an SPD-10A VP UV-VIS detector. Samples elution was monitored by 
UV detection at 214 nm and 254 nm. Purification of peptides was performed on a Vydac 
C18 reversed phase preparative column with a flow rate 15 mL min-1. Peptides were 
dissolved at a concentration of 5 mg ml-1 in a mixture of Acetonitrile/H2O/tert-
butanol=1:1:1 (v/v) and eluted with a linear gradient from B to A. Solvent A=acetonitrile, 
while solvent B=0.1% TFA in H2O. Acetylated peptides were purified using a 20 min 
gradient from 90% to 10% B, with a yield of 30%. MTSL labeled peptides were purified 
using a 25 min gradient elution from 80% to 20% B, with a typical yield of 20%. Purified 
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peptides were lyophilized and characterized by LC-MS using a Vydac C18 analytical 
column with a 1 mL min-1 flow rate. 
 
Circular Dichroism Spectroscopy. 
CD (circular Dichroism Spectroscopy) spectra were obtained using a Jasco J-815 
spectropolarimeter equipped with a peltier controlled thermostatic cell. The ellipticity is 
given as mean residue molar ellipticity, [θ] (103 deg cm2 dmol-1), calculated by Eqn (1).11, 
54  
 [θ] =  (θobs × MRW)/(10 × lc)                            (1) 
Where θobs is the ellipticity in millidegrees, MRW is the mean residue molecular weight, l 
is the path length of the cuvette in cm and c is the peptide concentration in mg/mL. 
A 1.0 mm quartz cuvette and a final concentration of 200 μM peptide in PBS (pH=7.4). 
Spectra were recorded from 250 nm to 200 nm at 25 °C. Unless stated otherwise data 
points were collected with a 0.5 nm interval with a 1 nm bandwidth and scan speed of 1nm 
per second. Each spectrum was an average of 5 scans. For analysis each spectrum had the 
appropriate background spectrum (buffer or 50% TFE) subtracted. 
For determination of the coiled coil thermal dissociation constant, temperature dependent 
CD spectra were obtained using an external temperature sensor immersed in the sample.55, 
56 The temperature was controlled with the internal sensor and measured with the external 
sensor. A 10 mm quartz cuvette was used, and the solutions were stirred at 900 rpm. 
Spectra were recorded from 250 nm to 200 nm, with data collected at 0.5 nm intervals with 
a 1 nm bandwidth and a scan speed of 1nm per second. The temperature range was 6 °C to 
96 °C with a temperature gradient of 2.0 °C/minute and a 60 s delay after reaching the set 
temperature. The spectrum of PBS at 6 °C (average of 5 scans) was subtracted from each 
spectrum. All the thermal unfolding curves were analyzed using a two-state conformation 
transition model.57, 58 
The data was analyzed using a two-state unfolding model to determine the fraction folded 
using Eqn. (2), 
Ff = ([θ] − [θ]U)/([θ]F − [θ]U)                           (2) 
Where [θ] is the observed molar ellipticity, [θ]U is the ellipticity at 222 nm of the denatured 




ellipticity at 222 nm of the folded state at that temperature as determined from a linear fit 
of the initial stages of the ellipticity vs. temperature curve. 
The fraction unfolded, FU, was calculated by Eqn. (3), 
FU = 1 − Ff                                    (3) 
The dimer dissociation constant in the transition zone was calculated using Eqn. (4), 
 KU = 2PtFU2/Ff                                  (4) 
Pt is the total peptide concentration. By taking the derivative of the ln(KU) vs. Temperature 
and using this in the van’t Hoff equation, Eqn. (5), the change in enthalpy associated with 
unfolding with temperature can be plotted:  
∆HU  =  RT2 ×  
dln(KU)
dT
                               (5) 
The gradient of enthalpy vs. Temperature plot ∆Cp, is the difference in heat capacity 
between the folded and unfolded forms, and can be used in the Gibbs-Helmholtz equation 
adapted to monomer-dimer equilibrium, Eqn. (6), to obtain the Gibbs free energy of 
unfolding as a function of temperature by least-squares fitting, 
               ∆GU = ∆Hm(1 − T/Tm) + ∆Cp[T − Tm − Tln(T/Tm)] − RTln[Pt]          (6) 
Tm and Hm is the temperature and enthalpy at the midpoint of the transition at which the 
fraction of monomeric peptide is 0.5.12 
 
1H-magnetic resonance spectroscopy. 
To monitor the aromatic region 1H-NMR signals in the range from 8 ppm to 6 ppm of the 
amino acid W and Y, the proton signals of the peptide amide bonds were suppressed by 
proton-deuterium exchange using D2O. Lyophilized peptide samples were dissolved at a 
concentration of 0.5 mg ml-1 and incubated in D2O for one hour, followed by lyophilization. 
This procedure was repeated three times. PBS (10ml, pH=7.4) was lyophilized and 
redissolved in D2O to prepare a PBS/D2O buffer solution. Peptide samples were prepared 
with a final concentration of 0.8 mM in PBS/D2O buffer solution. All 1H-NMR spectra 








Fluorescent experiments were conducted on a TECAN Infinite M1000 PRO fluorometer 
using a 96 well plate. The Z-position was 12500 μm, and the gain was optimized according 
to the amount of fluorophore in the sample. Excitation and emission slits were set at 5 nm. 
Emission spectra were measured from 290 nm to 450 nm in 1 nm steps at a fixed excitation 
wavelength of 275 nm. The temperature was set at 25℃. For consistent mixing, the plate 
was shaken inside the fluorometer for 30 seconds (2 mm linearly, 70 × per minute). The 
spectra were corrected by subtraction of PBS or PBS/ TFE=1:1 (v/v) spectra as a 
background spectrum. The concentration of peptide E or K was 20 μM in each 
measurement, with 250 μL volume of peptide solution in each well.  
 
Results and discussion 
Peptide design and synthesis. 
In this study the feasibility to use paramagnetic NMR and fluorescence spectroscopy to 
investigate the orientation of the complementary peptides in a coiled coil motif was 
explored. For this, the well-known shortest pair of heterodimeric coiled coil scaffold Coil-
K and Coil-E was used as a model system. These sequences were modified with an 
aromatic amino acid, either a tryptophan (W) or tyrosine (Y) at the C-terminus and the 
paramagnetic nitroxyl radical MTSL at selected position as the sensitive ‘signal 
suppression’ functional group (Table 1.).16, 18, 54 A Glycine residue was added between the 
aromatic fluorophore and the original peptide sequence to minimize any potential influence 
on the coiled coil assembly. Furthermore, a cysteine residue was introduced at either the C- 
or N-terminus in order to label the peptide with the paramagnetic nitroxide radical via a 
sited-directed spin labeling (SDSL) method. MTSL was introduced via a disulfide bond to 
a cysteine residue as ‘signal suppression’ functional group.59 The distance between the 
aromatic fluorophore and the nitroxide determines whether the signal is suppressed or not. 
Initially, MTSL was conjugated to the C-terminus of the peptide to probe the parallel 
assembly orientation in the coiled coil heterodimer. For comparison, the MTSL probe was 
placed at the N-terminus of the peptide to probe whether the antiparallel orientation would 




All peptides which are synthesis by standard Fmoc solid phase synthesis on Rink Amide 
resin, and further purified by C18 RP-HPLC are characterized by both MALDI-TOF MS 
and LC-MS mass spectrometry. Analytical HPLC confirmed the purity of the peptide to be 
99%, while UV measurements showed a purity of at least 95% (see Appendix).  
 

























2854 √ √ 
Coil-EY A
c-(EIAALEK)3GY










2833 √ √ 
 
a. Refers to 1D-proton NMR chemical signal for aromatic protons of tryptophan (W) and 
tyrosine (Y) in the range of 6-8 ppm. b. Refers to fluorescence emission spectra wavelength 
from 285-445 nm with excitation at 275 nm. Both 1H-NMR and fluorescence 
measurements were performed in presence of pH=7.4 PBS buffer. ‘√’ indicates there is 
signal observed while ‘×’ indicates there is no signal observed. 
 
Circular Dichroism Spectroscopy. 
As single mutations in an amino acid sequence might alter the propensity to form coiled 
coils, the secondary structures and binding properties of all the Coil-K and Coil-E peptides 
including their derivatives were studied using circular dichroism (CD) spectroscopy 
(Figure 1 and Table 2). These results showed that in PBS buffer (pH=7.4) there is no 
significant change in the peptide secondary structure after introduction of the aromatic 
amino acids and the spin-label MTSL. All single Coil-K and Coil-E peptides retained their 
α-helical signature with two minimal bimodal at 222 nm and 208 nm (Fig.1A and 1B). The 
α-helicity and value of [θ]222/[θ]208 increased when the peptides were measured in 1:1 (v/v) 
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TFE: PBS buffer as compared to the measurements performed in PBS buffer (Table 2). 
This indicates that all single peptides derivatives either with or without MTSL spin label 
consistently kept their ability to fold in a α-helix conformation. Thus, introduction of the 
MTSL label does not significantly alter the secondary structure of the peptides (CD spectra 
of the original Coil-K ((KIAALKE)3 ) and Coil-E ((EIAALEK)3 ) are shown in Appendix 
Figure A4) .  
Next, coiled coil formation of an equimolar mixture of Coil-K and Coil-E (including their 
MTSL derivatives) was studied, showing the typical coiled coil interactions with the helix 
content higher than 90% and the ratio of [θ]222/[θ]208 close to 1 (Figure 1C).60, 61 
Trifluoroethanol (TFE) is known to enhance the intramolecular α-helicity while disrupting 
intermolecular interactions.62, 63 Addition of TFE resulted in a lower [θ]222/[θ]208 ratio and a 
decreased α-helicity confirming the existence of a coiled coil complex CC-K/E (Figure 
1D).1 CD measurements on an equimolar mixture of peptide Coil-K and peptide Coil-E 
with or without MTSL label showed that this modification did not significantly alter the 






Figure 1. (A) CD spectra of secondary structure comparison of the peptides Coil-KW, Coil-
KW* and Coil-*KW were measured. (B) Secondary structure comparison of CD spectra from 
the peptides Coil-EY, Coil-EY* and Coil-*E. (C) Comparison of CD spectra of coiled coil 
motifs CC-K/E (including CC-KW/EY, CC-KW*/EY, CC-*KW/EY, CC- KW/EY*, CC-KW/*EY) 
from an equimolar mixture of Coil-K and Coil-E peptides in pH=7.4 PBS saline. (D) 
Comparison of the CD spectra of the coiled coil motifs CC-K/E (including CC-KW/EY, CC-
KW*/EY, CC-*KW/EY, CC-KW/EY*, CC-KW/*EY) from an equimolar mixture of Coil-K and 
Coil-E peptides in 1:1 (v/v) PBS: TFE. [Total peptide]= 200 μM, PBS, pH=7.4, 25 ℃. 
 
Table 2. Secondary and quaternary CD spectroscopic data of synthetic peptides used in 
this study. 
peptidea [θ]222 % α-helixb [θ]222/[θ]208 Coiled-coilc 
PBS 
50% TFE 
In PBS Benign 
50% TFE 
In PBS Benign 
50% TFE 
In PBS 
Coil-KW -13925 -19699 43 60 0.70 0.81 - 
Coil-KW* -15337 -19805 46 61 0.80 0.82 - 
Coil-*KW -15411 -20057 47 61 0.81 0.82 - 
Coil-EY -4748 -16080 14 50 0.53 0.78 - 
Coil-EY* -8180 -17727 25 54 0.61 0.78 - 
Coil-*EY -10119 -18886 31 58 0.70 0.80 - 
CC-KW/EY -28747 -23909 90 74 1.02 0.83 + 
CC-KW*/EY -31892 -24251 99 75 1.04 0.78 + 
CC-*KW/EY -31818 -260565 99 80 1.02 0.84 + 
CC-KW/EY* -33297 -267780 100 82 1.04 0.81 + 
CC-KW/*EY -31395 -25326 98 78 1.07 0.84 + 
a CC-K/E refers to equimolar concentration mixtures of the Coil-K and Coil-E peptides. b 
The percentage of α-helicity is calculated from 100 times the ratio between observed [θ]222 
to the predicted [θ]222 for an α-helical peptide of n residues. The predicted α-helicity is 
reckoned from formula: [θ]222=-4oooo×(1-4.6/n). 64, 65 c The signal + signifies a significant 
decrease in the [θ]222/[θ]208 ratio from benign to 50% TFE in PBS, indicative of the folded 
coiled-coil structure and vice versa. [Total Peptide]=200μM, PBS, pH=7.4, 25℃. 
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Next, the stoichiometry and binding energy of all coiled coil forming peptide pairs were 
determined. The binding stoichiometry of Coil-K and Coil-E mixtures was measured at a 
total peptide concentration of 200 μM with variable mol fractions of peptide Coil-K and 
Coil-E. A job-plot of [θ]222 as a function of the mol fraction of Coil-E peptide yields the 
binding stoichiometry.66, 67 For all CC-K/E (including their MTSL derivants) coiled coil 
complexes studied, a minimum of [θ]222 was always observed at an equimolar ratio of 
peptide Coil-K and Coil-E, indicating that peptide Coil-K (including MTSL derivants) and 
peptide Coil-E (including MTSL derivants) bind in a 1:1 stoichiometry (Figure 2A). This 
again proves that introduction of MTSL does not interfere with the classical 1 to 1 Coil-K 
and Coil-E heterodimerization (Original K/E stoichiometry see Appendix, Figure A5).  
The molar ellipticity at 222 nm is directly proportional to the amount of helical structure 
and therefore thermal denaturation curves provide information of their folding stabilities.64, 
68 Thus the thermodynamic stability of the CC-K/E pairs was determined by measuring the 
molar ellipticity at 222 nm wavelength as a function of temperature.11 All peptide pairs 
showed a smooth cooperative transition from an α-helical coiled-coil structure to a random 
coil conformation (Figure 2B). All transitions showed to be fully reversible by lowering the 
temperature (See Appendix Figure A6).  
 
 
Figure 2. (A) Mean residue molar ellipticities at 222 nm wavelength for mixtures of the 
Coil-K and Coil-E peptides as a function of the mol fraction of the Coil-E peptide. All the 
measurements were carried out at a total peptide concentration of 200 μM on 25℃, in 1 
mm quartz cuvette. (B) Thermal unfolding curves based on [θ]222 as a function of 
temperature. 1 cm quartz cuvette with stirring at 900 rpm was used. [Total peptide] = 40 




Temperature-dependent CD measurements showed that all the peptide complexes used in 
this study have an identical two-state transition denaturation process, dissociating from 
coiled coil to random coil. The binding parameters are summarized in Table 2. The 
dissociation constants for all coiled coils are in the same order of magnitude (10-8 M), 
showing that introduction of the MTSL residue does not influence the secondary structure, 
coiled coil formation and stability. 
 
Table 3. Dissiciation constants of E and K coiled coil complex from CD spectroscopy 
Coiled-coil Complex Tm(℃) b ∆Gu (kcal mol-1) c Kd (M) d 
CC-K/Ea 58 9.6 7×10-8 
CC-KW/EY 57 10.8 7.7×10-8 
CC-KW*/EY 56 11.6 6.4×10-8 
CC-*KW/EY 57 11.0 7.5×10-8 
CC-KW/EY* 56 11.8 6.5×10-8 
CC-KW/*EY 57 10.7 7.6×10-8 
a data taken from literature.11, 16 b Tm = melting temperature, at which half of the peptide is 




600 MHz 1H-nuclear magnetic resonance spectroscopy was used to study the peptide 
coiled coil complex formation of peptide Coil-K and Coil-E including orientation and 
binding stoichiometry. Tryptophan (W) and Tyrosine (Y) residues show characteristic 
aromatic signals with a chemical shift in the range of 6 to 8 ppm, which in this study were 
used as a ‘fingerprint’ region in peptide Coil-K and Coil-E respectively. To avoid overlap, 
the N-H signals were suppressed by ‘H-D exchange’. Typical NMR signals of tryptophan 
(W) and tyrosine (Y) in the 6-8 ppm range of peptide Coil-K and Coil-E separately are 
shown in (Figure 3 A/C, blue line). When a MTSL label is located close to the aromatic 
functional group in the same peptide, the aromatic signals are fully suppressed (Figure 3 
A/C, red line), due to paramagnetic relaxation enhancement (PRE).36, 41, 69-72 The linewidth 
of a proton signal will get significantly perturbed when the proton is within 13.0 Å from 
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the paramagnetic MTSL probe, and fully suppressed if the distance is less than 10.5 Å due 
to its fast transverse relaxation rate.19,43 Theoretical calculation using Hyperchem software 
showed that the average distance between the MTSL nitroxide radical and the aromatic 
protons of the Tryptophan (W) group is 6.6 Å in Coil-KW* while in peptide Coil-EY* the 
distance between MTSL and the aromatic Tyrosine (Y) group is 13.0 Å. Therefore a 
significant suppression of the NMR signals is observed (Figure 3 A/C, red line). In contrast, 
when the MTSL label is positioned on the N-terminus of the peptides, the distance between 
the nitroxyl radical and the tyrosine or tryptophan residues is too large in order to observe 
the PRE effect (Figure 3 A/C, black line). In peptide Coil-*KW, the average distance 
between radical and W is 36.7 Å while in peptide Coil-*EY the distance between radical 
and Y is 40.1 Å. Next, 1H-NMR spectra of the individual peptides were measured in 1:1 
(v/v) TFE: PBS solution to eliminate any line broadening caused by peptide aggregation 
and to induce maximum α-helicity.73 In NMR experiments, peptides aggregation results in 
the severe NMR signals decrease and line-broadening.18, 74-76 Even in TFE/PBS=1:1 (v/v) 
solution, a complete suppression of the aromatic proton was observed in Coil-KW* and 
Coil-EY* confirming that the NMR signal suppression is only due to intramolecular 






Figure 3. Aromatic region (6-8 ppm) of 600 MHz 1H-nuclear magnetic resonance spectra 
showing tryptophan indole and tyrosine hydroxyphenyl functional groups of Coil-K and 
Coil-E derivatives respectively. (A) From top to bottom are the aromatic signals of Coil-
KW, Coil-*KW and Coil-KW* in PBS. (B) From top to bottom are the aromatic signals of 
Coil-KW, Coil-*KW and Coil-KW* in 1:1 (v/v) PBS: TFE solution. (C) From top to bottom 
are the aromatic signals of Coil-EY, Coil-*EY and Coil-EY* in PBS. (D) From top to bottom 
are the aromatic signals of Coil-EY, Coil-*EY and Coil-EY* in 1:1 (v/v) PBS: TFE solution. 
[Total peptide]=0.8 mM. 
 
Next, the coiled coil assembly of all the peptide pairs has been investigated (CC-K/E, 
Scheme 1). In coiled coils, complementary peptides zip together into close proximity 
resulting in a tight peptide complex. Therefore the PRE effect can be utilized to probe 
coiled coil formation and the relative orientation of the peptides within the complex.  
When the MTSL label was positioned at the C-terminus of either Coil-K or Coil-E, it 
effectively gave suppression for both of their complementary peptides aromatic signals 
(Figure 4 A/C, compare blue and red trace). This indicates that peptide Coil-K and Coil-E 
assemble into a parallel coiled coil complex CC-K/E. In contrast, when the MTSL label 
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was positioned at the N- terminus, no PRE effect was observed, confirming the peptides 
parallel orientation (Figure 4 A/C, compare blue and black trace). 
Measuring the same peptide mixtures CC-K/E in 1:1 (v/v) TFE: PBS revealed the 
dissociation of the coiled coil complex as observed by the reappearance of the aromatic 
protons of the non-MTSL labeled peptide (Figure 4 B/D).  
 
 
Figure 4. Aromatic Region (6-8 ppm) of 600 MHz 1H-nuclear magnetic resonance spectra 
showing tryptophan indole and tyrosine hydroxyphenyl functional groups of equimolar 
mixtures of Coil-K and Coil-E (short name CC-K/E). (A) Aromatic signals of peptide CC-
K/E complex in PBS. Blue line indicates CC-KW/EY, black line indicates CC-*KW/EY and 
red line indicates CC-KW*/EY. (B) Aromatic signals of CC-K/E in 1:1 (v/v) TFE: PBS. 
Blue line indicate CC-KW/EY, black line indicates CC-*KW/EY and red line indicates CC-
KW*/EY. (C) Aromatic signals of CC-K/E in PBS. Blue line indicates CC-KW/EY, black line 
indicates CC-KW/*EY and red line indicates CC-KW/EY*. (D) Aromatic signals of CC-K/E 
in 1:1 (v/v) TFE: PBS. Blue line indicates Coil-KW/EY, black line indicates Coil-KW/*EY 





Next, 1H-NMR measurements were used to study the coiled coil binding stoichiometry. 
The molar ratio of Coil-K and Coil-E was varied from 2:1, 1:1 and 1:2 using peptides Coil-
KW* and Coil-EY (Figure 5 A). Parallel coiled coil formation results in PRE suppression of 
the tyrosine residue NMR signal at the Coil-EY peptide as well as the tryptophan residue 
NMR signal at peptide Coil-KW*, due to their close proximity with MTSL. The 
measurements show that at a 2:1 and 1:1 ratio, the aromatic NMR region is silent. However, 
at a 1:2 ratio of peptide Coil-KW* and Coil-EY, the tyrosine signals were visible. This 
shows that peptides Coil-K and Coil-E indeed form a 1:1 coiled coil complex as the excess 
of peptide Coil-EY is not bound to Coil-KW* and thus no longer suppressed. Measuring the 
1H-NMR spectrum of MTSL labeled peptide Coil-E and non-labeled peptide Coil-K 
mixtures confirmed this finding (Figure 5B). 
 
 
Figure 5. Aromatic region (6-8 ppm) of 600 MHz 1H-nuclear magnetic resonance spectra 
showing tryptophan indole and tyrosine hydroxyphenyl functional groups of different 
molar ratio mixtures of Coil-K and Coil-E. (A) Aromatic signals of peptide Coil-KW* and 
Coil-EY mixtures. From top to bottom, the molar ratio between Coil-KW* and Coil-EY is 2:1, 
1:1 and 1:2 respectively. (B) Aromatic signals of peptide Coil-KW and Coil-EY* mixtures. 
From top to bottom, the molar ratio between Coil-KW and Coil-*EY is 1:2, 1:1 and 2:1. 
[Total peptide]=0.8 mM 
 
Thus nitroxyl radical PRE ‘signal suppression’ in 1H-NMR experiments is a fast and 
reliable method to determine the peptide folding in a coiled coil motif, showing not only 
the peptide orientation but also the stoichiometry. 





To support 1H-NMR measurements, steady-state fluorescence spectroscopy was used to 
probe the orientation of peptide E and K in the coiled coils by monitoring fluorophore 
electron excited singlet state quenching.48 Within a 12 Å radius, fluorescence emission 
quenching occurs due to electron exchange interaction between the MTSL nitroxyl radical 
and a tryptophan (W) or a tyrosine (Y) fluorophore.46, 77-82 The degree of quenching is 
proportional to the electron exchange interaction, which is inverse proportional to the 
distance.83, 84  
Excitation at a wavelength of 275 nm results in fluorescence of both tryptophan and 
tyrosine residues. When a MTSL group is present at the C-terminus, significant 
fluorescence quenching was observed for Coil-KW* and Coil-EY* (Figure 6, blue line). 
However, when the MTSL label is positioned at the N-terminus, the quenching is almost 
absent (Figure 6, red line).  
 
 
Figure 6. Fluorescence emission spectra (extension at 275 nm) of fluorescent labeled 
peptides Coil-K and Coil-E 50 μM in pH=7.4 PBS buffer solution on 25 ℃. (A) Presents 
peptide Coil-KW (□) in black, Coil-*KW (○) in red and Coil-KW* (△) in blue. (B) Presents 
peptide Coil-EY (□) in blank, Coil-*EY (○) in red and Coil-EY* (△) in blue. Green arrow 
signs the fluorescence quenching position. 
 
In the CC-K/E coiled coils both the donor fluorophore tyrosine (Y) and the acceptor 
fluorophore tryptophan (W) are located at the C- terminus. If peptide Coil-KW and Coil-EY 
are adopting a parallel coiled coil orientation, the distance between W and Y is within the 




When the peptides assemble in an antiparallel fashion, no FRET will be observed.85 
Indeed, an equimolar mixture of peptide Coil-KW and Coil-EY results in an increased 
fluorescence signal of acceptor tryptophan (W) and a decreased fluorescence signal of 
donor tyrosine (Y) due to FRET, thus indicating a parallel coiled coil orientation of peptide 
E and K. In the presence of TFE, the energy transfer is lost due to the dissociation of coiled 
coil complex (Figure 7A).  
When the MTSL nitroxyl radical is close to the fluorophore on the C- terminus, the 
fluorophore signal will be quenched due to the electron exchange interaction (Figure 6). If 
the complementary peptide is close to the MTSL labeled peptide due to coiled coil 
formation with a parallel orientation, the signal of the complementary peptide fluorophore 
is also quenched (Figure 7 B/C). For example, in peptide Coil-KW*, the MTSL quenches 
the tryptophan signal. In an equimolar mixture of Coil-KW* and Coil-EY, the tyrosine (Y) 
is also quenched, indicating that the tyrosine is in the vicinity of MTSL due to coiled coil 
formation. This can only occur when peptide Coil-K and Coil-E assemble into a parallel 
heterodimer. Addition of TFE results in separation of the peptides and the tyrosine signal 
reappears (Figure 7B). This indicates that peptide Coil-K is close to peptide Coil-E with a 
parallel orientation in the coiled coil motif. 
The fluorescence quenching on the other peptide pair, Coil-EY* and Coil-KW has also 
been studied. In this complementary coiled coil forming peptide pair, peptide Coil-EY* 
was labeled with both the MTSL and Tyrosine (Y) at the C- terminus. As a result, the 
Tyrosine emission signal was quenched. In an equimolar mixture of Coil-EY* and Coil-
KW, the signal of Tryptophan (W) was significantly quenched but was recovered upon 
TFE addition due to the coiled coil dissociation (Figure 7C). This again proves the parallel 













Figure 7. Fluorescence emission spectra of fluorescence labeled peptides Coil-K, Coil-E 
and CC-K/E (an equimolar mixture of Coil-K and Coil-E) in pH=7.4 PBS buffer solution 
and in 1:1 (v/v) PBS: TFE on 25℃. [Total peptide]=50 μM. (A) Presents peptide Coil-KW 
(□) in black, Coil-EY (○) in red, CC-KW/EY (△) in blue and CC-KW/EY+TFE (▽) in pink. 
(B) Presents peptide Coil-KW* (□) in black, Coil-EY (○) in red, Coil-KW*/EY (△) in blue and 
Coil-KW*/EY+TFE (▽) in rosy. (C) Presents peptide Coil-EY* (□) in black, Coil-KW (○) in 
red, Coil-EY*/KW (△) in blue and Coil-EY*/KW+TFE (▽) in pink. Green arrow signs the 
fluorescence quenching position. 
 
Conclusions 
Here a new approach to investigate the supramolecular assembly of a well-known coiled 
coil pair, using a combination of 1H-NMR and fluorescence measurements has been shown. 
Labeling of the peptides with Tryptophan, Tyrosine and MTSL did not influence the 
secondary structure of the peptides. MTSL induced suppression of specific NMR signals 
enables the determination of the orientation and the stoichiometry in coiled coil motifs. 
Fluorescence quenching by MTSL using the same peptides confirmed the finding of the 
NMR studies. In this study aromatic fluorophore were used as the proton signals are well-
separated from the other peptide signals. In principle however, every proton signal could 
be used for this purpose, for example the amide signal.41 
Comparing with the existing methods to study coiled coil assembly, this method does not 
require changing of the environment (e.g. Crystallization necessary for X-ray diffraction) 
and avoid intermolecular interaction competition between chemical bond and hydrophobic 
core (e.g. disulfide exchange). The field of paramagnetic NMR spectroscopy is rapidly 
developing, and in this contribution the use in coiled coil assembly is shown. In addition, it 
is compatible with two- or multi-dimensional NMR, and the same peptides can be used for 
EPR measurements as well for further studies.86  
All the required manipulations are easily performed and with high efficiency. The careful 
choice in labeling combined with fast 1H-NMR, fluorescence measurement significantly 
simplifies they study of non-covalent interactions in coiled coil s or other supramolecular 
assemblies. Further development of this approach will extensively spread on investigation 
of not only the peptide quaternary structure, but also most self-assembly systems. 
   





Part 1. Mass spectra for all the purified peptides 
LC-MS spectra of all the purified peptides are shown in Figure A1. 
 
Figure A1. (A) LC-MS spectra of purified Coil-KW, (B) LC-MS spectra of purified Coil-
EY. From top to bottom: UV (ultraviolet-visible) spectrum, ESI (electrospray ionization) 























Figure A2. (A) LC-MS spectra of purified Coil-KW*, (B) LC-MS spectra of purified Coil-
EY*. From top to bottom: UV (ultraviolet-visible) spectrum, ESI (electrospray ionization) 























Figure A3. (A) LC-MS spectra of purified Coil-*KW, (B) LC-MS spectra of purified Coil-
*EY. From top to bottom: UV (ultraviolet-visible) spectrum, ESI (electrospray ionization) 
spectrum, and mass spectrum. 
 
Part 2. CD analysis for the Hodges Coil-K and Coil-E binding. 
 
Figure A4. CD-spectra of peptide Coil-K (Ac-(KIAALKE)3-CONH2), Coil-E (Ac-
(EIAALEK)3-CONH2), 1:1 mixture of Coil-K and Coil-E (CC-K/E) [total peptide]=200 






Table A1. CD spectroscopic data of Coil-K, Coil-E and equimolar mixtures thereof. 
 
Peptide a 
θ222 % α-helix b θ222/ θ208 
Coiled-coilc 





Coil-K -15010 -19788 48 63 0.86 0.92 - 
Coil-E -6016 -17067 19 55 0.6 0.78 - 
CC-K/E -27923 -23234 90 74 1.01 0.82 + 
 
a CC-K/E refers to an equimolar mixture of Coil-K and Coil-E. b The percentage α-helicity 
is calculated from 100 times the ratio between observed [θ]222 to the predicted [θ]222 for an 
α-helical peptide of n residues. The predicted α-helicity is calculated using the formula: 
[θ]222=-40000×(1-4.6/n).64, 65 c The + sign signifies a significant decrease in the [θ]222/[θ]208 
ratio from PBS to 50% TFE in PBS, indicative of the folded coiled-coil structure and vice 
versa. [Total Peptide]= 200 μM in pH=7.4 PBS at 25℃. 
 
 
Figure A5. (A) Job plot of the mean residue molar ellipticity (222 nm) for mixtures of 
Coil-K and Coil-E as a function of the mole fraction of the Coil-E peptide. All the 
measurements were carried out at a total peptide concentration of 200 μM in pH=7.4 PBS 
saline buffer on 25℃, in a 1 mm quartz cuvette. (B) Thermal unfolding curve based on 
changes in [θ]222 due to dissociation of coiled coil CC-K/E. [Total peptide]=40uM, PBS, 
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Part 3. CD association fraction folded transitions of all coiled coils. 
 
Figure A6. Thermal folding curve based on changes in [θ]222 as followed by CD by 
decreasing the temperature from 360 to 280 K. [Total peptide]=40 uM, PBS, pH 7.4, 1 cm 
quartz cuvette. 
 
Part 4. Hyperchem simulations87 
Hyperchem release 8.0 package has been used to simulate the peptide conformation and to 
determine the distance between MTSL and the aromatic amino acids in Coil-E and Coil-K. 
For this, Coil-K, Coil-E or their 1:1 complex were placed in a periodic box containing 
water molecules and the system was equilibrated at 300 K. The peptide can move in a 
constant-density environment which is similar to being in a liquid. The size of the box was 
set as a cube with W=H=D= 56.104 Å, and the minimum distance between solvent and 
solute atoms (atoms from peptides) is 2.3 Å.88 
Molecular Mechanics simulation was based on a classical Newtonian calculation. Here, 
atoms were treated as Newtonian particles interacting through a potential energy function, 
which depend on bond lengths, bond angles, torsion angles, and nonbonded interactions 
(including van der Waals forces, electrostatic interactions, and hydrogen bonds). In these 
calculations, the forces on atoms are functions of the atomic position. 
Furthermore, the AMBER force field which is typically used for developing proteins and 
nucleic acids was used to develop an all-atom model. The simulations were performed in 
standard way, with temperature at 300 K and 30 ps run time.  
Figures beneath shows the details of the peptide comformation zoom in to atom level after 
simulation. In general, Coil-K peptide secondary structure is shown in red color, Coil-E 




brown color. From Hyperchem simulation, information of the different distances between 
MTSL nitroxide radical with either proton on W or on Y have been gained as support 
information to the paramagnetic 1D-proton NMR spectra results (Figure A7-10).  
 
 
Figure A7. Structure tertiary structures of peptide Coil-KW* (A) and Coil- *KW (B). In A) 
D1 indicates the distance between nitroxyl group and the W in peptide Coil-KW*. The 





Figure A8. Structure of peptide Coil-EY* (A) and Coil- *EY (B). (A) the average distance 
D1= 13.0357 Å. (B) The average distance D2 = 40.0889 Å. 
 





Figure A9. Coiled coil CC-K/E quaternary structure between subunits Coil-K (red) and 
Coil-E (blue). (A) Quaternary structure of peptide coiled coil complex CC-KW*/EY, the 
average distance D1=8.9315 Å. (B) Quaternary structure of CC-*KW/EY, the average 
distance D2=37.2628 Å. 
 
       
 
Figure A10. Coiled coil CC-K/E quaternary structure between subunits Coil-K (red) and 
Coil-E (blue). (A) Quaternary structure of peptide coiled coil complex CC- KW/EY*, the 




distance D2=38.7715 Å. 
 
Part 5. The summary of the signal intensity associated with distance. 
 
Figure A11. The distance depended signal intensity of FRET, PRE or fluorescence 
quenching method. The black line indicates the response distance between the FRET pair 
(donor and acceptor) in fluorescence resonance energy transfer (FRET) measurement; the 
red line indicates the response distance between the aromatic fluorophore and the MTSL 
nitroxyl radical in paramagnetic 1H-NMR measurement; the blue line indicates the 
response distance between the fluorophore and the MTSL nitroxyl radical in fluorescence 
quenching measurement. 
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The complementary peptides Coil-K and Coil-E were designed to assemble into a 
heterodimeric coiled coil. In this chapter the effect of reversing the amino acid sequence of 
peptide Coil-E on complex formation with peptide Coil-K was investigated. Coiled coil 
assembly was studied using multiple techniques including circular dichroism, paramagnetic 
proton NMR, steady state fluorescence spectroscopy measurements, sedimentation 
equilibrium analytical ultracentrifugation and computational simulations. All results show 
that the reversed peptide Coil-Er folds with Coil-K to form a stable antiparallel coiled coil 
tetramer and not an antiparallel heterodimer as previously reported. Thus, this study shows 
that reversing the amino acid sequence of coiled coil peptides can strongly affect the self-
assembly process. Cholesterol modified peptide Coil-K and Coil-Er were tested as a model 
system for membrane fusion and its fusogenity was compared to the original model system. 
Lipid and content mixing assays showed no significant difference between the 
heterodimeric and the tetramer coiled coil mediated fusion. This indicates that peptide 




One of the most important vital vesicle trafficking processes is SNARE-dependent 
(SNARE: soluble N-ethylmaleimide-sensitive factor attachment protein receptor) 
membrane fusion.1-3 There are three key steps in this process: membrane surface 
conjugated SNARE proteins self-assemble as SNAREpins (a four-helix SNARE proteins 
coiled coil bundle), followed by docking of the two opposing lipid membrane resulting in 
full fusion and content transfer.4    
One of the reduced SNARE membrane fusion models is based on the complementary 
peptide pair Coil-K ([KIAALKE]3) and Coil-E ([EIAALEK]3).5 These two peptides were 
designed to assemble into a parallel heterodimeric coiled coil. In this reduced peptide-
induced membrane fusion model, the SNARE proteins are mimicked by lipidated 
conjugates of Coil-K and Coil-E.6-9 Upon mixing equimolar amounts of Coil-E modified 
liposomes with Coil-K liposomes, parallel coiled coil formation (CC-K/E) forces the two 
opposing membrane into close proximity resulting in full fusion of the liposomes.10, 11 
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Recently, there were two contradictory studies with the point of contention that whether the 
parallel zipper-like coiled coil motif orientation is required for membrane fusion. Two 
different approaches were used to design a non-zipper-like coiled coil motif orientation: the 
Diederichsen group designed an anti-parallel coiled coil motif in which the membrane 
anchor is located at both peptides C-terminus; while Kros designed parallel coiled coil 
forming peptides in which the membrane anchor is located at opposite peptide termini (See 
Appendix Figure A1).12, 13 In the first approach it was shown that a non-zipper-like coiled 
coil assembly inhibits membrane fusion, indicating the necessity of a zipper-like coiled coil 
orientation in the fusion process similar to the SNARE protein mediated fusion; In contrast, 
Kros showed that a non-zipper-like coiled coil motif also induces membrane fusion, 
indicating that the coiled coil orientation (i.e. parallel vs antiparallel) does not affect the 
rate of fusion with these short peptides. It is important to note that while the Kros group 
used the original Coil-K/Coil-E (CC-K/E) peptides; the Diederichsen group used Coil-E 
with a reversed amino acid sequence (i.e. Coil-Er). It was hypothesized that Coil-K with 
Coil-Er ([KELAAIE]3) would form an antiparallel dimeric coiled coil. However no 
experimental data supporting this assumption was given.  
The effect of reversing the amino acid primary sequence on self-assembly behavior has 
been studied before.14-16 However most of these studies on inverted protein/peptide focused 
on single protein/peptide intramolecular interactions and not on heterodimeric coiled coil 
motifs.17 Therefore we set out to study the assembly of Coil-K and Coil-Er and to find out 
whether an antiparallel heterodimer is formed (Scheme 1). 
For this, a variety of spectroscopic techniques were used to study the coiled coil assembly 
of Coil-E and Coil-Er with Coil-K. Circular Dichroism (CD) showed that the peptides Coil-
E and Coil-Er have a similar α-helical secondary structure. However, when mixed with an 
equimolar amount of Coil-K, different coiled coil assemblies were observed. While Coil-K 
and Coil-E form a parallel dimer, Coil-K and Coil-Er assemble into an antiparallel tetramer. 
Paramagnetic NMR and fluorescence studies revealed the antiparallel orientation. 
Furthermore, computer simulations and sedimentation equilibrium ultracentrifugation 
experiments confirmed the formation of a stable tetrameric species. This study thus showed 
that reversing the amino acid sequence of a hetero coiled coil motif can significantly alter 
its self-assembly behavior.5, 14, 18-20 Finally the fusogenity of cholesterol anchored Coil-K 






Scheme 1. Schematic representation of Coil-E, Coil-Er and their assembly with Coil-K. 
The green arrow indicates the orientation of peptide from N terminus to C terminus. An 
equimolar mixture of Coil-E with Coil-K yields a parallel dimer. An equimolar mixture of 




Fmoc-protected amino acids and Rink Amide resin (0.53 mmol g-1) were purchased from 
NovaBiochem. HCTU (O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,2,2-tetramethyluronium 
hexafluorophosphate), HOBT (1-Hydroxybenzotriazole) and DIPEA (N,N-
Diisopropylethylamine) were from IRIS Biotech GmbH. NMP (N-methyl-2-pyrrolidone) 
and DMF (N,N-dimethylformamide) were from Biosolve. DCM (dichloromethane), TFE 
(2,2,2-Trifluoroethanol), TFE-D3 (2,2,2-Trifluoroethanol-d3), and deuterium oxide were 
obtained from Sigma-Aldrich. Acetic anhydride, piperidine, MeCN (acetonitrile), TFA 
(trifluoroacetic acid), and TIS (triisopropylsilane) were obtained from Fluka Chemie 
GmbH. MTSL ((S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl 
methanesulfonothioate) was obtained from Toronto Research Chemicals Inc. PBS buffer 
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contains: 30 mM K2HPO4, 19 mM KH2PO4, 150 mM NaCl, pH=7.4. The pH value was 
adjusted with either 0.1 M HCl or 0.1 M NaOH. Tris buffer contains 1M tris (2-Amino-2-
hydroxymethyl-propane-1,3-diol), pH=7.0.  
 
Peptide Synthesis. 
Solid-phase peptide synthesis. 
Peptides were synthesized on a CEM-Liberty 1 Single Channel Microwave Peptide 
Synthesizer using standard Fmoc chemistry.21 Fmoc-protected Rink amide resin (0.53 
mmol g-1) was used to synthesize the peptides on a 0.25 mmol scale. The resin was swollen 
in DMF for 30 mins before use. Fmoc deprotection was performed using 20% (v/v) 
piperidine in DMF for 3 mins at 50 W with a maximum temperature of 80 ℃. Four 
equivalents of a Fmoc-amino acid, four equivalents of HCTU and five equivalents of 
DIPEA in DMF were used for amino acid coupling for 5 mins at 40 W with a maximum 
temperature of 80 ℃. For each amino acid coupling cycle, a deprotection and coupling 
time of 5 and 30 mins were used respectively. For cysteine coupling a cycle comprising 2 
mins at 0 W followed by 4 mins at 40 W with a maximum temperature of 50 oC was used. 
Two wash steps (1.5 mL DMF) were performed between every amino acid coupling cycle. 
All peptides were acetylated manually at the N-terminus after completion of the synthesis 
using 20% (v/v) acetic anhydride in DMF for 1.5 hour. Peptides without a cysteine residue, 
were cleaved from the resin and side-chain deprotected using a mixture of 
TFA/water/TIS=95:2.5:2.5 (v/v) for 1 hour.22 Peptides with a Trt (trityl-) protected cysteine 
residue were cleaved from the resin with simultaneous side-chain deprotection using 
TFA/thioanisole/ethandithiol/phenol/H2O=8.4:0.7:0.5:0.2:0.2 (v/v) for 3 hours at room 
temperature.23 The resulting solution was added drop-wise into an excess of 50 ml cold 
diethyl ether to precipitate the deprotected peptide, followed by centrifugation and the 
liquid supernatant was removed. This procedure was repeated 3 times with the addition of 
fresh cold diethyl ether. All the peptides were dried under vacuum, dissolved in MilliQ 






MTSL nitroxyl radical label. 
MTSL was conjugated to the peptide via a disulfide bond with the cysteine residue. One 
equivalent peptide (1 mM) was dissolved in 1 M tris buffer (pH=7.0) and five equivalents 
of MTSL in DMF (50 mM) were added slowly under an argon atmosphere and the final 
mixture was stirred for 3 hours at room temperature.24 Next, the samples were lyophilized 
and stored at -20 ℃ before purification. 
Peptide Purification. 
The crude peptides were purified by RP-HPLC, using a Shimadzu HPLC system with two 
LC-8A pumps, and an SPD-10A VP UV-VIS detector. Samples elution was monitored by 
UV detection at 214 nm and 254 nm. Purification of peptides was performed on a Vydac 
C18 reversed phase preparative column with a flow rate 15 mL min-1. Peptides were 
dissolved at a concentration of 5 mg ml-1 in a mixture of Acetonitrile/H2O/tert-
butanol=1:1:1 (v/v) and eluted with a linear gradient from B to A. Solvent A=acetonitrile, 
while solvent B=0.1% TFA in H2O. Acetylated peptides were purified using a 20 min 
gradient from 90% to 10% B, with a yield of 30%. MTSL labeled peptides were purified 
using a 25 min gradient elution from 80% to 20% B, with a typical yield of 20%. Purified 
peptides were lyophilized and characterized by LC-MS using a Vydac C18 analytical 
column with a 1 mL min-1 flow rate. 
 
Circular Dichroism Spectroscopy. 
CD (circular dichroism spectroscopy) spectra were obtained using a Jasco J-815 
spectropolarimeter equipped with a peltier controlled thermostatic cell. The ellipticity is 
given as mean residue molar ellipticity, [θ] (103deg cm2 dmol-1), calculated by Eqn (1).6, 25  
                  [θ] =  (θobs × MRW)/(10 × lc)                    (1) 
Where θobs is the ellipticity in millidegrees, MRW is the mean residue molecular weight, l 
is the path length of the cuvette in cm and c is the peptide concentration in mg/mL. 
A 1.0 mm quartz cuvette and a final concentration of 200 μM peptide in PBS (pH=7.4) 
were used. Spectra were recorded from 250 nm to 200 nm at 25 °C. Unless stated 
otherwise data points were collected with a 0.5 nm interval with a 1 nm bandwidth and 
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scan speed of 1nm per second. Each spectrum was an average of 5 scans. For analysis each 
spectrum had the appropriate background spectrum (buffer or 50% TFE) subtracted. 
For determination of the coiled coil thermal dissociation constant, temperature dependent 
CD spectra were obtained using an external temperature sensor immersed in the sample.26, 
27 The temperature was controlled with the internal sensor and measured with the external 
sensor. A 10 mm quartz cuvette was used, and the solutions were stirred at 900 rpm. 
Spectra were recorded from 250 nm to 200 nm, with data collected at 0.5 nm intervals with 
a 1 nm bandwidth and a scan speed of 1 nm per second. The temperature range was 6 °C to 
96 °C with a temperature gradient of 2.0 °C minute-1 and a 60 s delay after reaching the set 
temperature. The spectrum of PBS at 6 °C (average of 5 scans) was subtracted from each 
spectrum. All the thermal unfolding curves were analyzed using a two-state conformation 
transition model.28, 29 
The data was analyzed using a two-state unfolding model to determine the fraction folded 
using Eqn. (2), 
Ff = ([θ] − [θ]U)/([θ]F − [θ]U)                    (2) 
Where [θ] is the observed molar ellipticity, [θ]U is the ellipticity at 222 nm of the denatured 
state, as determined from the plateau of the ellipticity vs. temperature curve, and [θ]F is the 
ellipticity at 222 nm of the folded state at that temperature as determined from a linear fit 
of the initial stages of the ellipticity vs. temperature curve. 
The fraction unfolded, FU, was calculated by Eqn. (3), 
                                                        FU = 1 − Ff                                       (3) 
The dimer dissociation constant in the transition zone was calculated using Eqn. (4), 
                                                      KU = 2PtFU2/Ff                                    (4) 
Pt is the total peptide concentration. By taking the derivative of the ln(KU) vs. temperature 
curve and using this in the van’t Hoff equation, Eqn. (5), the change in enthalpy associated 
with unfolding with temperature can be plotted: 
                                                 ∆HU  =  RT2 ×  
dln(KU)
dT
                             (5) 
The gradient of the enthalpy vs. temperature plot ∆Cp, is the difference in heat capacity 
between the folded and unfolded forms, and can be used in the Gibbs-Helmholtz equation 
adapted to monomer-dimer equilibrium, Eqn. (6), to obtain the Gibbs free energy of 
unfolding as a function of temperature by least-squares fitting, 




Tm and Hm are the temperature and enthalpy at the midpoint of the transition at which the 
fraction of monomeric peptide is 0.5.9 
 
1H-magnetic resonance spectroscopy. 
To monitor the aromatic region 1H-NMR signals in the range from 6 ppm to 8 ppm of the 
amino acids W and Y, the peptide amide proton signals were suppressed by proton-
deuterium exchange using D2O. Lyophilized peptide samples were dissolved at a 
concentration of 0.5 mg ml-1 and incubated in D2O for one hour, followed by lyophilization. 
This procedure was repeated three times. PBS (10 ml, pH=7.4) was lyophilized and 
redissolved in D2O to prepare a PBS/D2O buffer solution. Peptide samples were prepared 
with a final concentration of 0.8 mM in PBS/D2O buffer solution. All 1H-NMR spectra 




Fluorescence experiments were conducted on a TECAN Infinite M1000 PRO fluorometer 
using a 96 well plate. The Z-position was 12500 μm, and the gain was optimized according 
to the amount of fluorophore in the sample. Excitation and emission slits were set at 5 nm. 
Emission spectra were measured from 290 nm to 450 nm in 1 nm steps at a fixed excitation 
wavelength of 275 nm. The temperature was set at 25℃. For consistent mixing, the plate 
was shaken inside the fluorometer for 30 seconds (2 mm linearly, 70 × per minute). The 
spectra were corrected by subtraction of PBS or PBS/ TFE=1:1 (v/v) spectra as a 
background spectrum. The concentration of peptide E or K was 20 μM in each 
measurement, with 250 μL volume of peptide solution in each well.  
 
Sedimentation Equilibrium Analytical Ultracentrifugation 
Sedimentation equilibrium analytical ultracentrifugation measurements were conducted 
using a Beckamn-Optima XL-I analytical ultracentrifuge fitted with an An-60 Ti rotor. 
Peptide solutions were prepared in PBS buffer, pH 7.4, at peptide concentrations which 
gave an initial absorbance in the range 0.2-0.6 A.U. The samples were spun at three speeds 
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(between 34,000-50,000 rpm) at 20 oC. The data was then fitted to a single-ideal species 
model using Ultrascan.30 
 
Molecular simulation 
All simulations were carried out with the GROMACS molecular dynamics package using 
the version 2.1 of the MARTINI coarse-grained force field and its extension to proteins.31-
33 Using this model, the association behavior of several proteins in model membranes has 
been already simulated and the computational results show good agreement with previous 
atomistic simulations or experiment.34-36 To characterize the self-assembly process of Coil-
Er and Coil-K peptides, we have performed 20 independent simulations of four peptides 
(two Coil-Er and two Coil-K) randomly distributed in solvent (water with Na+ and Cl- ions). 
The starting coarse-gained structures for the Coil-K have been mapped from the 20 
atomistic models of the exactly same peptide reported by Hodges group using NMR.37 The 
structures for the Coil-Er were mapped from 20 coordinates frames obtained during 
atomistic simulation of a generated α-helical peptide in solution. Before carrying out the 
MD (molecular dynamics) simulations, a steepest descent minimization was performed, 
followed by relaxation of the solvent (position restrains on the whole peptide) and of the 
side chain beads (position restraints on the peptide backbone). After this, the system was 
further simulated without any restraints to allow self-assembly and equilibration of the 
formed supramolecular structures for at least 40 microseconds. The detailed description of 
the model and the simulation conditions are given in the appendix. 
 
Results and discussion 
Peptide design and Synthesis. 
In this study, Coil-K retains its original sequence whilst Coil-Er was designed with the 
reversed amino acid sequence from Coil-E (Table 1). Tryptophan (W) and Tyrosine (Y) 
were attached to the C- terminus of peptide Coil-K and the N- terminus of peptide Coil-Er 
respectively to allow for quantification and analytical studies. A glycine was introduced in 
order to act as a spacer. This results in derivatives Coil-KW and Coil-YEr. To study the 




to the C-terminus of Coil-KW by introduction of the MTSL to a cysteine. When MTSL is 
conjugated to the C-terminus, it yields peptide Coil-KW*; whereas on the N-terminus, 
peptide Coil-*KW will be generated. This approach offers the opportunity to investigate the 
intermolecular self-assembly stoichiometry and the relative peptide orientation by 
paramagnetic proton NMR and steady state fluorescence measurements.  
 


















































-CONH2  2324 N/A N/A N/A 
Coil-YEr Ac
-YG(KELAAIE)3
-CONH2  2544 N/A √ √ 
      
a. ‘D’ short for distance, ‘*’ denotes the position of the ‘MTSL’ spin label and ‘W’ 
denote for the tryptophan residue, indicating the distance between the MTSL and the 
tryptophan functional group. Distances between the ‘*’ paramagnetic nitroxide and the 
tryptophan play a decisive role in both the NMR and fluorescence signal of ‘W’. Within 
10.5 Å, the NMR signal of W will get totally suppressed while its fluorescence signal gets 
quenched.38-48 b Refers to 1D-proton NMR chemical shifts from 6-8 ppm. c Refers to 
fluorescence emission spectra from 285-445 nm with excitation at 275 nm. Both NMR and 
fluorescence measurements were performed in presence of pH=7.4 PBS buffer. ‘√’ 
indicates there is signal observed while ‘×’ indicates there is no signal observed. 
 
All peptides were synthesized by standard Fmoc solid phase synthesis on Rink Amide resin 
and further purified by C18 RP-HPLC. Peptides were identified using LC-MS mass 
spectrometry and analytical HPLC results confirm that the purity of the peptides is higher 









Circular Dichroism spectroscopy 
Circular dichroism spectroscopy was used to study the secondary structure of the peptides. 
Both Coil-K and Coil-Er show α-helical structures with two minima at 222 nm and 208 nm 
wavelength in phosphate buffered saline (PBS, pH=7.4) at room temperature. The 
equimolar mixture shows typical coiled-coil characteristics with the [θ]222/[θ]208 
ellipticity ratio > 1 (Figure 1A).49 To further investigate the peptide secondary structure, 
TFE was added. TFE is known to enhance intramolecular α-helicity while disrupting any 
intermolecular interactions (i.e. coiled coil assemblies).50 Comparison of the [θ]222/ [θ]208 
ellipticity ratio and α-helix values before and after TFE addition showed that in both 
peptides Coil-K and Coil-Er, the [θ]222/[θ]208 ellipticity ratio and α-helix values increases, 
indicative of monomeric α-helices. In contrast, for the equimolar peptide complex CC-K/Er, 
both the ellipticity ratio and helicity decreased, indicating the disturbance of intermolecular 
coiling, affirming the existence of coiled coils (Table 2).51   
 
 
Figure 1. Circular dichroism spectra of peptide Coil-K, Coil-Er and their 1:1 mixture. (A) 
Secondary structures of peptide Coil-K, Coil-Er and their equimolar mixture CC-K/Er in 
pH=7.4 PBS buffer, as well as CC-K/Er in TFE/PBS=1:1 (v/v) solution. (B) Binding 
stoichiometry of the peptide Coil-K and Coil-Er. Mean residue molar ellipticities at 222 nm 
wavelength for mixtures of the Coil-K and Coil-E peptides as a function of the mol fraction 
of the Coil-E peptide. [Total peptide]= 200 μM, PBS, pH=7.4, 25 ℃. 
 
Furthermore, CD spectra were also used to determine the coiled coil binding properties. 
First the Coil-K and Coil-Er binding stoichiometry was measured using a Job-plot by 




peptide concentration constant at 200 μM (i.e. Plotting [θ]222 as a function of the mole 
fraction of Coil-Er). A minimum molar ellipticity at [θ]222 was observed when Coil-K and 
Coil-Er were mixed with equimolar amounts, indicative of a 1:1 stoichiometry (Figure 1B). 
 
Table 2. Secondary and quaternary CD spectroscopic data of CC-K/Er. 
 
Peptide a 
[θ]222 % α-helix b [θ]222/[θ]208 Coiled-Coilc 
Benign 50% TFE Benign 50% TFE Benign 50% TFE 
Coil-K -14105 -19965 45 64 0.82 0.85 - 
Coil-Er -5758 -16476 18 53 0.83 0.85 - 
CC-K/Er -29163 -23280 93 75 1.13 0.87 + 
 
a CC-K/Er refers to an equimolar concentration of Coil-K and Coil-Er. b The percentage of 
α-helicity is calculated from 100 times the ratio between observed [θ]222 and predicted 
[θ]222 for an α-helical peptide of n residues. The predicted α-helicity is determined from the 
formula: [θ]222=-40000×(1-4.6/n). 52, 53c The signal + signifies a significant decrease in the 
[θ]222/[θ]208 ratio from PBS to 50% TFE in PBS, indicative of the folded coiled-coil 
structure and vice versa. [Total Peptide]=200 μM, PBS, pH=7.4, 25℃. 
 
Next, the thermal stability of CC-K/Er was determined by plotting the molar ellipticity at 
222 nm as a function of temperature.6,52 The transition showed to be reversible (Figure 2). 
 
 
Figure 2. The thermal dissociation and association curves of CC-K/Er, indicated by the 
temperature dependent value of [θ]222. (A) Reveals decreasing absolute values of [θ]222 due 
to the disassembly of the CC-K/Er complex by temperature increase. (B) Reveals 
increasing absolute values of [θ]222 due to the assembly of the CC-K/Er complex by 
temperature decrease. [Total peptide]= 40 μM, PBS, pH=7.4. 
 
 




CC-K/Er showed to have a two-state transition from 100% folded to 0% folded. The Tm 
was determined from the unfolding curve to be 58 oC (Figure 3A). The enthalpy of the 
temperature dependent unfolding curve was calculated from the Van’t Hoff plot (Figure 
3B). For the CC-K/Er complex, the enthalpy value increases linearly with rising 
temperature, which is the expected behavior for a two-state transition (Figure 3C). 40  The 
gradient of the enthalpy-temperature curve is the heat capacity between the folded complex 
state and the unfolded monomer state.54 The positive value (0.26 kcal mol-1 K-1) of the heat 
capacity indicates that nonpolar surfaces are exposed to water during dissociation of the 
coiled coil complex.55 Using the heat capacity value, the change in free energy of unfolding 
at different temperatures was calculated to be 9.6 kcal mol-1 (Figure 3D). This is similar to 
the original CC-K/E (See Appendix Figure A5). The dissociation constant at 25 oC 
associated with this ΔGH2O value is 6.4×10-8 M. This value is close to the reported 7.0×10-8 
M for CC-K/E (Table 3).25 
 
Figure 3. Thermal unfolding properties of CC-K/Er. (A) Thermal dissociation curve of 




the thermal denaturation of CC-K/Er. The dissociation constant at 25 oC is Ku = 6.4 ×
10−8 M. (C) Shows the linear dependence of the enthalpy of unfolding of CC-K/Er on 
temperature. (D) Describes the free energy associated with the unfolding of CC-K/Er as a 
function of temperature. The least-squares fit gives a ΔGH2O value at 25 oC of 9.6 kcal/mol. 
[Total peptide]= 40 μM, PBS, pH=7.4.  
 
Table 3. Coiled coil dissociation constant measured from CD spectroscopy. 
 
Coiled-coil Complex Tm (oC) b ∆Gu (kcal mol-1) c Kd (M) d 
CC-K/E a 58 9.6 7×10-8 
CC-K/Er 58 9.6 6.4×10-8 
 
a data taken from literature and we further confirmed by repeating the measurements (See 
Appendix).5, 6  b Tm = melting temperature, at which 50% of the coiled coil complex was 
dissociated. c Gibbs free energy of unfolding at 25℃. d Kd = the dissociation constant. 
 
Comparison of the CD spectra of CC-K/E and CC-K/Er did not show any significant 
differences. Remarkably, the binding energy was almost identical. To this point, CC-K/E 
and CC-K/Er showed to behave similarly. 
 
1H-proton NMR spectroscopy 
600 MHz 1H-nuclear magnetic resonance spectroscopy was used to study the orientation 
and assembly stoichiometry of the coiled coil scaffold CC-K/Er. Paramagnetic NMR 
spectroscopy was used to investigate the peptide quaternary structure. With this method, 
one can easily recognize the complementary coiled coil peptide orientation and assembly 
stoichiometry of the complex by determining whether suppression of the peptide specific 
proton signals due to the paramagnetic relaxation enhancement (PRE) effect. 56 
For this, the peptides need to have a functional group with a characteristic NMR signal and 
one of the peptides is modified with a signal suppressing paramagnetic spin label. In this 
study, Tryptophan (W) and Tyrosine (Y) were used to label the C- terminus of Coil-K and 
the N- terminus of Coil-Er respectively, as the characteristic aromatic signals are well 
separated from the other signals (i.e. Coil-KW and Coil-YEr). In addition, the paramagnetic 
spin label MTSL was introduced onto either the N- or the C-terminus of Coil-KW, yielding 
Coil-*KW or Coil-KW*. To avoid spectral overlap of the aromatic protons with N-H amide 
protons, the latter were suppressed by ‘H-D exchange’ before each NMR experiment.  
The aromatic region of tryptophan (W) has four multiplets while tyrosine (Y) shows two 
doublets within the 6 to 8 ppm range. Peptide Coil-KW* shows full suppression of the 
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tryptophan signals (Figure 4). This is due to the MTSL nitroxide PRE effect. PRE 
suppression only occurs when a nucleus is in close proximity with the paramagnetic center 
(< 13 Å), and full suppression occurs within a 10.5 Å radius.46 In peptide Coil-KW*, the 
average distance between the tryptophan aromatic protons and the nitroxyl radical is 6.6 Å, 
resulting in suppression of the aromatic protons. In contrast, in peptide Coil-*KW the 
average distance between the aromatic protons and the nitroxyl radical is 36.7 Å and 




Figure 4. Aromatic region (6-8 ppm) of 600 MHz 1H-nuclear magnetic resonance spectra 
showing tryptophan indole and tyrosine hydroxyphenyl functional groups of Coil-K and 
Coil-E derivatives respectively. (A) The aromatic signal of Coil-YEr, Coil-KW, Coil-*KW 
and Coil-KW* in PBS buffer. (B) The aromatic signal of single peptides in the presence of 
50% TFE in PBS buffer. [Total peptide]= 0.8 mM, 25 oC. 
 
An equimolar mixture of peptide Coil-KW and Coil-YEr and their MTSL labeled variants 
were studied in PBS at room temperature to obtain information regarding the relative 
peptide orientation (Figure 5). When the peptides are assembled into coiled coils, the 
characteristic knobs-into-holes packing leads to the close distance of the peptides identical 
termini, but the distance of the opposite termini is too large for the PRE effect (length of 
Coil-K = 37.1 Å).37 Thus the PRE effect can be used to determine the peptide orientation 
during self-assembly of the coiled coil. It is obvious that the tyrosine aromatic signals in 
Coil-YEr, only gets suppressed when an antiparallel orientation is adopted in coiled coil 
formation with Coil-KW*. This was indeed observed (Figure 5). Recovery of the tyrosine 




This strongly suggests that peptide Coil-KW and Coil-YEr form an antiparallel coiled coil 
motif. An equimolar mixture of Coil-*KW and Coil-YEr did not show suppression of the 
tyrosine signal, thereby supporting the antiparallel orientation (Figure 5).  
 
 
Figure 5. Aromatic Region (6-8 ppm) of 600 MHz 1H-nuclear magnetic resonance spectra 
showing tryptophan indole and tyrosine hydroxyphenyl functional groups of equimolar 
mixtures of Coil-K and Coil-E (short name CC-K/E). (A) Aromatic signals of peptide CC-
K/E complex in PBS. Blue line indicates CC-KW/YEr, pink line indicates CC-*KW/YEr and 
red line indicates CC-KW*/YEr. (B) Aromatic signals of CC-K/E in 1:1 (v/v) TFE: PBS. 
Blue line indicates CC-KW/YEr, pink line indicates CC-*KW/YEr and red line indicates CC-
KW*/YEr. [Total peptide]= 0.8 mM, PBS, pH=7.4, 25 oC. 
 
Next, the stoichiometry of Coil-K and Coil-YE coiled coil formation was investigated by 
paramagnetic NMR. First, Coil-KW* and Coil-YEr were mixed in a 2:1 molar ratio (Figure 
6). Here the tyrosine aromatic proton signals are fully suppressed. This was also observed 
for the equimolar mixture. However, when Coil-KW* and Coil-YEr were mixed in 1:2 molar 
ratio, tyrosine aromatic protons were observed. This is indicative that there is an excess of 
Coil-YEr which is not suppressed. This shows that Coil-K and the reverse sequence Coil-Er 













Figure 6. Aromatic region (6-8 ppm) of 600 MHz 1H-nuclear magnetic resonance spectra 
showing tyrosine hydroxyphenyl functional groups of different molar ratio mixtures of 
Coil-KW* and Coil-YEr. (A) From top to bottom, the molar ratio between Coil-KW* and 
Coil-YEr is 2:1, 1:1 and 1:2 respectively. [Total peptide]=0.8 mM, PBS, pH=7.4, 25 oC. 
 
Steady state fluorescence spectroscopy 
To confirm the relative peptide orientation in the coiled coil, steady state fluorescence 
spectroscopy studies were performed using FRET (fluorescence resonance energy transfer) 
or fluorescence quenching assays. The fluorescence emission spectra of the individual 
peptides are shown in Figure 7. Typical spectra were obtained except for Coil-KW*, due to 
the presence of spin label in the vicinity of the tryptophan (vide infra).  
FRET only occurs when the donor and acceptor are within the Förster Distance (≈ 1 nm).57 
When a mixture of Coil-YEr and Coil-KW forms coiled coils with an antiparallel orientation, 
FRET between the donor tyrosine and the acceptor tryptophan is expected. Indeed, FRET 
was observed using an excitation wavelength of 275 nm. From the emission spectra in 
Figure 8A, it is noticeable that when an equimolar mixture of Coil-KW and Coil-YEr is used, 
the Coil-KW fluorescence intensity increases while the Coil-YEr fluorescence intensity 
decreases due to the FRET phenomenon leading to the energy transfer from the donor Y to 
the acceptor W. This confirms the small distance between the N-terminus of peptide Coil-
YEr and the C-terminus of peptide Coil-KW, implying an antiparallel orientation of CC-




increase of tyrosine fluorescence, and a decrease of tryptophan fluorescence. Thus addition 




Figure 7. Fluorescence emission spectra of W and Y on peptide Coil-KW and Coil-YEr and 
their derivatives are shown with excitation at 275 nm. [Total peptide]= 50 μM, PBS, 
pH=7.4, 25 oC. 
 
This FRET assay strongly suggests an antiparallel orientation of the peptides in the coiled 
coil, but it might not be accurate enough to distinguish between dimeric or multimeric 
assemblies. 
Therefore a fluorescence quenching assay was performed. In fluorescence spectroscopy 
measurements, the fluorophore electron excited singlet state will be quenched when a 
stable nitroxyl radical is within a distance of 12 Å due to an electron exchange 
interaction.39, 41, 58-63 For example, tryptophan fluorescence is quenched in peptide Coil-KW*, 
as the distance to the nitroxyl radical of the MTSL label is shorter than 12 Å; while in 
peptide Coil-*KW no quenching is observed as the distance between the nitroxyl radical and 
tryptophan is longer than 12 Å (Figure 7) . 
Here, peptide Coil-KW* and peptide Coil-YEr were utilized to confirm the antiparallel 
orientation of the peptides in CC-K/Er. In an equimolar mixture of these two peptides, the 
fluorescence signal of Coil-YEr is quenched (Figure 8B). Addition of 50% TFE resulted in 
the dissociation of the coiled coil. As a result, the distance between Coil-KW* and Coil-YEr 
increases, and the tryptophan fluorescence was observed. These findings further proof that 
the CC-K/Er coiled coil motif has indeed an antiparallel orientation.    




Figure 8. Fluorescence emission spectra of W and Y on single peptides and in the coiled 
coil complex are shown with excitation at 275 nm. (A) presents the fluorescence spectra of 
Coil-KW and Coil-YEr, and their equimolar mixture emission FRET spectra in PBS buffer 
as well as emission spectra in TFE/ PBS=1:1 (v/v). The green arrow indicates the signal 
increase of W and the yellow arrow indicates the signal decrease of Y. (B) presents the 
single peptide fluorescence spectra of Coil-KW* and Coil-YEr, and their equimolar mixture 
emission quenching spectra in PBS buffer as well as emission spectra in TFE/ PBS=1:1 
(v/v). The yellow arrow indicates the signal decrease of Y. [Total peptide]=50 μM, 25 oC. 
 
In summary, FRET and fluorescence quenching experiments show strong evidence for the 
antiparallel peptide orientation in the CC-K/Er coiled coil motif. This result further 
supports the finding of the paramagnetic NMR study.  
 
Sedimentation Equilibrium 
To determine the oligomer state of the CC-K/Er species in solution, sedimentation 
equilibrium measurements were performed using ultracentrifugation (AUC). Datasets were 
fitted to a single-ideal species model using Ultrascan and the average mass of the species 
was determined to be 10,620 Da, with 95% confidence limits (determined by Monte Carlo 
analysis) to be +57 Da, -64 Da. There are no systematic residuals for the fitting. Hence, 
















Molecular simulation  
All the experimental data has shown so far that in an equimolar mixture of Coil-K and 
Coil-Er, coiled coils are only formed with an antiparallel orientation of the peptides. 
However, the exact arrangement of the peptides within this tetramer is still unknown. To 
have further information about the peptide orientation of the peptides within the tetramer, 
molecular simulations were performed. In all the simulations, the randomly distributed 
peptides (two Coil-K and two Coil-Er) spontaneously aggregated into supra-molecular 
structures. The four peptides first came into contact, and then orientate parallel to each 
other forming a 4-helix-bundle with a hydrophobic core. The aggregation process itself is 
relatively fast, approximately 0.5 microseconds, while 20 to 40 microseconds are needed 
for equilibration (each peptide rotation around its own axis or flipping to optimize the core). 
After equilibration, each peptide makes two longitudinal interfaces with two neighboring 
peptides, and the final cylinder is ~2.5 nm in diameter and the height. 
All the possible tetramer configurations can be classified in two major classes: (1) having 
four K-Er interfaces or (2) having two K-Er interfaces, together with one K-K and one Er-
Er interface. Likewise all the formed interfaces may be in parallel or in antiparallel 
orientation. This gives eleven distinct possible conformations for the obtained tetramers. 
Our self-assembly simulations show two possible tetramer structures with high forming 
probability and stability: one with two K-Er interfaces and the other with four K-Er 
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interfaces. Both of these complexes have antiparallel orientations between Coil-K and 
Coil-Er helices, but the two copies of both Coil-K and Coil-Er are taking parallel 
orientations (Figure 10). 
These simulations compliment the experimental techniques by providing information about 
binding motifs or conformations in the tetramers. As these binding conformations in 
solution are currently inaccessible for experimental imaging techniques, this is an 
important result. To decisively determine the most stable conformations by CGMD (coarse 
grained molecular dynamics), the systems should be equilibrated for considerably 
increased timescales and/or free energies should be extracted for all eleven possible 
conformations. Before such an effort is undertaken, one should judge whether the 
additional insight gained by such a study outweighs the huge computational investment 
required for such an analysis. Supported by our well-chosen computational setup, i.e. 
avoiding a bias in the starting conditions, and the observation of a complete reorientation 
event within simulation time for the heterodimer case, we are confident to conclude that 
the most probable binding conformations are indeed sampled by our CGMD simulations. 
Thus, this simulation showed unequivocally that Coil-K and Coil-Er assemble in a tetramer 























Figure 10. Two possible CC-K/Er tetramer configurations resulting from molecular 
dynamics simulations. Up is the lateral view and down is the top view. (A) shows CC-K/Er 
antiparallel tetramer with two K-Er interfaces. (B) shows CC-K/Er antiparallel tetramer 
with four K-Er interfaces.  
 
Liposome fusion study 
By using various analytical techniques it has been demonstrated that combining peptides 
Coil-K and Coil-Er leads to the formation of anti-parallel tetrameric coiled coils, whereas 
peptides Coil-K and Coil-E form parallel dimeric coiled coils. Remarkably, these two 
peptide pairs have a similar binding energy. Once incorporated into liposomal membranes, 
peptides Coil-K and Coil-E have shown to induce efficient and targeted membrane fusion.6 
Here the contest of the aggregation state and orientation vs. binding energy of the coiled 
coil complexes on the ability to induce membrane fusion was investigated (Scheme 2). For 
this reason, fusogenic peptides were synthesized which consist of three distinct segments: 1) 
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the peptide segment, which serves as the recognition unit, 2) a hydrophobic anchor, which 
enables the stable anchoring of the peptides into liposomal membranes and 3) a hydrophilic 
spacer, which supplies the peptides with the ability to reorient in order to form coiled coil 
motifs efficiently.13 The peptide segment consisted of Coil-K, Coil-E or Coil-Er, whereas 
the anchor was constituted by cholesterol and the spacer by 12-polyethylene glycol 
(PEG12). The resulting lipidated peptides are denoted CPK, CPE and CPEr. Peptide 
decorated liposomes were prepared (lipid composition: DOPC/DOPE/CH, 2/1/1 molar 
ratio and 1 mol% lipidated peptide) by mixing appropriate amounts of lipid and lipidated 
peptide stock solutions (in CHCl3 and CHCl3/MeOH 1/1 respectively), evaporating the 
solvent, addition of PBS buffer (yielding a total lipid concentration of 0.1 mM) and 
sonication for 1 minute at 50°C. A typical fusion experiment was performed by combining 
equimolar amounts of Coil-K decorated liposomes with Coil-E or Coil-Er decorated 
liposomes. The characterization of the fusion events was performed by optical density 




Scheme 2. Schematic diagram of liposome fusion. (A) zipper like fusion model: parallel 
dimeric coiled coil induced liposome fusion, the blue helix indicates the Coil-E peptide. (B) 
Non-zipper like fusion model: antiparallel tetrameric coiled coil induced liposome fusion, 
the blue helix indicates the Coil-Er peptide. Common symbols: light blue bilayer 
vesicle=liposome; red helix=Coil-K; green anchor=Cholesterol; light blue linker=PEG12; 





Upon combining Coil-K decorated liposomes with Coil-E (or Coil-Er) decorated liposomes, 
an increase in particle size is expected due to coiled coil formation. The particle size 
increase can reflect fusion events and/or aggregation and was determined by measuring the 
optical density of the mixed liposomes at λ=400 nm. A rapid increase in size was observed 
for both vesicle combinations (equimolar amount of CPK-liposome with CPE-liposome or 
with CPEr-liposome), which indicates that both coiled coil motifs are formed efficiently 
(Figure 11A).  
 
 
Figure 11. (A) Optical density measurements at λ=400 nm. (B) Dynamic light scattering of 
liposome fusion size increasing. Black line shows plots of equimolar mixture of Coil-K 
decorated liposome with Coil-E decorated liposome, while red line shows plots of 
equimolar mixture of Coil-K decorated liposome with Coil-Er decorated liposome. 
Liposome concentration is 0.25mM with 1% peptide decoration. All the measurements 
were done in PBS, pH 7.4, at 25 oC. 
 
DLS measurements confirmed these results and indicated that aggregates of particles >1 
µm were formed (Figure 11B). Next, lipid mixing experiments were performed to 
investigate the extent to which both coiled coil motifs were able to induce lipid mixing. For 
this assay, a FRET pair was incorporated in the membrane of the Coil-K decorated 
liposomes (donor: DOPE-NBD and acceptor: DOPE-LR). Upon lipid mixing of these Coil-
K liposomes (CPK-L) with Coil-E liposomes (CPE-L) or Coil-Er liposomes (CPEr-L), the 
average distance between donor and acceptor increases, giving rise to an increase in donor 
emission. The donor emissions were continuously measured for 30 minutes and the results 
show no notable differences between parallel and anti-parallel coiled coil formation, both 
coiled coil orientations are able to induce fusion between liposomes in an efficient manner 
(Figure 12A).  




Figure 12. (A) Fluorescence traces showing lipid mixing between fluoresecence 
(NBD/LR) labeled CPK liposomes with non-fluoresence labeled CPE or CPEr liposomes. 
(B) Content mixing between non-fluorescent CPK liposomes with sulforhodamine labelled 
(20mM) CPE or CPEr liposomes. Black line shows plots of equimolar mixture of CPK 
liposomes with CPE liposomes, while red line shows plots of equimolar mixture of CPK 
liposomes with CPEr liposomes. Liposome concentration is 0.1 mM with 1% peptide. All 
the measurements were performed in PBS, pH 7.4, at 25 oC. 
 
However, full fusion is defined as lipid and content mixing and therefore we proceeded by 
performing a content mixing assay. Here, Coil-E or Coil-Er decorated liposomes were 
loaded with sulforhodamine B at a self-quenching concentration of 20 mM. Content 
mixing of these Coil-E or Coil-Er decorated liposomes with the non-fluorescent Coil-K 
liposomes decreases the concentration of sulforhodamine B, which results in relief of self-
quenching and an increase in fluorescence intensity (Figure 12B). Consistent with the lipid 
mixing experiments, no significant difference in content mixing was observed between 
both coiled coil motifs, both orientations and oligomer states induce efficient content 
mixing. This indicates that for this peptide mediated fusion system, the coiled coil binding 




Reversing the peptide sequence of Coil-E yields Coil-Er which in the presence of 
equimolar amounts of Coil-K, results in the formation of an antiparallel tetrameric coiled 




sequence significantly alters the assembly behavior, which is in line with previous studies 
on proteins.5, 6, 37, 51  
Remarkably, the binding energy is similar but the oligomer state and relative peptide 
orientation are different. This study shows that reversing the amino acid sequence in a 
heterodimeric parallel coiled coil motif significantly alters its self-assembly property and 
one cannot assume that it yields an antiparallel heterodimer, as previously reported.12, 64 
This study demonstrates that a coiled coil assembly is sensitive to small changes and care 
should be taken when redesigning the amino acid sequence of known coiled coil structures. 
In addition, this study offers a new coiled coil candidate for the reduced SNARE induced 
membrane fusion model study. Cholesterol modified peptide Coil-K and Coil-Er induced 
liposome fusion comparable to the Coil-K and Coil-E induced liposome fusion. This 
suggests that in this peptide mediated membrane fusion system, the coiled coil binding 





























Part 1. Non-zipper like liposome fusion model. 
 
 
Figure A1. Schematic diagram of (A) Diederichsen and (B) Kros non-zipper like liposome 
fusion model. Red helix indicates peptide Coil-K ([KIAALKE]3), purple helix indicates 
peptide Coil-Er ([KELAAIE]3), blue helix indicates peptide Coil-E ([EIAALEK]3). The 
orange ball indicates the peptide N-terminus. 
 
Part 2. Mass spectra of the peptides 
LC-MS spectra of all the purified peptides are shown below (Figure A 2-4).  
 
Figure A2. (A) LC-MS spectra of purified Coil-K, (B) LC-MS spectra of purified Coil-Er. 
From top to bottom: UV (ultraviolet-visible) spectrum, ESI (electrospray ionization) 





Figure A3. (A) LC-MS spectra of purified Coil-KW, (B) LC-MS spectra of purified Coil-
YEr. From top to bottom: UV (ultraviolet-visible) spectrum, ESI (electrospray ionization) 
spectrum, and mass spectrum. 
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Figure A4. (A) LC-MS spectra of purified Coil-KW*, (B) LC-MS spectra of purified Coil-
*KW. From top to bottom: UV (ultraviolet-visible) spectrum, ESI (electrospray ionization) 
spectrum, and mass spectrum. 
 
Part 3. UV measurement for peptide concentration calculation 
Lyophilized peptides may contain anywhere 10%~70% bound water and salts by weight. 
Therefore, it is better to ascertain the actual peptide concentration by UV spectroscopy. 
The W and Y chromophore labeled peptide Coil-K and Coil-E concentration can be 
conveniently determined as follows: 
1. Molar extinction coefficients (Ɛ) of chromophoric residues at neutral pH using a 1 
cm cell:65, 66 
Tryptophan (W) 5690 AU/mmole/ml, peak at 280.8 nm wavelength. 
Tyrosine (Y) 1490 AU/mmole/ml, peak at 275.5 nm wavelength. 
2. Calculations: peptide concentration (mol/L) =(Apeak×DF)/Ɛ, where Apeak is the 
actual absorbance of the solution at peak value in a 1 cm cuvette, DF is dilution factor, 


















Part 4.CC-K/E CD thermal denaturation dissociation constant 
calculation 
Summary of the original CC-K/E temperature denaturation parameters. 
 
Figure A5. Thermal unfolding properties of CC-K/E. (A) Describes thermal dissociation 
curve of coiled coil complex CC-K/E, disassembling from 100% folding to 0% folding. 
Melting temperature is 331.15 K. (B) Describes the Van’t Hoff plot of the thermal 
denaturation of CC-K/E. The dissociation constant at 25 oC is Ku = 7.0 × 10−8 M. (C) 
Describes the dependence of the enthalpy of unfolding of CC-K/E on temperature. (D) 
Describes free energy associated with the unfolding of CC-K/E as a function of 
temperature. The least-squares fit gives a ΔGH2O value at 25 oC of 9.33 kcal/mol. [Total 
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Part 5. Hyperchem simulation of peptide structure67 
Hyperchem release 8.0 package was used to simulate the peptide conformation and to 
determine the average distance between the spin label and the W (Tryptophan) aromatic 
amino acids in both peptide Coil-KW* and Coil-*KW. 
For this, both Coil-K peptides were placed in a periodic box containing water molecules 
and the system was equilibrated at 300 K. The peptide can move in a constant-density 
environment which is similar to being in a liquid. The size of the box was set as a cube 
with W=H=D= 56.104 Å, and the minimum distance between solvent and solute atoms 
(atoms from peptides) is 2.3 Å.88 
Molecular Mechanics simulation was based on a classical Newtonian calculation. Here, 
atoms were treated as Newtonian particles interacting through a potential energy function, 
which depend on bond lengths, bond angles, torsion angles, and non-bonded interactions 
(including van der Waals forces, electrostatic interactions, and hydrogen bonds). In these 
calculations, the forces on atoms are functions of the atomic position. 
Furthermore, the AMBER force field which is typically used for developing proteins and 
nucleic acids was used to develop an all-atom model. The simulations were performed at 
300 K with a 30 ps run time. Figures A6 shows the peptide comformation after simulation. 
 
Figure A6. Structure of peptide Coil-KW* (A) and Coil-*KW (B). In A) D1 indicates the 
distance between nitroxyl group and the W in peptide Coil-KW*. The average distance D1 






Part 6. Molecular simulation 
In the Martini model, groups of atoms (typically four) are united into specific interaction 
centers that absorb all the molecular detail of the replaced atoms. The coarse-grained 
particles interact via Lennard-Jones potential (with different well depth parameters 
depending on the specific pair type), screened electrostatic Coulomb potential, while the 
connectivity of the molecules is modeled by elastic bonds and angle potentials. By 
reducing the number of particles and the complexity of the interactions between them, 
longer simulation times can be achieved. Each of the five types of amino acids: E, A, I, L 
and K, constituting either Coil-K or Coil-Er, is described at the coarse-grained level by an 
apolar interaction site representing the backbone and one or more interaction sites 
representing the side chains. The superposition of the atomistic and the coarse-grained 
representations of the CC-K/E coiled-coil structure is shown in Figure A7. The interaction 
parameters (hydrophobicity and polarity) for the coarse-grained particles have been set to 
closely reproduce the difference between particle’s solvation free energy in polar and in 
apolar media. The α-helicity of the peptides is imposed through dihedral potentials along 
the backbone beads during the simulations. 
 
Figure A7. Lateral and top views of the parallel CC-K/E, as reported by Hodges group by 
NMR measurements. Red backbone stands for the secondary structure of peptide Coil-K; 
while blue backbone stands for the secondary structure of either peptide Coil-E. Green 
bead is Glutamic acid (E); cyan bead is Lysine (K); green bead is Isoleucine (I); yellow 
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bead is Leucine (K) amino acid. Alanine (A) amino acid is omitted here. For each peptide, 
the starting amino acid on N-terminus is colored in black. In the lateral view, the atomistic 
structure is overlaid, in transparent licorice representation. 
In a typical simulation for this study, two Coil-K and two Coil-Er peptides are randomly 
distributed (position and rotation randomness) in an 11 nm × 11 nm × 11 nm simulation 
box and solvated by water and ions, mimicking the buffer solution. At completion, the 
system consists of ~10000 coarse-grained particles: four peptides (21 amino acids for each), 
water particles (one coarse-grained water particle representing four real water moleules) 
and ions (Na+ and Cl-). Periodic boundary conditions in all directions were employed. 
Standard MARTINI simulations were used.32 The Berendsen thermostat and barostat kept 
the temperature (t=300 K) and pressure (P=1 atm, isotropically) constant; the integration 
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The fusion of lipid membranes is essential for the delivery of chemicals across biological 
barriers to specific cellular locations. Intracellular membrane fusion is particularly precise, 
and is critically mediated by SNARE proteins. To allow membrane fusion to be better 
understood and harnessed, a simple bottom-up model in which synthetic fusogens replicate 
the essential features of SNARE proteins has been used to mimic this important process. In 
our fusogens, the coiled-coil molecular recognition motif of SNARE proteins is replaced 
by the coiled-coil E/K peptide complex, which is one ninth the size. The peptides are 
anchored in liposome membranes via pegylated lipids. Here, how the liposome fusion 
process is controlled by different parameters within the minimal model has been discussed. 
The lipopeptide fusogens form specific coiled coils that dock liposomes together, resulting 
in the merging of membranes via the stalk intermediate. Unusually for model systems, the 
lipopeptides can rapidly lead to fusion of entire liposome populations and the liposomes 
can undergo many rounds of fusion. The rate and extent of fusion and the number of fusion 
rounds can be manipulated by adjusting the fusogen and liposome concentrations. For 
example, these parameters can be tuned such that tens of thousands of ~100 nm liposomes 
fuse into a single giant liposome ~10 μm in diameter, alternatively, conditions can be 
selected such that only two liposomes fuse. The improved understanding of membrane 
fusion shows how application-specific fusion attributes can be achieved, and paves the way 




The fusion of biological membranes is a very significant process as it allows the delivery 
of molecules across lipid bilayers, barriers that are usually impervious to the molecules. 
Intracellular membrane fusion, which is mediated by SNARE-proteins, is of particular 
interest as it is highly controlled in terms of which membranes will fuse and the location of 
fusion. The mechanism relies on the specific coiled-coil interaction between 
complementary proteins that are spatially organized.1 The most widely studied SNARE-
proteins are involved with cell-to-cell communication in the nervous system. Within 
neurons there are small liposomes called synaptic vesicles that are packed with 
neurotransmitters and whose outer lipid surface is extensively covered by proteins.2 
SNARE-proteins make up ~0.35 mol% of the molecules of the synaptic vesicle.2 The 
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fusion process can be dissected into three stages: collision, docking, fusion. Firstly synaptic 
vesicles approach the neuronal membrane, they then dock to the target membrane by way 
of a coiled-coil bundle, which forms between the SNARE protein on the vesicle and two 
other complementary SNARE proteins, one anchored in the neuronal membrane, and one 
in the cytoplasm. Finally, lipid mixing results in the transfer of the neurotransmitters out of 
the neuron. In vitro experiments using reconstituted SNARE proteins have shown that the 
formation of the coiled-coil bundle docking the vesicles to the target membrane is 
sufficient to locally disrupt the lipids and cause the membranes to merge.3-5  
 The ability to controllably fuse specific lipid membranes has much potential, and an 
improved understanding of membrane fusion will allow the development of more 
sophisticated applications. The most highly anticipated application of controlled membrane 
fusion is the targeted transport of cargo such as drugs or gene therapies into cells. This 
would reduce side effects for patients and increase the efficacy of treatments.  
 For the application of controlled membrane fusion it is advantageous to use small synthetic 
fusogens rather than the groups of large proteins that have evolved in competitive cellular 
environments, which are cumbersome to manage. For the same reasons of ease of use and 
interpretation it is preferable to use liposomes or supported lipid bilayers as model 
membranes rather than whole cells. There have been previous membrane fusion models 
proposed using metal ions6, 7 or synthetic fusogens, most of which are based on the concept 
of the fusion of viruses with cells, in which case a conformational change in a peptide 
causes it to bury a hydrophobic domain into the ‘target’ membrane.8-13 In this case the 
binding is non-specific, with binding occurring randomly on the surface, and it is often a 
leaky process.11 In other models the fusion is more SNARE-like in that it relies on the 
specific interaction between molecules.14-20 In a previous contribution, our group presented 
the first model system in which the fusogens are simplified versions of SNARE proteins.21 
As with native SNARE-based fusion, the mechanism is based on the formation of coiled-
coil complexes which dock and fuse the target membranes (Scheme 1). Two coiled-coil 
forming peptides, denoted E and K, were lipidated via a short PEG spacer, and are denoted 
LPE and LPK.22 The lipid tail (DOPE) anchors the peptides into lipid membranes. One set 
of liposomes is decorated with LPE and another with LPK. It was shown that when the 
liposome populations are mixed, the interaction between the coiled-coil forming peptides E 
and K leads to mixing of the liposome membranes and contents mixing without leakage, ie. 




membrane fusion and the reduced SNARE proteins are also simple enough to enable ready 
synthesis and use in a range of settings. 
 
 
Scheme. 1. Schematic illustration of liposome fusion mediated by simple SNARE protein 
mimics. Liposomes are modified with the lipopeptides LPE or LPK and upon mixing the 
peptide interactions trigger liposome fusion. E-peptide is (EIAALEK)3 and K-peptide is 
(KIAALKE)3 from N- to C- terminus. 
 
Having established a model that achieves membrane fusion showing the desired 
characteristics, the boundaries within which it functions and it how the fusion process 
differs within this scope need to be thoroughly investigated to maximize its future use. 
Here the determinants for liposome fusion using this minimal model has been assessed. 
The influence of lipopeptide concentration, lipid concentration, and lipids of positive 
curvature on liposome fusion have been characterized. This chapter describes how the 
juxtaposition of liposome collision, docking and lipid mixing rates shapes the varied 
outcomes of liposome fusion within the reduced SNARE model. 
 
Results and Discussion 
 
1. Targeted fusion 
When anchored in liposome membranes the fusogens LPK and LPE can cause rapid and 
complete fusion of all initial liposomes, as determined by a fluorescence-based lipid 
mixing assay (Figure 2).23 Control experiments did not result in significant lipid mixing, 
confirming that the specific molecular recognition between peptides E and K is necessary 
for fusion, and that this is the only route to fusion in this model (Figure 2). 




Figure. 2. Lipid mixing as monitored by fluorescence spectroscopy between LPK-
modified and LPE-modified liposomes (●), LPK-modified and plain liposomes (×), LPE-
modified and plain liposomes (+), LPK-modified liposomes (○), LPE-modified liposomes 
(□), and plain liposomes (■). Fusogen proportion 1 mol%, [lipids] = 0.25 mM. 
 
Models for membrane fusion can be divided into two classes: non-targeted, in which the 
fusion is caused by interactions between the fusogen and lipid bilayers, and targeted, i.e. in 
which the fusion is caused by molecular recognition between membrane-bound fusogens.24 
Many peptide fusogens, both synthetic and native (i.e. those involved with virus-cell 
membrane fusion), are non-targeted. They adopt an amphipathic helical conformation in 
the presence of lipid bilayers and penetrate into the membranes, destabilizing them and 
causing membrane fusion,24 which is often accompanied by leakage.11 When anchored in 
liposomes, the peptide components of LPE and LPK are in the α-helical conformation, with 
isoleucine and leucine residues making up a hydrophobic face running the length of the α-
helix. However, when either LPK- or LPE-modified liposomes are added to non-modified 
liposomes there is no significant lipid mixing observed by fluorescence spectroscopy 
(Figure 2). These results demonstrate that the penetration of E or K peptides into the 
membrane of an opposing liposome does not cause membrane fusion, i.e. the fusion 
mechanism is not ‘virus-like’, but rather is ‘SNARE-like’, with membrane fusion triggered 
by molecular recognition between fusogens. As with SNARE-mediated fusion, this 
molecular recognition is specific to the hetero coiled-coil complex formation, with no 
significant lipid mixing occurring between LPK-modified liposomes or between LPE-
modified liposomes due to homocoiling (Figure 2). The possibility of the electrostatically 
neutral E/K peptide complex inserting into the bilayer was investigated with tryptophan 
fluorescence, which is highly sensitive to the polarity of its local environment (see 



















Appendix). For liposomes decorated with tryptophan-labeled LPK the tryptophan 
fluorescence indicates that the C-terminus of LPK is in close proximity to the liposome 
membrane. Upon mixing LPK- and LPE-modified liposomes the tryptophan emission 
maximum becomes typical of a completely water-exposed environment.25 These results 
indicate that after the molecular recognition between E and K the peptide complex remains 
outside the liposomes rather than penetrating into the liposome membrane. 
 
2. Effect of fusogen concentration on liposome fusion 
The specific molecular recognition between the peptides E and K can rapidly lead to 
complete membrane fusion of all liposomes (Figure 2). This efficiency is important for 
potential applications. To evaluate the effect of fusogen concentration on the fusion 
process, the lipid mixing assay was conducted with samples containing a fixed 
concentration of total lipids (1 mM), but with decreasing proportions of the lipopeptide 
fusogens (Figure 3A).26 Incorporating as little as 0.5 mol% lipopeptide results in all of the 
initial liposomes going through at least one round of fusion (which is the limit of lipid 
mixing that can be monitored with this assay) within 30 minutes. Upon the incorporation of 
lower proportions of fusogen the rate of lipid mixing decreases, with the lower limit under 
these conditions being ~0.05 mol% lipopeptides, corresponding to an average of only 40 
lipopeptides decorating the outer surface of a 120 nm liposome. In comparison, synaptic 
vesicles are ~40 nm in diameter and are decorated with ~70 copies of the SNARE proteins 

















Figure. 3. A) Total lipid mixing recorded by fluorescence spectroscopy for liposomes 
modified with between 0 and 1 mol% LPE and LPK. B) Average particle sizes determined 
by DLS for liposomes modified with between 0 and 1 mol% LPE and LPK. [Lipids] = 1 
mM. 
 
The general trend of increasing membrane fusion rates with increasing proportions of 
fusogens arises because two liposomes that diffuse into close proximity are more likely to 
be displaying complementary peptides in the correct orientation for binding in the 
approaching area, and hence are more likely to dock and undergo fusion. However, the 
most rapid lipid mixing occurs for liposomes with a surface modification of 0.75 mol% 
lipopeptides. Circular dichroism (CD) data demonstrates that when 0.75 mol% LPE or 
LPK are incorporated into the liposome membranes the peptides E and K have typical α-
helical conformations, with minima at 208 and 222 nm and an ellipticity ratio <<1 (Figure 
4A), implying that the lipopeptides are molecularly dispersed across the surface.27, 28 Upon 
mixing, E and K bind together forming coiled coils (ellipticity ratio >1, Figure 4A), which 
dock liposomes together and lead to their fusion. However, when the amount of fusogen 
decorating the liposomes is increased to 1 mol%, peptide K is more constrained on the 
surface of the decorated liposomes, with CD spectra indicative of LPK homo-coiled coils 
(Figure 4B). No change in liposome size, lipid mixing, or peptide structure is detected with 
time for LPK-modified liposomes, thus peptide K forms homo-coiled coils on the surface 
of individual liposomes rather than between liposomes. Upon mixing LPE and LPK 
liposomes with 1 mol% surface modification E/K coiled coils still form (Figure 4B), 
docking liposomes together, however the rate of lipid mixing is decreased in comparison to 
0.75 mol% fusogen due to the reduced accessibility of peptide K and the reduced energy 





Figure 4. Circular dichroism data of A) liposomes modified with 0.75 mol% LPE (□), 
LPK (○) and an equimolar mixture thereof (●). B) liposomes modified with 1 mol% LPE 
(□), LPK (○) and an equimolar mixture thereof (●). [Lipids] = 0.5 mM. 
 
2.1 Rapid Fusion of multiple liposomes  
At lipopeptide proportions above ~0.5 mol%, when complete lipid mixing is rapidly 
achieved (Figure 3A), the particle sizes increased upon mixing LPE- and LPK-modified 
liposomes, as monitored by DLS (Figure 3B) and the liposomes sedimented to the bottom 
of the flask within hours (note that this size increase is the reason for the truncated 
fluorescence data in Figure 3A).29 While the initial liposomes have an average diameter of 
~120 nm, upon mixing the LPE- and LPK-modified liposomes particles with a larger 
hydrodynamic diameter are formed which increase in diameter and intensity with time, 
while the distribution containing the original LPE and LPK modified liposomes decreases 
in intensity. 
Optical microscopy revealed that the macroscopic particles detected by DLS are clusters of 
docked and fused liposomes. An example of the morphological development is shown in 
Figure 5 for liposomes bearing 0.75 mol% fusogens. Initially the LPK- and LPE-modified 
liposomes are ~120 nm in diameter and are not visible by optical microscopy (Figure 5A). 
One hour after mixing the liposomes, particles ~1 µm in diameter are visible (Figure 5B), 
consistent with the sizes measured by DLS. Five hours after mixing, the liposomes are 
predominantly docked into large clusters and giant liposomes 5 µm in diameter can be 
discerned within the clusters (Figure 5C). These clusters of giant liposomes sediment out of 
solution. The liposomes continue to increase in size, with images taken three days after 
mixing showing the membranes of giant liposomes up to 10 µm in diameter (Figure 5D). 
These giant liposomes sometimes displayed elongated morphologies (Figure 5E), which 
may be a mechanism to conserve membrane area and internal volume. 












Figure 5. Optical and fluorescent microscopy images (left and right columns respectively) 
showing docking and fusion of liposomes modified with 0.75 mol% LPE and LPK. A) 5 
minutes after mixing. B) 1 hour after mixing. C) 5 hours after mixing. D, E) 3 days after 
mixing. [Lipids] = 1mM lipids. Scale bars 10 μm. 
 
For conditions under which liposome clustering occurs, the complete lipid mixing coupled 
with the large liposome size increases have molecular scale implications. The observation 
of liposome clusters means that a single liposome can be docked to multiple other 
liposomes, with the inference that not all of the lipopeptides that decorate a liposome are 
involved in a single fusion event. The accumulation of docked liposomes rather than their 
immediate transition through the fusion process is in line with expectations because each 
stage of liposome fusion – docking, hemifusion, complete fusion – requires further energy 
input.30 It is presumed that after docking the energy input required to complete the fusion 
process arises from the more gradual attainment of a critical number and/or arrangement of 
lipopeptides. This finding is in line with the enhancement of membrane fusion through the 
physical arrangement of multiple complexes as observed for SNARE-protein mediated 
membrane fusion by experimental and computational studies.29-335 
The increase in liposome diameter over two orders of magnitude, from ~100 nm to ~10 µm 
(meaning that over 5x105 of the original liposomes have fused to grow into a single giant 
liposome), demonstrates that the liposomes can go through many rounds of fusion. This 
means that some fusogens on liposomes that have already fused are able to participate in 
subsequent fusion events. It is presumed that unless physically or kinetically impeded, the 
lipopeptides are able to laterally diffuse through the lipid leaflet in which they are anchored, 
such that following a fusion event the peptides E and K that were not involved with the 
fusion event would diffuse into close proximity with one another and form a coiled coil on 
the surface of the liposome. Due to the low dissociation constant for an unmodified and 
isolated E/K coiled coil complex in solution (~ 3.3x10-8 M at 25 °C, see Appendix), 
lipopeptides that have formed a complex on the surface of a single liposome are presumed 
to be effectively blocked from further fusion events. It is therefore assumed that some of 
the lipopeptides are physically prevented from forming a complex on the surface of a pre-
fused liposome, most likely because the rate of docking is higher than the rate of lateral 
diffusion of the lipopeptides. Further study is required to elucidate how lipopeptides on 
pre-fused liposomes are available for subsequent fusion rounds. 
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2.2 Fusion of two liposomes 
When the total lipid concentration is maintained at 1 mM but the liposomes are decorated 
with lower proportions of lipopeptide, the fusion process results in distinctly different 
physical changes to the liposome populations. For mixtures of liposomes modified with 
0.25 mol% of each lipopeptide or less, the lipid mixing (e.g. Figure 6A) is accompanied by 
an initial small size increase of the particles as detected by DLS followed by a gradual 
decrease (e.g. Figure 6B). After mixing LPE- and LPK-modified liposomes the 
hydrodynamic diameter of the particles increases close to that expected if two liposomes 
have docked. The hydrodynamic diameter then decreases with time, reaching a plateau at 
the size corresponding to the fusion of two liposomes in which the volume is conserved 
rather than the outer surface area. These results are in accordance with our previous 
experiments in which no leakage was detected during fusion, and cryo-TEM images, in 
which internalized bilayers were observed.21 
The two liposome fusion regimes, i.e., the fusion of tens of thousands of liposomes and the 
fusion of two liposomes, have the same total lipid concentration, therefore the liposome 
collision rate is the same. The dramatically different outcome arises because with fewer 
fusogens decorating the surface of the liposomes there is a lower probability that colliding 
liposomes are properly oriented to allow docking. The observation that with 0.25 mol% 
fusogen or less present an average of two liposomes fuse is presumably because after the 
first fusion event the lipopeptides that were not involved in the fusion event diffuse on the 

















Figure 6. A) Total lipid mixing recorded by fluorescence spectroscopy for liposomes 
modified with 0.25 mol% (●) and 0 mol% (○) LPE and LPK. B) Average particle sizes 
determined by DLS for liposomes modified with 0.25 mol% (●) and 0 mol% (○) LPE and 
LPK. [Lipids] = 1 mM. 
 
3. Effect of lipid concentration on membrane fusion 
The fusion process is less sensitive to dilution of the liposomes, i.e. changing the liposome 
collision rate, than it is to the lipopeptide concentration, i.e. changing the probability that 
peptides are at the correct position and orientation for docking. Fluorescence time series 
were recorded to follow the total lipid mixing of mixtures containing 1 mol% fusogen and 
different concentrations of lipid (Figure 7A). Complete lipid mixing is observed within 30 
minutes for lipid concentrations from 1 mM to 0.25 mM. In more dilute samples the rate of 
lipid mixing decreases, but remains significant at 0.01mM lipids. The lipid mixing is more 
efficient if there are more fusogens on fewer liposomes rather than fewer fusogens on more 
liposomes (Figure 7A vs. Figure 3A). DLS time series (Figure 7B) showed large particle 
size increases for lipid concentrations down to 0.1mM, while at 0.025 mM lipids (i.e. 0.25 
μM lipopeptide) and lower there is no sustained size increase with time, rather a slight 
increase is followed by a decrease to the hydrodynamic diameter expected for volume-
conserved two-liposome fusion. For mixtures with 1 mM lipids and different lipopeptides 
concentrations this transition between the multiple liposome fusion regime and the two 
liposome fusion regime occurred at 0.25 mol% fusogen (i.e. 2.5 μM lipopeptide). This 
means that the multiple liposome fusion regime is maintained with ~10x less fusogen if the 
liposomes are diluted in buffer rather than the number of fusogens modifying the surface of 
the liposomes is reduced. The docking efficiency is determined more by the number of 
fusogens (so that two approaching liposomes are more likely to be in the correct orientation 
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for the complementary lipopeptides to form a coiled-coil complex bridging the liposomes), 
than by the number of liposomes (the time between liposomes diffusing into close 
proximity). 
 
Figure 7. A) Total lipid mixing recorded by fluorescence spectroscopy for liposomes 
modified with 1 mol% LPE and LPK.  Total [lipid] is varied between 0.01 and 1 mM. B) 
Average particle sizes determined by DLS for liposomes modified with 1 mol% LPE and 
LPK. Total [lipid] is varied between 0.01 and 1 mM. 
 
4. Effect of positive curvature lipids on fusion process 
In a previous contribution introducing this minimal model it was shown that the fusion 
mechanism proceeds through the stalk intermediate that is thought to be part of native 
fusion.21 In the stalk intermediate the outer leaflets of two approaching liposomes have 
merged at the contact point, forming a ‘stalk’ that connects the liposomes. The stalk 
intermediate requires a negative curvature, and while lipids of positive curvature are able to 
form part of a bilayer they are physically unsuited to the structure of the stalk intermediate, 
therefore their incorporation into liposomes reduces lipid mixing. The role of the positive 
















Figure 8. A) Total lipid mixing recorded by fluorescence spectroscopy for liposomes with 
the standard composition (●) and with 15 mol% LPC (○). B) Average particle sizes 
determined by DLS for liposomes with the standard composition (●) and with 15 mol% 
LPC (○). 1 mol% lipopeptides, [lipid] = 0.25 mM. 
 
As expected, the inclusion of 15 mol% LPC to liposomes dramatically decreases lipid 
mixing (Figure 8A). However, a large size increase was observed with DLS for liposomes 
with and without LPC (Figure 8B). With optical microscopy the cause of this size increase 
is apparent (Figure 9). It can be seen that for liposomes of the standard composition there 
are many giant liposomes ~5 μm in diameter one day after mixing, with ~10 giant 
liposomes docked together in clusters. In contrast, for liposomes containing 15 mol% LPC 
there are hundreds of liposomes of less than 1 μm docked into clusters. These results show 
that LPC does not prevent the first step of fusion, docking, which is insensitive to the 

















Figure 9. Optical and fluorescent microscopy images (left and right columns respectively) 
showing docking and fusion of liposomes one day after mixing. A) Standard liposome 
composition, i.e. DOPE/DOPC/CH 50/25/25 mol%. B) With 15 mol% LPC, i.e. 
DOPC/DOPE/CH/LPC 43/21/21/15 mol%. 1 mol% lipopeptide, [lipid] = 0.25 mM. Scale 




The functional determinants of a reduced SNARE model for membrane fusion were 
investigated. Complementary lipopeptides are incorporated into liposomes and lead to their 
docking, then via the stalk intermediate to complete membrane fusion. As with SNARE 
protein mediated fusion, molecular recognition occurs through coiled-coil binding, without 
fusion caused by viral-like aspecific peptide-lipid interactions. The coiled-coil formation 
can lead to the rapid membrane mixing of all initial liposomes, and the effects of 
lipopeptide and lipid concentrations on this process were studied. The optimal surface 
modification for rapid lipid mixing occurs when 0.75 mol% lipopeptide is incorporated 
into the liposome membrane, while complete lipid mixing still occurs with lower 
proportions of fusogens than there are SNARE proteins in synaptic vesicles. DLS and 






liposomes through multiple fusion rounds into giant liposomes up to 10 μm in diameter, 
and the fusion of two liposomes. This mapping of the rate and route of liposome fusion 
under different conditions gives a detailed understanding of the capacity of the reduced 
SNARE model to fuse liposome membranes. This understanding paves the way for future 
applications of the minimal model such as controlled nanoreactor mixing and the directed 

































Lipopeptides were synthesized and purified as described previously.21 The amino acid 
sequence of peptide K was (KIAALKE)3-NH2, and that of peptide E was (EIAALEK)3-
NH2. The molecular weights of LPK and LPE were 3703.7 gmol-1 and 3706.6 gmol-1 
respectively. DOPE was purchased from Lipoid AG, and cholesterol was obtained from 
Fluka. DOPE-NBD and DOPE-LR were obtained from Avanti Polar Lipids. All other 
reagents and solvents were obtained at the highest purity available from Sigma-Aldrich or 
BioSolve Ltd. and used without further purification. Milli-Q water with a resistance of 
more than 18.2 MΩ/cm was provided by a Millipore Milli-Q filtering system with filtration 
through a 0.22 μm Millipak filter. 
 
Liposome Preparation 
Liposomes were composed of DOPC/DOPE/CH (50:25:25 mol%). Fluorescently labeled 
liposomes also contained 0.5 mol% LR-DOPE and NBD-DOPE. Lipid stock solutions (1 
mM) were prepared in chloroform. Lipopeptide stock solutions (10 µM) were prepared in 
1:1 (v/v) chloroform:methanol. Liposomes were prepared by drying appropriate volumes 
of the lipid and lipopeptide stock solutions in a 20 mL bottle under reduced pressure, 
addition of TES buffer (N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid sodium 
salt 10 mM, NaCl 100 mM, adjusted to pH 7.4) and sonication for ~5 minutes in a bath 
sonicator with the water bath at ~60°C. 
 
Experimental Methods 
Differential interference contrast (DIC) optical micrographs were recorded with a Zeiss 
axiovert-200 inverted microscope equipped with a 63 x objective long-range working lens. 
The images were recorded with a black and white CCD camera (AxioCam MRm) 
connected to an image-recording and -processing system (Axiovision 4.4). 
Experimental diffusion coefficients, D, were measured at 25 °C by dynamic light scattering 
using a Malvern Zetasizer Nano ZS ZEN3500 equipped with a peltier-controlled 
thermostatic cell holder. The laser wavelength was 633 nm and the scattering angle was 
173˚. The Stokes-Einstein relationship D = kBT/3πηDh was used to estimate the 




The results are expressed as the hydrodynamic diameter with units of nm. For individual 
liposome batches the sample was allowed to equilibrate for 2 minutes. For DLS time series 
the solutions were mixed in the cuvette (1000 rpm for 30 seconds). Measurements were 
started immediately after mixing.  
FRET-based lipid mixing experiments were conducted on a Tecan X fluorometer using a 
96 well plate. The z-position was 12500 µm, and the gain was optimized according to the 
amount of fluorophore in the sample. Excitation and emission slits were set at 10 nm. The 
excitation wavelength was 460 nm, and NBD emission was monitored 535 nm. The 
temperature was set at 24 °C and the measured temperature was 28 – 29 °C. 100 µL of 
fluorescent and non-fluorescent liposomes were combined, and for consistent mixing the 
plate was shaken inside the fluorometer for 30 seconds (2mm linearly, 70 x per minute). 
Data was collected every 20 seconds for at least 1 hour. Using 0.5 mol% of each 
fluorophore in the fluorescent liposomes and mixing fluorescent and non-fluorescent 
liposomes in a 1:1 molar ratio the increase in NBD fluorescence is proportional to lipid 
mixing (see Appendix). The data was calibrated to show the percentage of liposomes that 
have undergone lipid mixing by LM (%) = (It – I0)/(I100-I0) x 100, where I0 is the NBD 
intensity of 1:1 (v/v) fluorescent liposomes:TES, and I100 is the NBD intensity of liposomes 
of the same concentration prepared using an equimolar mixture of fluorescent and non-
fluorescent stock solutions. I0 and I100 were monitored with time as they are temperature 
sensitive. This assay only detects fusion between the original liposomes. e.g. if two pre-
fused liposomes fuse the distance between the fluorophores does not change so the event is 
not detected.  
Circular dichroism spectra were obtained using a Jasco J-815 spectropolarimeter equipped 
with a peltier-controlled thermostatic cell holder (Jasco PTC-423S). Spectra were recorded 
from 260  nm to 200 nm in a quartz cuvette with 5.0 mm pathlength at 25  °C. Data were 
collected at 1.0 nm intervals with a 1 nm bandwidth and 1 s readings. Each spectrum was 
the average of 5 scans. The spectra had a baseline of plain liposomes in TES buffer 
subtracted. The ellipticity is given as the mean residue molar ellipticity, [θ] (103 deg cm2 
dmol-1), calculated from [θ] = (θobs  × MRW)/(10 × l × c), where θobs is the observed 
ellipticity in millidegrees, MRW is the mean residue molecular weight (i.e. the molecular 
weight of the peptide divided by the number of  amino acid residues), l is the path length of 
the cuvette in cm and c is the peptide concentration in mg mL-1. The mean residue 
molecular weights are 107.8 g mol-1 and 107.7 g mol-1, and the peptide concentrations of 1 
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mol% in 0.5 mM lipid suspensions correspond to 11.3 mg L-1 and 11.3 mg L -1 for peptides 







Part 1. CD of acetylated peptides in TES 
 
 
Figure A1. CD Spectrospcopic Data of E (Δ), K (+), and an equimolar mixture of E and K 
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Figure A2. A) Thermal unfolding curve of unmodified E/K in TES buffer, pH 7.4, as 
followed by CD. [Total Peptide] = 40 μM. B) Van’t Hoff plot of the thermal denaturation 
of E/K. C) Dependence of the enthalpy of unfolding of E/K on temperature. ΔHu values 
were obtained from the derivative of the van’t Hoff plot. D) Free energy associated with 
the unfolding of E/K as a function of temperature. The least-squares fit gives a ΔGu value 
at 25 °C of 10.2 kcal mol-1. 
 
Temperature dependent CD spectra were obtained using an external temperature sensor 
immersed in the sample. The temperature was controlled with the internal sensor and 
measured with the external sensor. A 10 mm quartz cuvette was used, and the solutions 
were stirred at 900 rpm. Spectra were recorded from 260 nm to 200 nm, with data collected 
at 0.5 nm intervals with a 1 nm bandwidth and 1 s readings. Each spectrum was one scan. 
The temperature range was 4 °C to 96 °C with a temperature gradient of 2.0 °C/minute and 
a 60 s delay after reaching the set temperature. The spectrum of TES at 4 ° C (average of 5 
scans) was subtracted from each spectrum.  
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The data was analyzed using a two-state unfolding model to determine the fraction folded 
using Eqn. (1), 
Ff =  (θ - θu) / (θf - θu)                                                   (1) 
Where θ is the observed ellipticity at 222 nm, θu is the ellipticity at 222 nm of the 
denatured state, as determined from the plateau of the ellipticity vs. temperature curve, and 
θf is the ellipticity at 222 nm of the folded state at that temperature as determined from a 
linear fit of the initial stages of the ellipticity vs. temperature curve. 
The fraction unfolded, Fu, was calculated by Eqn. (2), 
Fu = 1 - Ff                                                               (2) 
The dimer dissociation constant in the transition zone was calculated using Eqn. (3), 
Ku = 2 PtFu2 / Ff                                                                (3) 
where Pt is the total peptide concentration. By taking the derivative of the ln(Ku) vs. 
temperature and using this in the van’t Hoff equation, Eqn. (4), the change in enthalpy 
associated with unfolding with temperature can be plotted: 
dln(Ku) / dT = ∆Hu / RT2                                                   (4) 
The gradient of this plot, ∆Cp, is the difference in heat capacity between the folded and 
unfolded forms, and can be used in the Gibbs-Helmholtz equation adapted to monomer-
dimer equilibrium, Eqn. (5), to obtain the Gibbs free energy of unfolding as a function of 
temperature: 
∆Gu = ∆Hm (1 - T / Tm) + ∆Cp [T-Tm-Tln(T/Tm)]-RTln[Pt]                          
(5)                                
where Tm and Hm are the temperature and enthalpy at the midpoint of the transition, as 
determined by the maximum of the derivative of the ellipticity vs. temperature graph. 
 
Part 3. Calibration of fluorescence based lipid mixing assay 
The lipid mixing assay monitors NBD fluorescence, which depends on the distance 
between the FRET pair NBD and LR. One liposome population contains 0.5 mol% of 
DOPE-NBD and DOPE-LR (headgroup labeled), while the other population is non-
fluorescent. As non-fluorescent and fluorescent liposomes fuse the distance between the 
fluorophores increases, resulting in decreased FRET efficiency and an increase in NBD 
fluorescence. Using 0.5 mol% of each fluorophore the increase in NBD fluorescence is 
proportional to lipid mixing (Figure A3). 





Figure A3. Samples which simulated 0-100% lipid mixing were prepared by combining 
the appropriate ratios of fluorescent and plain lipid stock solutions. The NBD fluorescence 
of these samples was monitored for 1 hr. The relative NBD fluorescence increases linearly 
with increasing fusion percent.  
 
For the lipid mixing experiments each sample was calibrated by monitoring its 
fluorescence over time relative to an I0 sample (the fluorescent liposomes were diluted 1:1 
with TES) and an I100 sample (liposomes prepared from an equimolar mixture of 
fluorescent and plain lipid stock solutions). The NBD fluorescence of mixed liposomes is 
not affected by the lipopeptide, thus the I100 samples did not contain lipopeptide. 
Using this assay the lipid mixing is calibrated using an “I100” sample that simulates the 
distance between the fluorophores (and hence NBD intensity) if all of the original 
liposomes have fused. The most commonly used method for calibrating the fluorescence 
data is to add Triton-X to the sample after monitoring. This method results in a very large 
distance between the fluoropohores, much larger than is possible using 1:1 fluorescent and 
non-fluorescent liposomes. In that case the monitored fluorescence increase is not 





































Part 4. Tryptophan fluorescence 
The manner in which the coiled-coil formation between SNARE proteins leads to 
membrane distortion and fusion is unknown. A possible mechanism for both SNARE-
mediated and LPK/LPE-mediated membrane fusion is molecular recognition followed by 
‘virus-like’ membrane penetration and destabilization. This is of particular consideration 
for the minimal model as the E/K coiled-coil dimer is electrostatically neutral and hence 
may have a greater propensity for membrane insertion. In order to probe this possibility a 
tryptophan residue was included in the first generation LPK. Tryptophan fluorescence is 
highly sensitive to the polarity of its local environment, and to monitor environmental 
changes during the fusion process the LPK fusogen was synthesized containing tryptophan 
at the C-terminus (with the PEG spacer and lipid anchor at the N-terminus). Before fusion 
the C-terminus of LPK is in a relatively polar environment (the tryptophan emission 
maximum of LPK-decorated liposomes is at 342.5 nm, Figure A4).25 Within one minute of 
mixing LPK- and LPE-modified liposomes the tryptophan emission maximum had red-
shifted to 350 nm, indicating that upon E/K complex formation the C-terminus of the 
peptide moves from a relatively polar to a completely water-exposed environment.25, 34 
These results indicate that after the molecular recognition between E and K initiates 
membrane fusion the peptide complex is situated outside the liposomes, rather than buried 
in the liposome membrane. Thus, the membrane distortion required for membrane fusion 
does not appear to arise via penetration of the peptide complex into the bilayer. Having 
established that the E/K peptide complex is unlikely to cause liposome fusion by ‘viral-like’ 
membrane burial, the second generation LPK, as employed for all other experiments in this 















Figure A4. The wavelength of the tryptophan fluorescence maximum before (t = 0 minutes) 
and during lipopeptide induced fusion of liposomes. Lipid concentration 1mM, fusogen 
proportion 3%. 
 
Tryptophan emission spectra were measured with a FS920 fluorometer from Edinburgh 
Instruments with a DTMS-300X excitation monochrometer and a peltier-controlled 
thermostatic cell. Spectra were obtained at 25 °C using a quartz cuvette with a 1 cm path 
length. The step size was 0.5 nm, with a sampling time of 0.5 s at each wavelength, and 1 
scan was measured for each spectrum. The excitation and emission slits were 5 nm.  
Emission spectra were measured from 330 nm to 360 nm at a fixed excitation wavelength 
of 280 nm. Measurements were started immediately after mixing the solutions in the 




































Part 5. Optical microscopy control experiment 
 
Figure A5. Optical and fluorescent microscopy images (left and right columns 
respectively) of liposomes without lipopdetide modification. A) 5 minutes after mixing  
plain and fluorescently labeled liposomes. B) 1 hour after mixing. C) 5 hours after mixing. 
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Part 6. Content mixing 
 
Figure A6. Content mixing recorded by fluorescence spectroscopy for liposomes modified 
with 1 mol% LPE and LPK. [lipid] 0.25 mM (●), 0.1 mM (+), 0.025 mM (×).  Control with 
liposomes modified with 1 mol% LPE and 0 mol% LPK, [lipid] 0.1 mM (○). 
 
To measure content mixing, LPE-modified liposomes containing sulforhodamine B at a 
self-quenching concentration were added to LPK-modified liposomes. Upon fusion the 
contents of the liposomes mix, resulting in an increased sulforhodamine B fluorescence 
signal due to the relief of self-quenching.3,4 The fluorescence signal is calibrated by 
adding Triton-X to lyse the liposomes and reach the maximum dilution. The 
sulforhodamine B dilution is much greater than the two-fold dilution expected if all LPE- 
and LPK-modified liposomes fuse, therefore the extent of the content mixing cannot be 
compared with the extent of the lipid mixing. In previous experiments (3 mol% fusogen, 
[lipid] 0.4 mM, PBS buffer), it was observed that content mixing proceeded without 
leakage.5  
For content mixing experiments a dried film containing DOPC/DOPE/CH 50:25:25 mol% 
and 1 mol % LPE was hydrated and sonicated (5 min at 50 °C) in TES buffer solution (N-
Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid sodium salt 10 mM, NaCl 100 
mM, adjusted to pH 7.4) containing sulforhodamine B (20 mM). The final lipid 
concentration was 1 mM. To remove the non-encapsulated dye, the liposome suspension 
was subjected to Sephadex (G50, Superfine) using TES buffer as the eluent. The fraction 
containing liposomes was collected and diluted to the final lipid concentration. 
Sulforhodamine fluorescence was measured with a Perkin Elmer Luminescence 


























Spectrometer LS 50B at room temperature. The excitation and emission slits were 2.5 nm. 
The excitation wavelength was 520 nm and the emission wavelength was 580 nm. 800 µL 
of the LPE-decorated liposomes with encapsulated sulforhodamine B were added to a 
small volume disposable cuvette. The fluorescence signal of the sulforhodamine was 
detected and 800 µL of unmodified or LPK-modified liposomes (1:1 molar ratio with the 
LPE-modified liposomes) were added and the increase of sulforhodamine B fluorescence 
was detected due to a relief of self quenching. After 30 minutes 160 µL of 10% (v/v) 
solution of Triton X was added. To calculate the percentage of fluorescence increase the 
following equation was used: 
F% = (F(t) – F(0)) / (F(max) – F(0)) × 100 
where F(t) is the fluorescence at a certain time, F(max) is the fluorescence after lyses of the 
liposomes with Triton X and F(0) is the starting fluorescence after addition of the LPK-
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Sets of complementary lipidated coiled-coil forming peptides inducing membrane fusion 
have been designed. The influence of the coiled-coil motif on the rate of liposome fusion 
was studied, by varying the number of heptad repeats. It was shown that an increased 
coiled-coil stability of complementary peptides translates into increased rates of membrane 
fusion of liposomes.  
 
Introduction 
The onset of supramolecular chemistry in recent decades has supplied scientists with a 
wealth of strategies to design functional materials.1-7 The self-assembly of molecular 
components into well-defined supra structures is governed by non-covalent interactions. 
The careful orchestration of these weak molecular interactions allows for the rational 
design of supramolecular complexes with predictable and tunable properties.8-14 Often, the 
inspiration for these assemblies comes from nature. Living systems display a staggering 
number of simultaneous orthogonal self-assembly processes. In particular, the well-defined 
secondary, tertiary and quaternary structures present in proteins have served as an 
invaluable motivation for research. For example, the specific recognition of DNA, RNA 
and carbohydrates, by proteins is based on the exact spatial placement of amino acid 
residues in the protein structure. With the rise of solid phase peptide chemistry it has 
become almost trivially easy to synthesize parts of proteins, i.e. peptides, with a well-
defined amino acid structure and controllable self-assembly properties.15-19 These peptides 
are therefore often able to mimic protein functions. An important area of research where 
this principle has been convincingly shown is membrane fusion. Membrane fusion is a vital 
process for the transport of molecules in all eukaryotic cells.20-23 SNARE proteins are an 
important family of proteins which induce membrane fusion in vivo through the formation 
of a coiled coil complex and have been studied extensively.24, 25 Recently, synthetic 
systems have been shown to promote membrane fusion based on specific interactions 
between a variety of fusogenic entities, such as peptides,26-30 DNA31-33 and other 
supramolecular recognition motifs.34 Inspired by native SNARE proteins, our group has 
synthesized simplified SNAREs which are composed of a pair of coiled coil forming 
lipidated peptides (LPE and LPK). In our model system, molecular recognition between 
membrane bound peptides E and K leads to coiled coil formation, which drives fusion 
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between liposomes.35 The synthetic lipopeptides consist of a hydrophobic tail (DOPE),a 
flexible linker (PEG12) and coiled coil forming peptides E and K (Scheme 1). Peptides “E3”  
(EIAALEK)3 and “K3” (KIAALKE)3 consist of three heptad repeats, which form a 
heterodimeric coiled-coil motif upon binding.36 The lipid tail ensures the efficient 
confinement of the peptide at the surface of the liposome. The advantage of our model 
system is that these peptide amphiphiles can be synthesized in a few days and chemical 
modifications can be easily introduced. Therefore, they can be tailored according to the 
needs of the particular application.  
 
 
Scheme 1: Schematic illustration of liposome fusion mediated by lipopeptides, as well as 
an overview of the lipopetides used in this study. Liposomes are decorated with LPKx (red) 
or LPEx (blue) and upon mixing coiled-coil formation brings the opposite liposomes in 
close proximity, and ultimately leads to fusion. 
 
Results and discussion 
In this chapter, the relationship between the stability of the coiled-coil motif formed by the 
membrane bound peptides and the efficiency of liposome-liposome fusion process was 
investigated. Therefore three sets of lipidated coiled-coil forming peptides Ex-Kx composed 
of 2, 3 and 4 heptad repeat units were synthesized. It is envisaged that the peptide length 
could influence the efficiency of lipopeptide mediated fusion through the stability of the 
resulting coiled-coil complex. First, the stability of coiled-coils assembled from 
complementary acetylated peptides was evaluated using circular dichroism (CD) 




measuring the ellipticity at 222 nm, which yields insights into the stability of all peptide 
pairs. First the symmetrical peptide pairs have been evaluated, i.e. peptide pairs with 
identical numbers of heptad repeats in each peptide. It was observed that the magnitude of 
the binding affinity was ordered as expected: K4-E4> K3-E3> K2-E2. The K3-E3 pair has a 
binding affinity of 11 kcal/mol at 25 ℃, whereas the values for K4-E4 and K2-E2 could not 
be determined as they are either too strong or too weak to be measured, respectively. Thus, 
increased coiled-coil stability is obtained upon increasing the peptide chain length, due to 
the increased number of non-covalent interactions between peptides E and K. Next, the 
ability to induce fusion between liposomes was studied for all symmetrical lipidated 
peptide pairs. First, a lipid mixing assay37-39 was used to compare the extent of mixing of 
the membrane constituents of the liposomes (Fig. 2). In this assay, LPKx decorated 
liposomes (with a hydrodynamic diameter of ~120 nm) contained the FRET pair DOPE-
NBD (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-
yl) and DOPE-LR (1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine-lissamine-
rhodamine B), while the LPEx decorated liposomes (~100 nm) did not contain any 
fluorescent label.  
 
 
Figure 1: Thermal folding curve of Ex/Kx, as obtained from CD curves. [Total peptide] = 
40 μM in PBS (pH=7.4, 50mM phosphate, 150mM NaCl).   
Both sets of liposomes were stable in time and did not show any auto-fusion. However, 
upon mixing the two batches of liposomes, an increase in the NBD emission was observed 
due to the increased average distance between the NBD and LR dyes. This is indicative of 
Controlling the rate of coiled coil driven membrane fusion 
 
120 
lipid mixing between the liposomes. Interestingly, a correlation between the stability of the 
coiled-coil motif and the extent of lipid mixing was observed. The largest fluorescence 
increase was found for liposomes decorated with LPK4-LPE4, followed by LPK3-LPE3 and 
finally LPK2-LPE2 (Fig. 2). The LPE2/LPK2 decorated liposomes show some degree of 
lipid mixing, even though the acetylated peptides E2/K2 are unable to form a  coiled-coil 
complex. However, confinement of peptides at a lipid membrane interface induces α-
helicity, even when these peptides adopt a random coil conformation in solution. This 
induced folding induces the complementary peptides to interact (see Table A2). Control 
experiments showed that lipid mixing only occurs when both complementary peptides are 
present and are able to form a coiled-coil motif, when one of the peptides is omitted, no 
lipid mixing occurs (Fig.2). Additional experiments were performed to investigate the 
effect of coiled-coil formation on the extent of lipid mixing as a function of temperature. 
Increasing the temperature from 25 ºC to 60 ºC led to strongly decreased lipid mixing for 
LPE3-LPK3 modified liposomes and no fusion at all was observed for LPE2-LPK2. In 
contrast, lipid mixing for LPE4-LPK4 decorated liposomes was hardly influenced (Fig. 2B). 
This observation is consistent with the CD measurements of the acetylated peptides, 
namely that E3-K3 show a decreased ability to assemble into coiled-coils upon raising the 
temperature to 60 °C, while E4-K4 remains predominantly in a coiled-coil formation. 
Several reports have shown that the fusion of liposomes can be halted at the hemifusion 
state, resulting in lipid mixing only.21 
To test whether the trend in lipid mixing translated to full fusion events, a content mixing 
fluorescence assay was performed (Fig. 3). In this experiment, LPE-decorated liposomes 
were loaded with sulphorhodamine B at a self-quenching concentration (20 mM). Upon the 
addition of non-fluorescent LPK liposomes, content mixing results in a dilution of the dye, 
diminishing self-quenching and resulting in an increased fluorescent intensity. Consistent 
with the lipid mixing data, liposomes decorated with LPE4 and LPK4 showed the most 
efficient content mixing, followed by LPE3 and LPK3 and finally LPE2 and LPK2 (Fig 4). 









Figure 2. Fluorescence increase at A) 25 °C and B) 60 °C, due to lipid mixing between two 
batches of liposomes decorated with 1 mol% LPE2-LPK2, LPE3-LPK3, LPE4-LPK4. Two 
control experiments are shown; lipid mixing between LPK3 or 4-decorated liposome with 
plain liposomes (PL). [lipid] = 0.1 mM. LPKx-decorated liposomes contained 0.5 mol% of 
DOPE-NBD and 0.5 mol% of DOPE-LR.  
 
In addition, the evolution of particle sizes was measured upon mixing batches of LPEx- and 
LPKx-decorated liposomes using dynamic light scattering (DLS). Again, the strongest 
effect was observed for LPE4 and LPK4 modified liposomes, which is in good agreement 
with the content and lipid mixing assays. A summary of all fusion experiments, including 
content mixing (CM), lipid mixing (LM) and size increase (SI) measurements is given in 
table 1 and Figure 4. Next, the fusogenity of the various lipopeptide-decorated liposomes 
as a function of pH was investigated. This parameter strongly influences coiled-coil 
formation, since the peptides are designed to display opposite charges (Lys vs. Glu) at 
fixed sites of the assembly, controlling orientation and stability of the coiled-coil motif. 
The lipopeptide pairs LPE3/LPK3 and LPE4/LPK4 show significant lipid mixing throughout 
the studied pH range (pH 5-8, see Figure A16-19). Especially the peptide pair with four 
repeating heptads showed high lipid mixing values irrespective of pH , indicating that 
hydrophobic interactions are the driving force for coiled-coil formation, whereas the 
stabilization of the coiled-coil through opposite charges plays a minor role. These findings 
reveal that the E4/K4 coiled-coil binding motif can be used under a wide range of 
conditions (pH = 5-8, T = 25-60 °C). Finally, the properties of asymmetric peptide pairs 
have been evaluated, i.e. peptide pairs with a different number of heptad repeat units. 
It was found for the acetylated peptides that both K2/E3 and K3/E2 showed no significant 
binding, which translated for the lipopeptides in negligible lipid mixing, content mixing 
and particle size increase (Table 1 and Figure 4). Large binding energies were found for 
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samples containing the acetylated pairs K4/E2 and K2/E4, although they were lower than for 
K3/E3. 
 
Figure 3: Content mixing assay; LPEx decorated liposomes were loaded with 20 mM 
sulphorhodamine B and mixed with LPKx liposomes. All spectra were obtained after 
mixing the liposomes. [total lipid] = 0.1 mM and 1% of lipopeptides LPE4-LPK4, LPE3-
LPK3 or LPE2-LPK2, in HEPES buffer at pH = 7.2. 
 
It is known that K4 and E4 form homocoils, complicating interpretation of binding energies. 
However, control lipid mixing experiments in which one lipopeptide from asymmetric 
pairs were omitted did not result in any significant lipid mixing (Fig. 2), indicating that 













Table 1: Summary of coiled-coil formation studies of acetylated peptides and key data of 
liposome fusion studies using the lipidated peptide pairs LPEx and LPKx. aC-C = coiled 
coil; the + sign signifies the formation of a coiled-coil motif. b BE = binding energies in 
kcal/mol, c Tm = melting temperature in °C. n.d.= not determined. dCM = content mixing 
after 10 minutes, eLM = lipid mixing after 10 minutes, fSI = size increase of liposomes 
after 60 minutes, gR-LM=initial lipid mixing rate.  
 
The strong tendency of the 4 heptad repeat peptides to form α-helices ensures the folding 
of the 2 heptad repeat peptides into α-helices upon binding. When confined to the surface 
of liposomes, these peptide pairs induced significant lipid and content mixing albeit to a 
lesser extent than E3/K4. Finally, samples containing the pairs K4/E3 and K3/E4 showed 
slightly higher binding energies than E3/K3 and yielded similar lipid and content mixing 
efficiencies. These results show that the stability of the coiled-coil pairs is reflected by the 
















Figure 4: Correlation of lipid and content mixing to the coiled-coil lipidated peptide pairs 
with increasing stability.  
 
Conclusion 
In summary, the increased coiled-coil stability of complementary peptides translates into 
increased rates of membrane fusion of liposomes modified with the corresponding 
lipidated peptides, as observed by the different assays (content mixing, lipid mixing and 
size increase). Liposomes carrying lipidated peptides with 4 repeating units (i.e. E4 and K4) 
were found to be the most fusogenic, and can be used in a wide range of temperature and 
pH. 
This lipopeptide induced fusion system can be applied beyond traditional membrane fusion, 
enabling the formation of complex supramolecular assemblies composed of nontraditional 














1. Materials and Methods 
1.1 Materials 
Fmoc-protected amino acids and Sieber Amide resin were purchased from Novabiochem. 
Fmoc-NH-PEG12-COOH was purchased from IRIS Biotech. DOPC was purchased from 
Avanti Polar Lipids, DOPE was purchased from Phospholipid, and cholesterol was 
obtained from Fluka. DOPE-NBD and DOPE-LR were obtained from Avanti Polar Lipids, 
All other reagents and solvents were obtained at the highest purity available from Sigma-
Aldrich or BioSolve Ltd. And used without further purification. Milli-Q water with a 
resistance of more than 18.2 MQ cm-1 was provided by a Millipore Milli-Q filtering 
system with filtration through a 22 um Millipak filter. Phosphate buffered saline, PBS: 5 
mM KH2PO4, 15mM K2HPO4, 150 mM NaCl, pH 7.4. 
1.2 General Methods 
RP-HPLC was performed with a Shimadzu HPLC system with two LC-8A pumps, and an 
SPD-10A VP UV-VIS detector, Sample elution was monitored by UV detection at 214nm 
and256nm. Sample elution was monitored by UV detection at 214nm and 256 nm. Samples 
were eluted with a linear gradient from A to B, A being ACN, and B 0.1% (V:V) TFA in 
H2O. Purification of the peptides and hybrids was performed on a C18 Vydac Column 
with a flow rated of 15ml/min. Sample purity was verified by LCMS. MALDI-TOF mass 
spectra were acquired using an Applied Biosystems Voyager System 6069 MALDI-TOF 
spectrometer with an ACH matrix. Samples were dissolved in 1:1 (v/v) 0.1% TFA in 
water:acetonitrile(TA), at concentrations of ~0.3mg/ml for K and E. Solutions for spots 
consisted of  (V/V) 1:10 sample solution: 10 mg/ml ACH in TA. Phosphate buffered saline, 
PBS: 5 mM KH2PO4, 15 mM K2HPO4, 150 mM NaCl, pH 7.4. 
 
2. Experimental details 
2.1 Peptide Synthesis: 
The peptides Ex and Kx were prepared using standard Fmoc-chemistry on a Syro-1 peptide 
synthesizer (Biotage). The peptides were synthesized on Sieber-Amide resin (0.62 mmol/g 
of NH2). HCTU was used to activate the amino acids derivatives. The peptides were 
acetylated. Cleavage and de-protection was carried out using 95:2.5:2.5 (V/V) 
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TFA:H2O:TIS for 1 hour. The cleavage mixture and three subsequent rinses of the resin 
with the TFA mixture were added drop-wise to cold diethyl ether. The white precipitate 
was compacted with centrifugation and the supernatant removed. This was repeated three 
times with the addition of fresh diethyl ether. The pellets were dried in air or under reduced 
pressure. 
The crude products were purified by RP-HPLC. ACN used as mobile phase A, H2O with 
0.1% TFA as mobile phase B. Samples were eluted with a linear gradient from 90% to 10% 
B (V/V). After purification all compounds were lyophilized from water to give white 
material with typically a yield of 40% for all the peptides.  
2.2 Lipopeptide synthesis: 
The peptide components of LPE and LPK were prepared with standard solid-phase peptide 
synthesis protocols using Fmoc-chemistry on a Syro-1 automated peptide synthesizer 
(Biotage), with a PL-sieber Amide resin on a 0.25 mmol scale. The peptide coupling 
reagent was HCTU. The N-terminal Fmoc was removed with 20% (V/V) piperidine in 
NMP. After the peptide component was prepared, the resin was removed from the reaction 
vessel and Fmoc-NH-PEG12-COOH was coupled to the immobilized peptides. The resin 
was swollen in NMP for 1 hour. 2.5 equivalents of Fmoc-NH-PEG12-COOH and 2.5 
equivalents of HCTU were dissolved in NMP(20ml) and mixed with 5 equivalents of 
DIPEA. After pre-activation for 1 minute the mixture was added to the peptide-resin and 
shaken for 20 hours. The uncoupled amines were capped with 0.05 M acetic anhydride, 
0.125 M DIPEA in NMP. The N-terminal Fmoc was removed with 20% (V/V) piperidine 
in NMP. The resin was washed thoroughly with 10×10 ml DCM. Next, succinic anhydride 
was coupled to the immobilized peptide-PEG. The resin was swollen in NMP. 5 
equivalents of succinic anhydride were dissolved in NMP (20mL) and mixed with 6 TEA. 
The mixture was added to the resin and shaken for 15 hours. The resin was washed 
thoroughly with 10×10mL NMP, and 10×10mL DCM. DOPE was coupled to the 
immobilized peptide-PEG12-succinic acid in the same way, except that 3 equivalents of 
DOPE, 3 equivalents of HCTU, and 6 equivalents of DIPEA were used, and 1:1 (V/V) 
NMP: DCM was used to swell the resin and to couple the DOPE. After the peptide 
synthesis and after each subsequent coupling step the synthesis was tested by MALDI-TOF 
mass spectroscopy. Cleavage from the resin and deprotection was carried out by shaking 




three subsequent rinses of the resin with the TFA mixture were added drop-wise to cold 
diethyl ether. The white precipitate was compacted with centrifugation and the supernatant 
removed. This was repeated three times with the addition of fresh cold diethyl ether. The 
pellets were dried in air or under reduced pressure. Bulk cleavage of the compounds was 
performed in the same way except using Bulk cleavage of the compounds was performed 
in the same way except using 47.5: 47.5: 2.5: 2.5 (V/V) TFA: DCM: H2O: TIS for one 
hour. The crude products were purified by RP-HPLC, the yield of LPE2 and LPK2 are 40%, 
LPK4 30%, LPE4 20%. For each compound the purity was estimated from RP-HPLC to be 
greater than 95%, with a mobile phase of 0.1% TFA ACN, and H2O.  
2.3 Electrospray ionization (ESI) mass spectrometry and HPLC 
Lipopeptide Molecular weight HPLC purity 
LPE2 2952.8 > 95%  
LPK2 2950.9 > 95%  
LPE3 3706.2 > 95%  
LPK3 3703.4 > 95%  
LPE4 4461.6 > 95%  
LPK4 4458.3 > 95%  
Table A1: Overview about calculated and found masses via MALDI-MS 
 
Figure.A1: ESI-mass spectra of (A) LPK2 and (B) LPE2.  
 
Figure.A2: ESI-mass spectra of (A) LPK4 and (B) LPE4 




3.1 Liposome preparation: 
1mM lipid stock solutions were made in chloroform with the composition 
DOPC/DOPE/CH 50:25:25 mol%. 1mM lipopeptide stock solutions were made in 1:1 (v/v) 
chloroform: methanol. Unless otherwise stated, liposome solutions are 1 mM in PBS. 
Three types of liposome solutions were prepared: plain liposomes, liposomes with 1 mol% 
LPE (99:1 (v/v) lipid stock solution: LPE stock solution), and liposomes with 1 mol% LPK 
(99:1 (v/v) lipid stock solution: LPK stock solution). To prepare small unilamellar vesicles 
the solvent was removed from the stock solution (2 mL) using a rotary evaporator to get a 
lipid film. Following this PBS (2 mL) was added to prepare a 1 mM liposome solution. The 
sample was vortexed for 1 minute and sonicated at 50 °C to form large unilamellar vesicles 
(it takes approximately 5 minutes for plain liposomes and 2 minutes for decorated 
liposomes respectively). The hydrodynamic diameter was approximately 100 nm as 
determined by DLS. 
 
3.2 Content Mixing 
Content mixing experiments were carried out as follows: A dried film containing 
DOPC/DOPE/CH 50:25:25 mol% and the corresponding E-Peptides (1 % of either LPE2, 
LPE3 or LPE4) were hydrated and sonicated (5 min at 50°C)  with a sulforhodamine B (20 
mM) containing HEPES buffer solution (20 mM HEPES, 90 mM NaCl) at pH 7,2. The 
final lipid concentration was 1 mM. To get rid of non-encapsulated dye the liposomal 
solution was subjected to Sephadex (G50, Superfine) using HEPES (20 mM Hepes-Na, 90 
mM NaCl) buffer as eluent. The fraction containing liposomes was collected and diluted to 
a final liposome concentration of 0.1 mM. 400 µL of the E-Peptide containing liposomes 
with encapsulated sulforhodamine B were added to a small volume disposable cuvette. The 
fluorescence signal of the Sulforhodamine ( λem = 580 nm) was detected and another 400 
µL of the corresponding K-Peptide containing liposomes (0.1 mM) in HEPES-buffer at pH 
= 7,2 were added and the increase of sulforhodamine B fluorescence, due to a relief of self-
quenching, was detected. After a certain time 100 µL of 10% (v/v) solution of Triton X 
was added to lyse the liposomes and reach the maximum dilution. To calculate the 
percentage of fusion the following equation was used: 




where F(t) is the fluorescence at a certain time, F(max) is the fluorescence after lyses of the 
liposomes with Triton X and F(0) is the starting fluorescence after addition of the K-
Peptide containing liposomes.  
 
3.3 Lipid Mixing. 
All spectra were obtained at room temperature using a quartz cuvette with a 1 cm path 
length. Liposomes consisting of DOPC/DOPE/CHOL/NBD-DOPE/RHD-DOPE  
(49.5/24.75/24.75/0.5/0.5 mol %) and 1 % of LPKx where mixed with liposomes consisting 
of DOPC/DOPE/CHOL (59/25/25 mol %) and 1% of LPEx. The NBD fluorescence was 
used to calculate the lipid mixing percentage with time. Fluorescence time series 
measurements were started immediately after mixing 750 µL of the fluorescent-labeled 
liposome suspension with 750uL of unlabeled liposome suspension in the cuvette. The 
NBD fluorescence intensity at 530 nm was monitored in a continuous fashion for 3000 
seconds. After that the liposomes were lysed by the addition of 150 µL of 10 wt % Triton 
X-100 in PBS to obtain 100 % increments.  
The values measured after lysis were multiplied by 1.82 to take into account the effect of 
Triton X-100 on the NBD fluorescence and dilution, which was obtained from a separate 
lysis experiment of a liposome solution that only contained DOPE-NBD. The percentage 
of fluorescence increase (%) is calculated as: 
F(%) = (F(t) – F0) / (Fmax × 1.82 – F0) × 100  
where F(t) is the fluorescence intensity measured at time t, F0 is the 0% fluorescence and 
Fmax is the fluorescence intensity measured after addition of Triton X-100.  
 
3.4 Initial fusion rate 
The initial lipid mixing rate as characterization of the initial fusion rate and is calculated as: 
R=ΔF/Δt 
ΔF stands for Fluoresce increase, Δt is time increase after 1:1 equimolar mix fluorescent 
label K liposome with non-fluorescent label E liposome. The increase in lipid mixing 
during the first minute of fusion is almost linear, therefore the increase in fluorescence in 
the first minute is used to calculate the rate of fusion. 
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4. Additional measurements 
4.1 Circular Dichroism Spectroscopy 
4.1.1 Peptide conformation and binding energy assay: 
CD spectra were obtained using a Jasco J-815 spectropolarimeter equipped with a peltier 
controlled thermostatic cell (Fig. A3,4). The ellipticity is given as mean residue molar 
ellipticity, [θ](103degcm2dmol-1), calculated by Eqn. (1),  
[θ]= (θobs×MRW)/(10×lc)                                                    (1) 
Where θobs is the ellipticity in millidegrees, MRW is the mean residue molecular weight, l 
is the path length of the cuvette in cm and c is the peptide concentration in mg/mL. 
A 1.0mm quartz cuvette and 200 µM concentration of peptide in pH=7.4 PBS were used 
for detection of the peptide secondary structure. Spectra were recorded from 260nm to 
200nm at 25°C. Data was collected at 0.5nm intervals with a 1nm bandwidth and 1s 
readings. Each spectrum was the average of 5 scans. For analysis each spectrum had the 
appropriate background spectrum subtracted. 
Temperature dependent CD spectra (Fig. A3,4) for calculation of the peptide binding 
energy were obtained using an external temperature sensor immersed in the sample. The 
temperature was controlled with the internal sensor and measured with the external sensor. 
A 10 mm quartz cuvette was used, and the solutions were stirred at 900 rpm. Spectra were 
recorded from 260 nm to 200 nm, with data collected at 0.5 nm intervals with a 1 nm 
bandwidth and 1 s readings. Each spectrum was one scan. The temperature range was 6 °C 
to 96 °C with a temperature gradient of 2.0°C/minute and a 60 s delay after reaching the set 
temperature. The solutions took 5 minutes to return to 6 °C. The spectrum of PBS at 6 °C 
(average of 5 scans) was subtracted from each spectrum.  
The data was analyzed using a two-state unfolding model to determine the fraction folded 
using Eqn. (2), 
Ff=([θ]-[θ]U)/([θ]F-[θ]U)                                                            (2) 
Where [θ] is the observed molar ellipticity, [θ]U is the ellipticity of the denatured state, as 
determined from the plateau of the ellipticity vs. temperature curve, and [θ]F is the 
ellipticity of the folded state at that temperature as determined from a linear fit of the initial 
stages of the ellipticity vs. temperature curve. 
The fraction unfolded, FU, was calculated by Eqn. (3), 




The dimer dissociation constant in the transition zone was calculated using Eqn. (4), 
KU=2PtFU2/Ff                                                                    (4) 
Pt is the total peptide concentration. By taking the derivative of the ln(KU) vs. Temperature 
and using this in the van’t Hoff equation, Eqn. (5), the change in enthalpy associated with 
unfolding with temperature can be plotted: 
dln(KU)/dT=∆HU/RT2                                                         (5) 
The gradient of this plot ∆Cp, is the difference in heat capacity between the folded and 
unfolded forms, and can be used in the Gibbs-Helmholtz equation adapted to monomer-
dimer equilibrium, Eqn. (6), to obtain the Gibbs free energy of unfolding as a function of 
temperature 
∆GU=∆Hm(1-T/Tm)+∆Cp[T-Tm-Tln(T/Tm)]-RTln[P           (6)                                
Tm and Hm, the temperature and enthalpy at the midpoint of the transition, is determined by 
the maximum of derivative of the ellipticity vs. temperature graph. 
All binding energy calculations were based on the assumption that the peptide pairs form a 
1:1 heterodimer complex (1:1 complex of Ex and Kx).  
With the formula above, the binding energy of E/K complex from the graphs below has 
been calculated (Fig. A3,4):  
 
 
Figure.A3:  Temperature dependent CD spectra monitored molar ellipticity changing at 









Figure A4:  Temperature dependent CD spectra monitored molar ellipticity changing on 
wavelength 222nm.  Km/En pairs in 20mM phosphate, 150mM NaCl, pH 7.4, [Total peptide] 
= 40µM.  
 
Figure A5 and A6 show the temperature dependent CD-spectra  for E3-K3 and with E4-K4. 
With increasing temperature the E3-K3 coiled coil dissociates, but the E4-K4 coiled coil 
still exists even when the temperature reaches 96 °C.  
 
Figure.A5: 3D spectrum of the E3/K3 coiled-coil complex ellipticity upon increasing the 






Figure A6: 3D spectrum of E4/K4 coiled coil complex ellipticity following by the 
temperature increasing from 2-96°C.36. 
 
4.1.2 Determination of the percentage α-helix and the confirmation coiled-coils  
The percentage α-helicity is the ratio of the observed [θ]222 to the predicted [θ]222 for an α-
helical peptide of n residues ×100. The predicted [θ]222 = -40000×(1-4.6/n).40 Peptide 
interactions were further confirmed by TFE-CD measurements. TFE is known to enhance 
intramolecular α-helicity but decrease intermolecular interactions.41. Equimolar E and K 
mixture has been measured first in PBS, then TFE: PBS 1:1 (v/v). If there is a significant 
decrease in the in the [θ]222/[θ]208 ratio from PBS to 50% TFE in PBS, one can assume, that 
there is a destruction of the coiled-coil binding motif. Here total peptide concentration is 1 




















PBS 50%TFE  
E2 -2490 -17718 9 66 0.50 0.73 - 
K2 -1876 -14142 7 53 0.32 0.73 - 
E2+K2 -3561 -17786 13 66 0.37 0.73 - 
E3 -5819 -22465 19 72 0.59 0.84 - 
K3 -6638 -23139 21 74 0.73 0.84 - 
E3+K3 
 
-24705 -23277 79 75 1.10 0.90 + 
E4 
 
-22173 -23176 66 69 1.43 0.86 + 
K4 
 
-24714 -25812 74 77 1.25 0.86 + 
E4+K4 
 
-31066 -31341 93 94 1.11 0.90 + 
Table A1.: Concentrations of the peptides: 1mg/ml, Buffer 50mM phosphate, 150mM 
NaCl, pH 7.4, 25°C. 
 
4.1.3 Comparison of secondary structure of E2, K2 and liposomes modified with 
LPE2 and LPK2. 
Peptide % α-helicity 
 
Peptide % α-helicity 
Ac-E2 9 LPE2 20 
Ac-K2 7 LPK2 19 
Ac-E2+Ac-K2 13 LPE2+LPK2 40 
Table A2. Comparision of acetylated E2,K2, E2+K2 percentage of alpha-helix changed 
from uniform disperse in buffer with fixed on surface of liposome.  Acetylated peptide 
were measured in pH=7.4 PBS buffer (PBS buffer as baseline), 25℃. LPE2, LPK2 and 
LPE2+LPK2 were decorated on surface of liposome to make them water-soluble (plain 
liposome in same buffer as baseline). All the acetylated peptide were measured in 1mg/ml 
concentration, 1 mm cuvette was used, 4 scans for each peptide, while all the lipopeptide 
were decorated 1% on liposome surface which compose of 0.5mM lipid in pH=7.4 PBS in 





























25C 1mg/ml 1mm cuvette
 
Figure A7: CD spectroscopic data of acetylated E2, K2 and E2-K2 complex. 1mg/ml 
peptides in pH=7.4 PBS (50mM phosphate, 150mM NaCl) were measured with 1mm 
cuvette on 25℃. 
 
























0.5mM 1% 5mm cuvette
 
Figure A8: CD spectroscopic data of LPE2, LPK2, LPE2+LPK2 complex. All lipopeptide 
were decorated on surface of liposome, to make them water soluble, meanwhile use plain 
liposome as baseline during all the lipopeptide-liposome measurements. All the samples 
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Figure A9: Lipid mixing based on the fluorescence increase upon mixing LPKx decorated 
fluorescent liposomes and LPEx decorated liposomes. 









Figure A10: Lipid mixing based on the fluorescence increase upon mixing LPKx decorated 
liposomes and LPEx decorated liposomes with encapsulated sulphorhodamine (20 mM). 
 
4.4 Dynamic light scattering (cross combinations) 
Hydrodynamic diameters were estimated at 25 °C by dynamic light scattering 
using a Malvern Zetasizer Nano ZS ZEN3500 equipped with a peltier-controlled 
thermostatic cell holder. The laser wavelength was 633 nm and the scattering angle 
was 173°. For individual liposome batches the samples were allowed to equilibrate 
for 2 minutes. For DLS time series the solutions were mixed in the cuvette for 30 




sample equilibration, and continued for 1h: 
Size increase % = 100*(S1h-S0)/S0  
(S1h: Zeta average diameter after 1 hour mixing, S0: Zeta average diameter 
immediately after mixing).  
 
 
Figure A11: Size increase in percentage of all cross combination. 
 
4.5 Comparison of different conditions 
4.5.1 Rate of fusion as a function of temperature: 
The same method that mentioned in main text for the lipid mixing has been applied, except, 




Figure A12 : Lipid mixing at, pH=7.4.  




Figure A13 Lipid mixing at 37°C, pH=7.4. 
 
 
Figure A14: Lipid mixing at 60 °C, pH=7.4. 
 
 





4.5.2 Rate of fusion as a function of pH:  
The same lipid mixing method as mentioned before has been performed, except, that the 
pH was varied. 
 
Figure A16: Liposome fusion at 25°C, pH=5.0. 
 
 

















Figure A18: Liposome fusion at 25°C, pH=8.0. 
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The effect of Coil-K peptide homo interaction on coiled coil CC-K/E mediated liposome 
fusion efficiency was investigated. Coil-K clustering on liposome membranes was tuned by 
changing the electrostatic interaction between peptides. For this, the original amino acid 
sequence of Coil-K was varied at the f-position. The glutamate residue (‘E’) was replaced 
with either a serine (‘S’, no charge) or a lysine (‘K’, positive charge) residue, yielding 
Coil-KS and Coil-KK. Circular dichroism (CD) and fluorescence spectroscopy confirmed 
that the peptide modifications did not influence the coiled coil formation with the 
complementary peptide Coil-E. CD studies of lipidated Coil-KS and Coil-KK incorporated 
in liposomal membranes revealed that more electrostatic repulsion between the peptides 
increased the fusogenity. Lipid and content mixing assays showed more efficient liposome-
liposome fusion using Coil-Kk and Coil-Ks in conjunction with coil-E. A probable cause 
for this effect might be that repulsion between the peptides in the pre-fusion state results in 
a more homogeneous peptide distribution on the liposomal membrane. 
 
Introduction 
The 2013 Nobel Prize in Physiology or Medicine was awarded to James Rothman, Randy 
Schekman and Thomas Südhof for their seminal contributions in understanding vesicular 
transport mechanisms in cells.1 One of the important actors in membrane trafficking, so 
called SNARE proteins (soluble N-ethyl maleimide sensitive factor attachment protein 
receptors), mediate membrane fusion and are widely studied.2-4 In nature, the distance 
between biological membranes is typically around 10- 20 nm, due to the electrostatic 
repulsion between the charged bilayers and the steric interaction of membrane bound 
proteins and other biomolecules.5 Thus the first step of a fusion event is to bring the 
opposing membrane lipid bilayers into close proximity. Next, local disruption of the 
bilayer structure results in the formation of a stalk-like structure (Scheme 1). In the stalk 
intermediate the outer membranes of the approaching lipid bilayers have merged, but not 
the inner leaflets. It is believed that the stalk which expands into a hemifusion stalk or 
diaphragm, subsequently enlarges such a pore is being formed. As a result, the contents of 
the compartments mix, and the fusion process is completed.6, 7  
 





Scheme 1. (A) Two opposing membranes in the pre-fusion state. (B) A point-like 
membrane protrusion minimizes the energy of the hydration repulsion between the 
proximal leaflets of the membranes coming into immediate contact. (C) A hemifusion stalk 
with proximal leaflets fused and distal leaflets fused and distal leaflets unfused. (D) Stalk 
expansion yields the hemifusion diaphragm. (E) A fusion pore forms either in the 
hemifusion diaphragm bilayer or directly from the stalk (take from reference 5).8 
 
The lipid rearrangements of membrane fusion during intracellular transport are mediated 
by SNARE proteins.4 However, the molecular mechanism is still debated. To induce 
membrane fusion, a four-helix coiled-coil bundle forms between two membrane-bound 
SNARE protein subunits and a cytoplasmic SNARE protein subunits forcing the two 
membranes within a distance of 2-3 nm from one another, resulting in docking of the two 
opposing membranes followed by lipid and content mixing.5, 9 Inspired by this natural and 
highly controlled transport mechanism, supramolecular and biomaterials chemists designed 
synthetic targeted membrane fusion systems to study the mechanism of membrane fusion 
at a fundamental level, or to explore future applications in drug delivery or in the design of 
nanoreactors. Our previously published synthetic membrane fusion system has shown to be 
very effective in inducing liposome-liposome fusion (Scheme 2).10-12 There are three key 
components in the design of our fusion model. First there is the molecular recognition part, 
which drives the membrane of two liposomes into close proximity. For this we use the 
complementary peptides Coil-K and Coil-E, which were designed to form a heterodimeric 
coiled coil complex.10, 13 Flexibility and rotational freedom of the peptides is ensured by 
conjugation of a poly(ethylene glycol) spacer (PEG12) at the N-terminus of the peptides. 
The third component in our design is the lipid anchor 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), which is conjugated to the PEG spacer. This  guarantees 








Scheme 2. Illustration of liposome fusion mediated by lipopeptides, as well as an overview 
of the lipopeptides used in this study. Liposomes are decorated with LPK (red) or LPE 
(blue) and upon mixing coiled-coil formation brings the opposite liposomes in close 
proximity, and ultimately leads to fusion. 
 
From previous experiments, we realized that peptide homo-aggregation on the liposomal 
membrane before fusion reduces its fusion efficiency with the complementary fusion 
partner.11 It seems that there is an optimal peptide to lipid ratio of ~0.75 mol%. Higher 
ratios did not result in faster fusion. Circular dichroism (CD) spectroscopy showed that at 
high fusogen concentrations on the membrane, self-aggregation due to homocoiling and 
increased peptide-membrane interactions seem to occur resulting in a heterogeneous 
distribution of the peptides on the liposome surface.  
A driving force for the observed peptide aggregation might be electrostatic interactions. In 
the original coiled coil (CC) K/E design, position ‘a’ and ‘d’ in the helical wheel diagram 
are taken by the amino acid residues isoleucine (I) and leucine (L) respectively, forming 
the hydrophobic core (Scheme 3). Position ‘b’ and ‘c’ are occupied by alanine (A), which 
increases the propensity of the peptide to adopt an α-helical configuration.14 
Heterodimerization was programmed by incorporating charged residues at position ‘e’ and 
‘g’, adjacent to the hydrophobic core, being lysine (K) residues in peptide Coil-K and 
glutamate residues (E) in the Coil-E peptide. This coiled coil was designed to function at 
neutral pH, where the side chains of all lysine residues are protonated, and hence positive 
charged, while the side chains of all glutamate residue residues are deprotonated and hence 
negatively charged. The final position in the heptad repeat, position ‘f’, was occupied by an 




opposite charge relative to positions ‘e’ and ‘g’, in order to decrease the overall net charge 
of the single peptide. Due to the existence of opposite charges residues within one single 
peptide, electrostatic attraction could cause undesired peptide-peptide interactions at the 
membrane of the liposomes. This in turn lowers the effective monomeric peptide 
concentration at the membrane, resulting in the observed lower fusogenity at higher 
peptide concentrations. Circular dichroism and dynamic light scattering data shows that the 
acetylated peptides (i.e. no lipid anchor) uniformly disperse in PBS buffer (pH=7.4), with 
no noticeable homo-interaction being observed. However, the situation changes when the 
peptides are confined on a liposome surface. When the peptides are fixed to a liposomal 
surface through the phospholipid anchor, Coil-K peptide shows significantly homo-
interaction and peptide-membrane interactions, as observed in CD measurements.11 
However, it is important to note that this does not result in fusion. By decreasing the Coil-
K density on liposome surface to 0.75 mol%, the peptide self-interaction significantly 
decreased and coincidentally, the liposome fusion lipid mixing rate increased.  
 
 
Scheme 3. Parallel heterodimeric peptide used in this study. (A) column shows Coil-K (left) 
with Coil-E (right), (B) column shows Coil-KS (left) with Coil-E (right), and (C) column 
shows Coil-KK (left) with Coil-E (right). (A-1) presents lateral view of CC-K/E, (A-2) 
presents top view of CC-K/E (from N to C- terminus), (A-3) presents simplified top view 
(from N to C- terminus), so-called helical wheel of CC-K/E (same with column (B) and 
(C)). Amino acid were expressed by signal letter (K= lysine, I= isoleucine, S= serine, E 
=glutamate, L= leucine, A= alanine). Black arrows indicate hydrogen bonding, while red 





To investigate whether electrostatic interactions have an effect on Coil-K homo-interaction, 
the influence of a charge at position ‘f’ in peptide coil-K on the rate of membrane fusion 
was studied. Thus, the liposome fusion efficiency was investigated as a function of peptide 
aggregation by tuning the electrostatic interaction between the peptides on the liposomal 
surface (Scheme 4). Besides the original Coil-K with a glutamate residue at position ‘f’, 
two new sequences were synthesized with either the noncharged serine (S) or the positive 
charged lysine on position ‘f’, denoted Coil-KS and Coil-KK respectively. The aim here is 
to increase the electrostatic repulsion between the peptides, and thereby increasing the 
effective peptide concentration able to form a coiled coil motif with peptide Coil-E 
yielding a higher fusion efficiency.  
 
 
Scheme 4. Proposed peptide electrostatic interactions on liposome membrane surfaces 
(lower) and vertical view of peptides from C to N terminus (upper). (A) indicates 
interactions among Coil-K peptides when they are anchored on the membrane with 
crowded surface density. Identically, (B) indicates Coil-KS interactions, while (C) indicates 
Coil-KK interactions. Peptides were modeled by Hyperchem release 8.0 as classical L-
alpha helix, with three dihedral angels: ϕ= -58o, ψ= -47o, ω=180o. Amino acid residues 
were illustrated by using balls atom rendering. Positive charged lysine residues are in red, 
negative charged glutamate in blue and ‘0’net charged serine in yellow, meanwhile other 
zero net charged residues are in orange. Uniformly, gray bilayers indicates liposome 
membrane surfaces, PEG12 linker and DOPE anchor are omitted for clarity.  
 




Circular Dichroism (CD) spectroscopy showed that replacing the glutamate residues at 
position ‘f’ with serine or lysine reduces their tendency to aggregate. Fluorescence 
resonance energy transfer (FRET) measurements revealed that less peptide aggregation on 
liposomal membranes resulted in an increased lipid mixing rate in membrane fusion studies. 
More importantly, content mixing assays based on fluorescence dequenching of rhodamine 
B showed a significant increase in fusion efficiency for the least aggregated peptide Coil-
KK. These findings indicate that an increase in electrostatic repulsion yields less interacting 
Coil-KK in the pre-fusion state. Upon the addition of liposomes bearing the complementary 
peptide Coil-E, efficient fusion was observed for the least aggregated peptides. Thus, we 
successfully optimized our fusion model system resulting in a more efficient rate of content 
mixing.   
 
Results and discussion 
Peptide interaction study 
Peptide design 
In this study, the charged amino acid residue at ‘f’ position has been varied, yielding new 
coil-K peptide mutants, as shown in Table 1.11, 15 
 
Table 1. peptide primary structure 
 
‘+’ stands for positive charge, ‘-‘stands for negative charge. Yellow column indicates the ‘f’ 





Instead of the negatively charged glutamate residue, we introduced either the non-charged 
serine (S) or the positively charged lysine (K), yielding two new peptides Coil-KS and 
Coil-KK respectively (Scheme 3). Furthermore, Coil-K (and its derivatives) and Coil-E 
were conjugated to DOPE via the flexible spacer PEG12 at the N-terminus for the fusion 
studies. This design ensures the binding of these lipidated peptides in the membranes of 
liposomes (vide infra).  
 
Circular Dichroism Spectroscopy. 
CD measurements showed that all the peptides adopt to some degree an α-helical structure 
in PBS buffer with the molar ellipiticity ratio [ɵ]222/ [ɵ]208 <1. However Coil-KS revealed a 
relatively low α-helicity (24 %) compared to coil-K and coil-KK due to serine’s poor 
propensity to adopt an α-helical conformation (Figure 1A and Table 2).16 Next, the molar 
ellipticity of acetylated peptides was measured in a 1:1 (v/v%) mixture of trifluoroethanol 
(TFE) and PBS. TFE is known to enhance intramolecular α-helicity while disrupting 
intermolecular interactions.17 The molar ellipticity, as measured at 222 nm, revealed an 
increase for all acetylated peptides in the presence of 50 % TFE, verifying their propensity 
to adopt an α-helical secondary structure and that no peptide aggregation was present in 
PBS.  
When mixing equimolar amounts of Coil-K (or its derivatives: Coil-KS, Coil-KK) with 
Coil-E, the molar ellipticity intensity at 222 nm increased significantly (Figure 1C).14 For 
all the peptide pairs, the ellipticity ratio [ɵ]222/ [ɵ]208, increased to > 1 (Table 2), which 
indicated the formation of coiled coils.18 The peptide interactions were further studied by 
recording CD spectra in a 1:1 (v/v%) mixture of trifluoroethanol (TFE) and PBS. In this 
solvent mixture, the observed decrease in molar ellipticity and [ɵ]222/ [ɵ]208 ratios strongly 
suggest the presence of coiled coils, which are destabilized in the presence of TFE (Figure 
1D). These initial results confirm that individual Coil-K (and its derivatives) and Coil-E 
peptides adopt a random coil to α-helical structure in PBS buffer. However, when Coil-K 
(Coil-KS or Coil-KK) are mixed with equimolar amounts of Coil-E, coiled coils are formed 
immediately. More importantly, this study showed that the charge at the ‘f’ position of 
coil-K peptides can be varied without compromising their ability to form coiled coils with 
coil-E. 
 





Figure 1. (A) CD spectra of the peptides in PBS buffer and (B) in 1:1 (v/v) PBS: TFE. (C) 
CD spectra of an equimolar mixture of the Coil-K variants and Coil-E in PBS buffer and 
(D) in 1:1 (v/v) PBS: TFE. [Total peptide]= 100 uM, pH 7.4, 25 oC. 
 
Table 2. CD spectroscopic data of the acetylated peptides. 
 
a The percentage α-helicity is the ratio of the observed [ɵ]222 to the predicted [ɵ]222 for an α-
helical peptide of n residues times 100. The predicted α-helicity is calculated from [ɵ]222=-








Table 3. CD spectroscopic data of the peptide complexes. 
 
a A/B refers to mixtures of the stated compounds with equimolar concentrations. b The + 
sign signifies a significant decrease in the [ɵ]222/[ɵ]208 ratio from benign to 50% TFE in 
PBS, indicative of the folded coiled-coil structure in PBS.  
 
Next, the binding properties were determined of the coiled coil complexes (CC-K/E, CC-
KS/E, CC-KK/E) by CD spectroscopy. A job-plot showing the [θ]222 as a function of the 
mol fraction of Coil-E peptide yields information on the binding stoichiometry of the 
coiled coils.19, 20 The job-plot of Coil-K (and its derivatives) and Coil-E mixtures were 
measured with a total peptide concentration of 200 uM and with variable mol fractions of 
the two peptides. For all CC-K/E (including derivatives) coiled coil complexes studied, a 
minimum of [θ]222 was always observed at an equimolar ratio of peptide Coil-K (and 
derivatives) and Coil-E, revealing the formation of a coiled coil complex with a 1:1 
stoichiometry (Figure 2A).    
As the molar ellipticity at 222 nm is directly proportional to the amount of helical structure 
and therefore thermal denaturation curves provide information of their folding stabilities.18, 
21 Thus the thermodynamic stability of the CC-K/E pairs was determined by measuring the 
molar ellipticity at 222 nm wavelength as a function of temperature.13, 22 All coiled coil 
pairs showed a smooth cooperative transition from a α-helical coiled coil structure to a 
random coil conformation (Figure 2B). All transitions showed to be fully reversible by 
lowering the temperature (See Appendix Figure A4). Temperature-dependent CD 
measurements showed that all the peptide complexes used in this study have an identical 












Figure 2. (A) Mean residue molar ellipticities at 222nm wavelength for mixtures of the 
Coil-K (or its derivants) and Coil-E peptides as a function of the mol fraction of the Coil-E 
peptide. [Total peptide]=100 uM, 25 oC, 2 mm quartz cuvette. (B) Thermal unfolding 
curves of coiled coils in PBS buffer (pH=7.4) with increasing temperature. A 1cm quartz 
cuvette with stirring bar at 900 rpm was used. [Total peptide]=40 uM, PBS, pH=7.4. 
 
The binding parameters of the studied coiled coil heterodimers are summarized in Table 4. 
Either the similarity in binding stoichiometry or the resemblance in dissociation constant of 
all coiled coils show that replacing a glutamate (charge ‘-’) with a serine (charge ‘0’) or a 
lysine (charge ‘+’) residue on the ‘f’ position in peptide Coil-K did not influence the ability 
to form coiled coils, while the changes in ∆G were minor.  
 
Table 4. Binding constants of coiled coils from CD spectroscopy. 
 
a CC indicates coiled coil. b Tm=melting temperature, at which half of the peptide is in the 
unfolded form. c ΔGu= Gibbs free energy of unfolding at 25 oC. d Kd=dissociation constant 
at 25 oC. 
 
Fluorescence spectroscopy 
The relative peptide orientation within a coiled coil motif (i.e. parallel vs antiparallel) was 
investigated by fluorescence spectroscopy. For this, Coil-K (Coil-KS and Coil-KK) were 




see Table 5). In addition, Tyrosine (Y) was added to the C-terminus of Coil-E, giving Coil-
E’. As mentioned in Chapter 3 and Chapter 4, glycine (G) was added in between aromatic 
amino acid (W and Y) and original peptide sequence to avoid significant structure 
alteration. The relative orientation of the two peptides within a coiled coil complex was 
confirmed by a fluorescence resonance energy transfer (FRET) between the donor Y on 
Coil-E’, and the acceptor W on Coil-K’ (including its derivatives). Both fluorophores are at 
the C-termini of the peptides, and the Förster distance (R0≈ 1 nm) is shorter than the length 
of the peptides in a α-helical fashion (~ 3-4 nm) (see Appendix, Figure A4), which 
stringently ensures that FRET can only occur when the peptides are assembled with a 
parallel orientation, not when an antiparallel orientation is adopted.23  
 
Table 5. Fluorescent labeled peptide primary structure 
a All the peptides primary structures present from N to C terminus. b Mw= molecular 
weight. 
 
Figure 3 shows the emission spectra (excitation at 275 nm) of peptides Coil-K’ (and its 
derivatives) and Coil-E’, CC-K’/E’ (including its derivatives) in PBS and in 1:1 PBS: TFE 
solution. An equimolar mixture of Coil-K’ and Coil-E’ results in an increased fluorescence 
signal of acceptor W and a decreased fluorescence signal of donor Y due to fluorescence 
resonance energy transfer (FRET), thus indicating a parallel coiled coil orientation for CC-
K’/E’ (Figure 3A). In the presence of 50% TFE, the energy transfer is lost due to the 
dissociation of coiled coil complex. Consistently, CC-KS’/E and CC-KK’/E also showed a 










Figure 3. Fluorescence emission spectra (extension at 275 nm) of fluorescent labeled 
peptides 50 uM in either pH=7.4 PBS buffer or 1:1 TFE/PBS solution on 25 oC. (A) Coil-




KS’=Ac-(KIAALKS)3-CONH2. (C) Coil-KK’=Ac-(KIAALKK)3-CONH2. W is tryptophan, 
while Y is tyrosine.  
 
Both CD and fluorescence measurements showed that replacing the negatively charged 
glutamate residue at the ‘f’ position with either the positively charged lysine or non-
charged serine on position ‘f’ in Coil-K did not significantly alter the peptide ability to 
form a coiled coil. Hence, we consider the electrostatic interaction as the only difference in 
the following liposome fusion studies. 
 
Lipopeptide mediated liposome fusion study 
Lipopeptide synthesis 
The lipopeptides were synthesized as previously mentioned in Chapter 5. However, the 
lipopeptides cleavage from the resin was optimized by using a cocktail of TFA, DCM, 
phenol and TIS (70:22.5:5:2.5% v/v) for peptide precipitation. The purification of the 
crude lipopeptides was performed as described in Chapter 5 and the resulting products are 
presented in Table 6. 
 
Table 6. Lipopeptides used in this study 
 
a Mw is molecular weight. b and c were calculated after HPLC purification. 
 
CD spectroscopy 
The peptides were incorporated into the surface of liposomal membranes at a concentration 
of 1 mol%. Compared with the acetylated peptides in PBS, the membrane bound 
lipopeptides showed a red shift in the minumum (from 222 nm to 225 nm) in the CD 




spectra (Figure 4). This is due to different dielectric of the membrane environment relative 
to that of single peptides in aqueous buffered solutions.24-26  
CD measurements of lipopeptide LPK in liposomes revealed a [ɵ]225/[ɵ]208 ratio larger than 
1, indicating that it has a tendency to either homocoil or interact with the lipid membrane 
(Figure 4A). In contrast, the other individual lipopeptides (LPKS, LPKK and LPE) all 
showed a [ɵ]225/[ɵ]208 ratio <1, implying that homocoiling occurring at the membrane was 
significantly suppressed.22, 27 Upon equimolar mixing of LPE-modified liposomes with 
LPK-modified liposome, immediate coiled coiling of the peptides was observed as well as 
peptide aggregation since the ellipticity ratio increased significantly to larger than 1 (Figure 
4B).28 This ellipticity ratio increase was less pronounced for mixtures of LPKS (or LPKK) 
liposomes interacting with LPE liposomes. This circular dichroism study indicates that 
changes of the charge at the ‘f’ position in coil-K influences the peptide behavior at the 
liposomal membrane, most likely by decreasing the tendency to self-aggregate in the 
prefusion state.  
 
 
Figure 4. (A) Circular dichroism spectra of 1 mol% lipopeptide  on liposomal membranes. 
(B) Equimolar mixture of LPK (and its derivatives) and LPE on liposomes. [Lipids]=0.5 
mM, PBS buffer, pH=7.4, 25 oC.  
 
Liposome fusion studies 
The effect of charge at the ‘f’ position of coil-K on the rate of membrane fusion was 
studied with lipid and content mixing assays as well as dynamic light scattering (DLS). In 
general, the process of liposome fusion is initiated by docking of two opposing liposome 




intermediate and merging of two liposomes outer lipid leaflets (Scheme 1). Finally, a 
membrane pore is formed resulting in content mixing between the two liposomes. Coiled 
coil formation between the two complementary peptides on the opposing membranes is the 
driving force inducing liposome docking followed by fusion. Peptide aggregation at the 
surface of liposomes in the pre-fusion state might lead to steric hindrance at the membrane 
and/or lowering the effective peptide concentration. As a result, fewer peptides are 
available to form coiled coils which lowers the liposome fusion rate and efficiency.11, 28  
First, the rate of lipid mixing was determined by a standard FRET assay. Coil-K modified 
liposomes (shortname K-LF), contained both the donor dye nitrobenzofuran (NBD) and the 
acceptor dye lissamine rhodamine (LR) attached to the membrane, while Coil-E modified 
liposomes (shortname E-L) were not decorated with fluorescent dyes. These liposomes 
were stable with time and did not show any self-aggregation or fusion for at least 24h (See 
Appendix Figure A6). Upon equimolar mixing of K-LF liposomes with E-L liposomes, an 
immediate increase in the NBD emission was observed as a result of a decreased FRET 
efficiency due to the increase in the average distance between NBD and LR. This is due to 
lipid mixing between K-LF and E-L liposomes. Figure 5A shows that in all three 
experiments full lipid mixing (i.e. 100%) was achieved within 60 min. However, fusion 
between KK-LF and E-L liposomes showed the highest initial lipid mixing rate. Also fusion 
between KS-LF with E-L liposomes resulted in a higher lipid mixing rate as compared to 
the fusion induced by the original coil-K and coil-E peptides. Thus, varying the charge in 
coil-K at the ‘f’ position resulted in differences in the initial lipid mixing rate, albeit these 
became smaller at longer time scales.   
 
 
Figure 5. (A) Fluorescence traces showing lipid mixing between fluorescence (NBD/LR) 
labeled LPK (and derivatives) liposomes with non-fluorescence labeled LPE liposomes. (B) 




Content mixing between non-fluorescent LPK liposomes with sulforhodamine labelled (20 
mM) LPE liposomes. Liposome concentration is 0.1 mM with 1% peptide decoration. The 
bars show the standard deviations (σ). See Figure A6/A7 for the lipid mixing and content 
mixing fluorescence spectra. All the measurements were performed in PBS, pH 7.4, at 25 
oC.  
 
Next, a liposome fusion content mixing assay was performed, which revealed a more 
pronounced difference between the three pairs of lipidated peptides (i.e. CC-K/E, CC-KS/ E, 
CC-KK/E). In this experiment, Coil-E modified liposomes were loaded with 
sulphorhodamine B at a self-quenching concentration of 20 mM, yielding E-LRD liposomes, 
while Coil-K (including its derivatives) modified liposome did not contain dyes in the 
aqueous interior, yielding K-L liposomes. Upon mixing of the liposomes, fusion resulted in 
the transfer of content transfer with a concomitant dilution of the rhodamine dye, thereby 
alleviating the self-quenching and a subsequent increase in fluorescence intensity (Figure 
5B). 
Here, significant differences in content mixing were observed as a function of the peptides 
used. Within 60 min, fusion between E-LRD liposomes and KK-L liposomes yielded 85% of 
content mixing, which is significantly higher as compared to the original peptide design 
(i.e. coil-K/coil-E modified liposomes) Using coil-KS/coil-E modified liposomes with a 
neutral charge at the ‘f’ position also gave an increased fusion efficiency, but less 
pronounced when compared to the coil-Kk/coil-E liposomes.         
 
Dynamic light scattering 
To study the size increase due to aggregation and fusion events upon mixing of the 
liposomes, we used dynamic light scattering (DLS) measurements in order to determine 
whether the average liposome size increase correlated with the lipid and content mixing 
results. The results revealed similar initial docking rate and size increasing due to the 
limited instrumental sensitivity. It is important to note that dynamic light scattering cannot 
distinguish between liposome-liposome docking and liposome-liposome fusion events. 
Therefore it can be concluded that all studied coiled coil pairs were able to at least induce 
docking between opposing liposomes with comparable efficiency. After 30 minutes the 
increase in the hydrodynamic diameter deviates. However, at these diameters DLS 
becomes less reliable and therefore it is difficult to draw any conclusions on the size 






Figure 6. Hydrodynamic diameter increase of the liposomes as a function of time, 
determined by dynamic light scattering of liposome fusion size increasing. Liposome 
concentration is 0.1 mM with 1% peptide decoration. See Figure A8 for size increase in the 
control samples. All the measurements were performed in PBS, pH 7.4, at 25 oC.  
 
Conclusion 
In this study the effect of charge at the f- position of one of the peptides in a heterodimeric 
coiled coil pair on the rate of liposome fusion was investigated. Studies with the acetylated 
peptides showed that varying the charge at the ‘f’ position of coil-K did not alter the ability 
to form coiled coils. In contrast, when lipidated versions of these peptides were 
incorporated in liposome membranes, a significant difference in fusion efficiency was 
observed. Remarkably, the content mixing rate is strongly dependent on mutations of the f- 
position. By replacing the original negative charge with either no charge or a positively 
charged side group, the rate of fusion increased as was shown by a content mixing assay. 
This might be due to lowering the amount of homocoiling in the pre-fusion state resulting 
in a higher effective peptide concentration. However, more research is needed to confirm 










Peptides and lipopeptides were synthesized and purified as described previously.29 DOPE 
was purchased from Lipoid AG, and cholesterol was obtained from Fluka. DOPE-NBD 
and DOPE-LR were obtained from Avanti Polar Lipids. All other reagents and solvents 
were obtained at the highest purity available from Sigma-Aldrich or BioSolve Ltd. and 
used without further purification. Milli-Q water with a resistance of more than 18.2 
MΩ/cm was provided by a Millipore Milli-Q filtering system with filtration through a 0.22 
μm Millipak filter. 
 
Liposome Preparation 
Liposome for lipid mixing and DLS measurement 
Liposomes were composed of DOPC/DOPE/CH (50:25:25 mol%). Fluorescent labeled 
liposomes also contained 0.5 mol% LR-DOPE and NBD-DOPE. Lipid stock solutions (1 
mM) were prepared in chloroform. Lipopeptide stock solutions (10 µM) were prepared in 
1:1 (v/v) chloroform:methanol. Liposomes were prepared by drying appropriate volumes 
of the lipid and lipopeptide stock solutions in a 20 mL bottle under reduced pressure, 
addition of PBS buffer (pH 7.4) and sonication for ~5 minutes in a bath sonicator with the 
water bath at 55°C. liposome samples for DLS measurement follow the same procedure as 
above, but without fluorescent dyes.  
 
Liposome for content mixing 
For this assay, 1 mM 1mol % Coil-E decorated liposome was prepared, encapsulating 20 
mM sulforhodamine B in pH=7.4 PBS buffer (shortname E-LRD). E-LRD was futher 
purified by sephadex G-100 column manually (column length= 400 mm, diameter= 30 mm, 
flow rate= 1 drop s-1), yielding 0.1 mM with 1 mol% Coil-E decoration ERD-L. Meanwhile, 
0.1 mM 1 mol % Coil-K decorated liposome was prepared as the way mentioned above 









Experimental diffusion coefficients, D, were measured at 25 °C by dynamic light scattering 
using a Malvern Zetasizer Nano ZS ZEN3500 equipped with a peltier-controlled 
thermostatic cell holder. The laser wavelength was 633 nm and the scattering angle was 
173˚. The Stokes-Einstein relationship D = kBT/3πηDh was used to estimate the 
hydrodynamic radius, Dh. Here kB is the Boltzman constant, and η is the solvent viscosity. 
The results are expressed as the hydrodynamic diameter with units of nm. For individual 
liposome batches the sample was allowed to equilibrate for 2 minutes. For DLS time series 
the solutions were mixed in the cuvette (1000 rpm for 30 seconds). Measurements were 
started immediately after mixing.  
FRET-based lipid mixing experiments were conducted on a Tecan X fluorometer using a 
96 well plate. The z-position was 12500 µm, and the gain was optimized according to the 
amount of fluorophore in the sample. Excitation and emission slits were set at 10 nm. The 
excitation wavelength was 460 nm, and NBD emission was monitored 535 nm. The 
measurements were done in room temperature. 100 µL of fluorescent and non-fluorescent 
liposomes were combined, and for consistent mixing the plate was shaken inside the 
fluorometer for 30 seconds (2mm linearly, 70 x per minute). Data was collected every 20 
seconds for at least 1 hour. Using 0.5 mol% of each fluorophore in the fluorescent 
liposomes and mixing fluorescent and non-fluorescent liposomes in a 1:1 molar ratio the 
increase in NBD fluorescence is proportional to lipid mixing. The data was calibrated to 
show the percentage of liposomes that have undergone lipid mixing by LM (%) = (It – 
I0)/(I100-I0) x 100, where I0 is the NBD intensity of 1:1 (v/v) fluorescent liposomes:PBS, 
and I100 is the NBD intensity of liposomes of the same concentration prepared using an 
equimolar mixture of fluorescent and non-fluorescent stock solutions. I0 and I100 were 
monitored with time as they are temperature sensitive. This assay only detects fusion 
between the original liposomes. e.g. if two pre-fused liposomes fuse the distance between 
the fluorophores does not change so the event is not detected.  
For content mixing assay, the fluorescence signal of the sulforhodamine (λem= 580 nm) 
was detected once upon 1:1 mixing ERD-L (100ul) with K-L (100 ul). The increase of 
sulforhodamine B fluorescence is due to a relief of self-quenching following by content 
mixing, named Ft. The F0 is 100 uL ERD-L with 100 ul PBS, and the F100 is the 
fluorescence signal intensity after addition of 1% (w/v) Triton X-100 in PBS into the ERD-




L+K-L well. And the content mixing is calculated by CM (%) = (Ft – F0)/(F100-I0) x 100. 
All the data are calculated from 3 times measurements.  
For either lipid mixing or content mixing, the standard deviations (σ) are calculated by 
formula: 𝜎 = �1
𝑁
∑ (𝑥𝑖 − 𝜇)2𝑁𝑖=1 , where µ =
1
𝑁
∑ xi𝑁𝑖=1  (xi is the fluorescence intensity from 
measurement, N is the number of measurement. In this study, N=3). 
Circular dichroism spectra were obtained using a Jasco J-815 spectropolarimeter equipped 
with a peltier-controlled thermostatic cell holder (Jasco PTC-423S). Spectra were recorded 
from 260  nm to 200 nm in a quartz cuvette with 5.0 mm pathlength at 25 °C. Data were 
collected at 1.0 nm intervals with a 1 nm bandwidth and 1 s readings. Each spectrum was 
the average of 5 scans. The spectra had a baseline of plain liposomes in TES buffer 
subtracted. The ellipticity is given as the mean residue molar ellipticity, [θ] (103 deg cm2 
dmol-1), calculated from [θ] = (θobs × MRW)/(10 × l ×c), where θobs is the observed 
ellipticity in millidegres, MRW is the mean residue molecular weight (i.e. the molecular 
weight of the peptide divided by the number of  amino acid residues), l is the path length of 
the cuvette in cm and c is the peptide concentration in mg mL-1.  
A 1.0 mm quartz cuvette and a final concentration of 200 μM peptide in PB S (pH=7.4). 
Spectra were recorded from 250 nm to 200 nm at 25 °C. Unless stated otherwise data 
points were collected with a 0.5 nm interval with a 1 nm bandwidth and scan speed of 1nm 
per second. E ach spectrum was an average of 5 scans. For analysis each spectrum had the 
appropriate background spectrum (buffer or 50% T FE ) subtracted. 
For determination of the coiled coil thermal dissociation constant, temperature dependent 
CD spectra were obtained using an external temperature sensor immersed in the sample.30, 
31 T he temperature was controlled with the internal sensor and measured with the external 
sensor. A  10 mm quartz cuvette was used, and the solutions were stirred at 900 rpm. 
Spectra were recorded from 250 nm to 200 nm, with data collected at 0.5 nm intervals with 
a 1 nm bandwidth and a scan speed of 1nm per second. T he temperature range was 6 °C to 
96 °C with a temperature gradient of 2.0 °C/minute and a 60 s delay after reaching the set 
temperature. T he spectrum of PB S at 6 °C (average of 5 scans) was subtracted from each 
spectrum. A ll the thermal unfolding curves were analyzed using a two-state conformation 




The data were analyzed using a two-state unfolding model to determine the fraction folded 
using E qn. (2), 
Ff = ([θ] − [θ]U)/([θ]F − [θ]U)                           (2) 
Where [θ] is the observed molar ellipticity, [θ]U is the ellipticity at 222 nm of the denatured 
state, as determined from the plateau of the ellipticity vs. temperature curve, and [θ]F is the 
ellipticity at 222 nm of the folded state at that temperature as determined from a linear fit 
of the initial stages of the ellipticity vs. temperature curve. 
T he fraction unfolded, FU, was calculated by E qn. (3), 
FU = 1 − Ff                                                 (3) 
T he dimer dissociation constant in the transition zone was calculated using E qn. (4), 
 KU = 2PtFU2/Ff                                             (4) 
Pt is the total peptide concentration. B y taking the derivative of the ln(K U) vs. temperature 
and using this in the van’ t Hoff equation, E qn. (5), the change in enthalpy associated with 
unfolding with temperature can be plotted:  
∆HU  =  RT2 ×  
dln(KU)
dT
                                     (5) 
T he gradient of enthalpy vs. temperature plot ∆Cp, is the difference in heat capacity 
between the folded and unfolded forms, and can be used in the Gibbs-Helmholtz equation 
adapted to monomer-dimer equilibrium, E qn. (6), to obtain the Gibbs free energy of 
unfolding as a function of temperature by least-squares fitting, 
               ∆GU = ∆Hm(1 − T/Tm) + ∆Cp[T − Tm − Tln(T/Tm)] − RTln[Pt]          (6) 
T m and Hm are the temperature and enthalpy at the midpoint of the transition at which the 









1. Liquid chromatography mass spectroscopy 
 
Figure A1. LC-MS spectra of peptide (A) Coil-K, (B) Coil-KS, (C) Coil-KK, (D) Coil-
E. From top to bottom: UV (ultraviolet-visible) detection wavelength at 214 nm, and 







Figure A2. LC-MS spectra of fluorescent labeled peptide (A) Coil-K’ (Ac-
(KIAALKE)3-GW-CONH2) , (B) Coil-KS’ (Ac-(KIAALKS)3-GW-CONH2), (C) Coil-
KK’ (Ac-(KIAALKK)3-GW-CONH2), (D) Coil-E’ (Ac-(EIAALEK)3-GW-CONH2). 
From top to bottom: UV (ultraviolet-visible) detection wavelength at 214 nm, and ESI 
(electrospray ionization) mass spectrum. 
 





Figure A3. LC-MS spectra of fluorescent labeled peptide (A) LPK, (B) LPKS, (C) 
LPKK, (D) LPE. From top to bottom: UV (ultraviolet-visible) detection wavelength at 










2. Hyperchem simulation 
 
Figure A4. Hyperchem simulation structures of peptides Coil-K, Coil-KS and Coil-KK. 






















3. CD thermal dynamic curves 
 
 
Figure A5. Thermal folding curve based on changes in [θ]222 as followed by CD by 
decreasing the temperature from 360 to 280 K. [Total peptide]= 40 uM, PBS pH=7.4, 25 
oC, 1 cm quartz cuvette. 
 
4. Liposome fusion control data 
 
4.1 Lipid mixing control 
 
 
Figure A6. Lipid mixing control as monitored by fluorescence spectroscopy between 
fluorescent labeled K-LF (and its derivatives) and non-fluorescent K-L (and its derivatives). 







4.2 Content mixing control 
 
Figure A7. Content mixing control as monitored by fluorescence spectroscopy between 
sulphorhodamine B loaded E-LRD and non-loaded E-L. Fusogen proportion =1 mol%, 
[lipids]=0.1 mM, PBS buffer, pH=7.4, 25 oC. 
 
 
4.3 DLS size increasing control 
 
Figure A8. DLS size increasing control as monitored by dynamic light scattering. Fusogen 
proportion =1 mol%, [lipids]=0.1 mM, PBS buffer, pH=7.4, 25 oC. 
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Fusion of lipid bilayers in cells facilitates the active transport of chemicals. Non-viral 
membrane fusion is regulated by a cascade of proteins as the process is highly regulated 
both in space and time. In eukaryotic cells, the so-called SNARE protein complex is at the 
heart of fusion. However, little is known about the actual mechanism at the molecular level. 
Inspired by the SNARE protein complex, our group previously developed a model system 
composed of a pair of lipidated complementary coiled coil peptides enabling targeted 
liposome-liposome fusion. This model system possesses all the key characteristics of 
membrane fusion similar to SNARE mediated fusion. The tetrameric coiled-coil of 
SNAREs is mimicked by a complementary pair of coiled coil forming peptides composed 
of three heptad repeat units (denoted “coil-E” and “coil-K”). A flexible poly(ethylene 
glycol) spacer is conjugated to the N-terminus ensuring rotational freedom of the peptides. 
Lipidation warrants the anchoring of the peptides in the membrane by means of a 
phospholipid anchor (DOPE), mimicking the transmembrane domain of SNAREs. 
In order to develop future applications of this model system, the mechanism of membrane 
fusion needs to be studied in more detail and this has been the goal of this thesis. The first 
part of this thesis (Chapter 2 and 3) studies the peptide self-assembly, while in the second 
part (Chapter 4,5 and 6) liposomal fusion studies are described and the effect of the peptide 
design on the rate of fusion. 
Chapter 2 shows a a new method to determine the oligomeric state and orientation of 
coiled-coil peptide motifs is described. Peptides K and E, which are designed to form a 
parallel heterodimeric complex in aqueous solution, were labeled with the aromatic amino 
acids tryptophan and tyrosine on the C-terminus respectively as ‘fingerprint’ residues. One 
of the peptides was also labeled with the paramagnetic probe MTSL. One dimensional 
proton NMR spectroscopy was used to study the peptide quaternary structure by 
monitoring the signal suppression of the aromatic labels due to proximity of the nitroxyl 
radical. 1D-NMR confirmed that the peptides K and E form a heterodimeric coiled coil 
with a parallel orientation. In addition, fluorescence emission quenching of the aromatic 
labels due to electron exchange with a nitroxyl radical confirmed the parallel coiled coil 
orientation. Thus, paramagnetic nitroxide and aromatic fluorophore labeling of peptides 
yields valuable information regarding the quaternary structure from 1D-NMR and steady-
state fluorescence measurements. This convenient method is useful not only to investigate 




In Chapter 3, the reversed sequence of coil-E was synthesized and its self-assembly 
behavior with coil-K was studied using the method described in Chapter 2. These studies 
were combined with modeling data, showing that Coil-Er and Coil-K assemble into an 
antiparallel tetrameric coiled coil motif (CC-K/Er). Interestingly, the stability of this 
complex was comparable to the original heterodimeric CC-K/E. Next, the CC-K/Er 
triggered liposome fusion was determined and compared with CC-K/E triggered fusion. 
Surprisingly, the results show that both the fusion rate and efficiency are similar. This  
indicates that in our peptide mediated membrane fusion system, the peptide orientation or 
oligomer state is not a critical factor.  
In Chapter 4, the effect of lipopeptide and lipid concentration on liposome fusion were 
investigated. The lipid mixing efficiency was obtained when the liposomes were decorated 
with 0.75 mol% lipopeptide. Dynamic light scattering and optical microscopy studies 
revealed that by tuning the lipid and peptide concentrations, two fusion regimes are 
possible: in the first regime multiple rounds of fusion results in the formation of giant 
liposomes, while in the second regime fusion can be limited to a single liposome-liposome 
fusion event. The mapping of the rate and route of liposome fusion under different 
conditions gave a detailed understanding of the capacity of the SNARE mimicking model 
system. This understanding paves the way for future applications of the fusion model 
system such as utilizing liposomes as nanoreactors and as a drug delivery tool.  
In Chapter 5, the rate of peptide mediated liposome fusion was controlled by varying the 
coiled coil binding energy. In the original model system , both coil-E and coil-K were 
composed of 3 heptad repeat units. In this study the length of the peptides was decreased to 
2 heptad repeats (coil-E2, coil-K2) or increased to 4 repeat units (coil-E4, coil-K4 ). Next, 
the thermal stability of the coiled coils was studied in order to determine the binding 
energy of the peptide complexes. As expected, the binding energy was the highest for the 
longest peptides. Next the rate of fusion was studied using dynamic light scattering studies 
as well as lipid mixing and content mixing assays. The strongest-binding coiled coil E4/K4 
motif induced membrane fusion most efficiently. In addition, this coiled coil is also able to 
induce liposomal membaren fusion in a wide range of either temperature or pH. This study 
expands the possible scope of future applications of this fusion model system.  
In Chapter 6, the influence of electrostatic interactions on the rate of liposome fusion was 
investigated. In order to design new derivatives of CC-K/E with a similar binding energy, 
Chapter 7 
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coil-K mutants were synthesized in which the charge at the ‘f’ position was modified. The 
fusogenicity of the new derivatives Coil-KS (no charge on ‘f’) and Coil-KK (positive charge 
on ‘f’) in combination with coil-E was investigated. Remarkably, the rate of content 
mixing and efficiency was strongly dependent on these mutations at the ‘f’ position of 
Coil-K. By replacing the original negative charge (Coil-K) with either no charge (Coil-KS) 
or a positively charged (Coil-KK) side group, the rate of lipid  and content mixing 
increased significantly. This might be due to lowering the amount of homocoiling in the 
pre-fusion state resulting in a higher effective peptide concentration. However, more 
studies are required to support this hypothesis. This thesis focuses on de novo designing 
coiled coil forming peptides and optimizing coiled coil mediated liposome fusion. There is 
still room for improvement. In Chapter 3, the sequence of Coil-E was reversed. However, it 
will be of interest to reverse in future studies the sequence of coil-K, as recent studied have 
shown that this peptide interacts with liposomal membranes via a so-called snorkeling 
mechanism. This in turn might destabilize the lipid packing resulting in the observed 
efficient membrane fusion in this model system. By reversing the sequence of Coil-K this 
hypothesis might be validated. Chapters 4, 5 and 6 present data showing that this model 
system can be improved in terms of lipid- and content mixing, which will pave the way for 
using this model system in an in vivo environment. If this can be achieved, this model 


























































Eén van de manieren waarop chemicaliën getransporteerd worden binnen de cel is door 
fusie van lipide bilagen. Membraanfusie wordt gereguleerd door een verzameling eiwitten, 
zodat er controle is over waar en wanneer er fusie plaatsvindt. In eukariotische cellen zijn 
het SNARE eiwitten die aan de basis staan van fusie. Echter, er is nog weinig bekend over 
het mechanisme waardoor fusie plaatsvindt op het moleculaire niveau. Onze groep heeft 
een modelsysteem voor membraanfusie ontwikkeld, dat geïnspireerd is door het natuurlijke 
SNARE eiwit complex. Dit modelsysteem bestaat uit twee complementaire, gelipideerde, 
coiled coil vormende peptiden die de gerichte fusie tussen liposomen mogelijk maken. In 
dit modelsysteem worden alle essentiële eigenschappen van SNARE-gedreven fusie 
nagebootst. Het tetramerische coiled coil complex wordt nagebootst door een 
complementair paar van coiled coil vormende peptiden, die elk bestaan uit 3 repeterende 
eenheden van 7 aminozuren (genaamd “coil-E” en “coil-K”). Aan de N-terminus van deze 
peptiden werd een flexibele poly(ethyleenglycol) keten gekoppeld, die ervoor zorgt dat de 
peptiden vrijelijk kunnen bewegen op het oppervlak van liposomen. Vervolgens werd er 
een lipide gekoppeld, zodat we zeker konden zijn dat het peptide zich zou verankeren in 
lipide membranen. 
Om toepassingen te kunnen ontwikkelen voor dit modelsysteem, moet het mechanisme 
waardoor fusie plaatsvindt in meer detail bestudeerd worden. Dit is dan ook het doel van 
dit proefschrift. Het eerste deel van dit proefschrift (hoofdstuk 2 en 3) bestudeert de 
zelfassemblage van de peptiden terwijl het tweede deel (hoofdstuk 4, 5 en 6) zich richt op 
fusie tussen liposomen, waarin het effect van variaties in de structuur van de peptiden op 
de mate van membraanfusie wordt beschreven. 
Hoofdstuk 2 beschrijft een nieuwe methode om de oligomere toestand en orientatie van 
coiled coil peptiden te bepalen. Peptiden K en E zijn ontworpen om parallelle, 
heterodimerische coiled coils te vormen (CC-K/E) en deze peptiden werden gelabeld met 
de aromatische aminozuren tryptofaan en tyrosine aan hun C-termini. Vervolgens werd één 
van de peptiden gelabeld met een paramagnetische groep, MTSL genaamd. Proton NMR 
metingen werden vervolgens gebruikt om te bepalen in welke mate het signaal van de 
aromatische protonen onderdrukt werd door het nitroxyl radicaal. Hiermee kon de 
quaternaire structuur van de peptiden bepaald worden en werden de parallelle oriëntatie en 
de heterodimerische zelfassemblage van peptiden E en K bevestigd. Bovendien 
onderdrukken de MTSL labels ook de fluorescentie van de aromatische aminozuren en 




peptiden met nitroxyl radicalen en aromatische, fluorescente groepen zeer waardevolle 
informatie kan geven over de quaternaire structuur van de peptiden. Deze handige methode 
kan bovendien toegepast worden op alle supramoleculaire systemen die een goed 
gedefinieerde structuur hebben. 
In hoofdstuk 3 werd de aminozuur sequentie van coil-E omgedraaid en de zelfassemblage 
met peptide K bestudeerd, gebruik makend van dezelfde methode als in hoofdstuk 2. Deze 
studies werden aangevuld met data uit computersimulaties en laten zien dat coil-Er en coil-
K assembleren in een anti-parallel, tetramerisch coiled-coil motief (CC-K/Er). Verassend 
genoeg bleek de stabiliteit van dit complex vergelijkbaar met de originele heterodimerische 
coiled coil CC-K/E. Vervolgens werd de mate waarin CC-K/Er membraanfusie kon 
veroorzaken bepaald en vergeleken met CC-K/E. Beide coiled coils laten vergelijkbare 
fusie efficiënties en snelheden zien, wat demonstreert dat in ons modelsysteem voor 
membraanfusie zowel de oriëntatie en oligomere toestand van de coiled coil geen cruciale 
rol spelen. 
In hoofdstuk 4 wordt de invloed van de concentratie van lipiden en gelipideerde peptide 
op de fusie van liposomen besproken. Het mengen van de lipiden van liposomen was 
optimaal wanneer 0.75 mol% gelipideerde peptiden werden gebruikt. Dynamische 
lichtverstrooiing (DLS) en microscopie studies laten zien dat het variëren van de lipide en 
peptide concentraties toegang geven tot twee fusie regimes: in het eerste regime resulteren 
meerdere fusies van liposomen tot de vorming van zeer grote liposomen, terwijl in het 
tweede regime fusie beperkt blijft tot gemiddeld twee liposomen die met elkaar fuseren. 
Door fusie experimenten uit te voeren onder verschillende condities was het mogelijk om 
de potentie van ons model systeem voor membraan fusie gedetailleerd in kaart te brengen. 
De resultaten maken de weg vrij voor toekomstige toepassingen zoals bijvoorbeeld 
nanoreactoren en drug delivery. 
In hoofdstuk 5 werd de mate waarin fusie plaatsvond gecontroleerd door de 
bindingsenergie van de coiled coils te variëren. In het oorspronkelijke modelsysteem 
bestonden zowel coil-E als coil-K uit drie repeterende eenheden van 7 aminozuren. In dit 
hoofdstuk werd de lengte van de peptiden gevarieerd tussen respectievelijk twee (coil-E2, 
coil-K2) en vier (coil-E4, coil-K4) repeterende eenheden. Eerst werden de 
bindingsenergieën bepaald van de peptiden en zoals verwacht bleek de stabiliteit van de 
langste peptiden het hoogst. De mate waarin deze peptiden fusie konden induceren werd 
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vervolgens bepaald door DLS metingen en door de menging van de lipiden en inhoud van 
de liposomen te kwantificeren. Het langste coiled coil paar (K4/E4) induceerde fusie op de 
meest efficiënte manier en bovendien bleek deze coiled coil resistent tegen hoge 
temperaturen en ongevoelig voor variaties in de pH. Dit onderzoek breidt de potentiele 
toepassingen van het modelsysteem verder uit. 
In hoofdstuk 6 werd de invloed van elektrostatische interacties op de mate van fusie 
onderzocht. Om ervoor te zorgen dat de bindingsenergie van afgeleiden van CC-K/E niet 
verschillend waren van de oorspronkelijke coiled coil, werden er coil-K peptiden 
gesynthetiseerd die een andere lading hadden op de ‘f’ positie. De mate waarin de nieuwe 
coil-K derivaten (coil-KS (geen lading op ‘f’) en coil-KK (positieve lading op ‘f’) in staat 
waren om, in combinatie met coil-E, fusie te induceren werd onderzocht. Opmerkelijk was 
dat de invloed van de lading op de ‘f’ positie zeer groot was, wat bleek uit experimenten 
waarin het mengen van lipiden en inhoud van de liposomen werd gemeten. Door de 
oorspronkelijke negatieve lading (coil-K) te vervangen door geen lading (coil-KS) en een 
positieve lading (coil-KK) werd de fusie significant versterkt. Mogelijk komt dit doordat er 
minder KK coiled coils zijn voordat fusie plaatsvindt. Er is echter meer onderzoek nodig 
om deze hypothese te bevestigen.  
Dit proefschrift richt zich op het ontwerpen van nieuwe coiled coil peptiden en het 
optimaliseren van coiled coil gedreven membraanfusie. Er is nog ruimte voor 
vervolgstudies, bijvoorbeeld in hoofdstuk 3, waarin de aminozuur sequentie van coil-E 
werd omgedraaid. Het zou bijvoorbeeld interessant kunnen zijn om de sequentie van coil-K 
om te draaien omdat recent onderzoek heeft laten zien dat coil-K interacteert met 
membranen. Deze interacties zorgen er wellicht voor dat de membranen verstoord worden 
waardoor de fusie zo efficiënt mogelijk verloopt. Door de sequentie van coil-K om te 
draaien zou deze hypothese bevestigd kunnen worden. Hoofdstukken 4, 5 en 6 laten zien 
dat het modelsysteem nog sneller en efficiënter fusie kan induceren, wat een belangrijke 
stap is voor het in-vivo gebruik van dit model systeem. Als dat gerealiseerd kan worden is 
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